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Zusammenfassung 
Aus der Rhizosphäre  isolierte Bacillus amyloliquefaciens  FZB42 is t ein Gram-positives 
sporenbildendes Bakterium . Als Biodünger bes itzt er einen beeindruckenden Ef fekt zur 
Verbesserung des Pflanzenwach stums sowohl im  Labor als au ch in Feldexperim enten. Die 
Mechanismen der Pflanzenwachstumsförderung, vor  allem auf molekularer Ebene, sind nach 
wie vor sehr schwer zu erfassen.  
Um diese zu verstehen, wu rde das kom plette Genom  von B. amyloliquefaciens  FZB42 in 
dieser Arbeit sequenziert. In der Zusammenarbeit mit dem Göttingen Genomik Laboratorium, 
wurden verschienden e Methoden wie Shotgun, Fosmid Biblioth ek, Multip lex-PCR usw . 
eingesetzt. Dies ist da s erste seq uenzierte Gram -positive Bakterium m it der Fähigkeit,  
Pflanzenwachstum zu fördern. Das 3916 kb gr oße Genom , codiert m it 3693 Proteinen, ist 
relativ klein, dies könnte auf die fehlende n Phagen zurückzuführen sein.  Die weit 
verbreiteten Phagen sind ein besonderes Merkmal  im Genom von B. subtilis 168, der in enger 
Verwandtschaft zum FZB42 steht. Anderer Seits enthält das Genom von B. amyloliquefaciens 
FZB42 viele DNA-Inseln, in denen unikale Ge ne in FZB42 als Clus ter gefunden wurden. 
Viele Gene, die möglicherweise zur Pflanzenwachstumsförderung beitragen, wurden in dieser 
Arbeit identifiziert. Dazu gehören Gene, die Signaltrans-duktionsweg, Interaktionen zwischen 
Bakterien und Pflanzen, Sekretionssystemen und Nährstofferwerb/Nutzung mit einbeziehen. 
 B. amyloliquefaciens  FZB42 ist natür lich ko mpetent. Für die genetische T ransformation 
wurde ein modifiziertes Ein-Schritt-P rotokoll benutzt, das ursprünglich für B. subtilis  168 
entwickelt wurde. Ein e Reihe  vo n Mutan ten wurde über die hom ologe Rekombination 
hergestellt. Das kom petente Stadium in FZB42 komm t früher als in B. subtilis  168, nä mlich 
während der späten exponentiellen W achstumsphase. Das FZB42-Genom enthält den 
kompletten Satz von Genen, die für die Entwic klung der genetischen Kom petenz nötig sind. 
Die Mehrzahl der Kompetenz-Gene von FZB42 ist sehr ähnlich zu denen in B. subtilis  168. 
Nur das Quorum -Sensing-System von FZB 42 (comQ, com X, comP) weist geringe  
Ähnlichkeit mit den jeweiligen Genen von B. subtilis 168 (36%, 31% bzw. 55%) auf. 
 Das FZB42 Genom bir gt ein enormes Potential zur Produktion von sekundären Metaboliten. 
Anhand der Deletionsmutanten  und der Inform ationen über die Genomsequenz,  konnten die 
drei pks Genecluster als Bacillaene, Dif ficidin und Makrolactin iden tifiziert und ihre 
Biosynthesewege aufgeklärt werden. Nach über 10 Jahren Genom sequenzierung von  B. 
subtilis 168 konnte zum  ersten Mal das pksX Gen-Cluster in B. sub tilis 168 B acillaene 
zugeordnet werden. Genetische Manipulationen wurden durchgeführt, um die Funktionen der 
trans-AT Dom änen und der Modifikationsdom änen in  den PKS-Gen-Clustern zu erklären. 
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Zusätzlich zu diesen drei PKS-Gen-Clustern wurden sechs riesig e Gen-Cluster id entifiziert, 
die für die Produktion von nicht-ribosom alen s ynthetisierten Peptiden zuständig sind,. Mit 
Ausnahme von vier Gen-Clustern in B. subtilis  168 (Surfactin, Fengycin, Bacillibactin und 
Bacilysin), sind Bacillomycin D und ein hypothetis ches Tripeptid einzigartig im  Genom der 
FZB42. FZB42 kann kein bekanntes ribosom al synthetisiertes Bacteriocin produzieren kann. 
Gleichzeitig beinha ltet s ein Genom  ein Gen-Cl uster, das wahrscheinlich für die Produktion 
eines neuartigen Bacteriocins verantwortlich ist. Insgesamt nutzt FZB42 mehr als 8,5% seiner 
gesamten Genom kapazität, um  antim ikrobielle Stoffe zu synthetisier en. Die eindrucksvolle 
genetische Kapazität zur Herstellung von antagonistischen sekundären Metaboliten 
ermöglicht es FZB42, nicht nur erfolgreic h neben konkurrierenden Or ganismen innerhalb 
seiner natürlichen Umgebung zu überleben, sondern auch Pflanzen gegen pathogene 
Bakterien und Pilze zu schützen. 
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Abstract 
Bacillus amyloliquefac iens strain F ZB42, a Gram -positive endospore form ing bacteria, was  
isolated from the rhizosphere. As a biofertiliz er, it has been already shown an i mpressed the 
effect in the laboratory as well as in field experiments to enhance plant growth.  However, the 
mechanisms of plant growth prom otion, especially at the molecular biological level, rem ain 
elusive. T o com prehensively understand thes e m echanisms, the complete genom e of B. 
amyloliquefaciens FZB42 was sequenced in this work by using variable tools like shotgun, 
fosmid library, multiplex PCR etc. in co-oper ation with Göttingen Geno mic Laboratory. This 
is th e f irst sequenced  r epresentative of  Gr am-positive ba cteria with b iocontrol an d plan t 
growth-promoting activity . The genom e of  3,916 kb containing 3,693 protein-coding 
sequences is re latively sm all; this could be  ex plained by the ab sence of  extende d phag e 
insertions which are typical for the closely related B. subtilis 168 genome but contains. On the 
other hand, several DNA  islands where unique genes in FZB42 were found clustered. Many 
candidate genes that may contribute to the pl ant growth prom otion were iden tified in this  
works. These include genes th at involved in signa l transduction pathways, plant-bacterial 
interactions, secretion systems and nutrient acquisition/utilisation. 
B. amyloliquefaciens FZB42 is naturally com petent and amenable for genetic tran sformation 
using a m odified one-step protoc ol, originally developed for B. subtilis  168. This property 
was used to generate a set of mutants im paired in m any distinct functions by a gene 
replacement strategy via hom ologous recombination. FZB42 exhibited its m aximal 
competence earlier th an B. subtilis,  during late exponential grow th. Not surprisingly , the 
FZB42 genom e harbors the com plete set of genes necessary for developm ent of genetic 
competence. The majority of competence genes is highly homologous to their counterparts in 
B. subtilis 168, but the genes that control the com petence quorum-sensing system of FZB42 
(comQ, comX, comP ) exhibit low sim ilarity to the respe ctive genes of  B. subtilis  168 (36%, 
31%, and 55% respectively). 
The FZB42 genom e harbors an enor mous potential to p roduce secondary metabolites, which 
was investigated in the second part of this wo rk. According to the info rmation of the genome  
sequence and the m utants with disruption in th ese three pks gene clusters, they could be 
identified as bacillaene, dif ficidin and macrolactin and their biosynthesis pathways could be 
elucidated. For the first tim e, bacillaene c ould be assigned as the product for pksX gene 
cluster in B. subtilis  168, after over 10 year s completely sequencing the genom e of BS168. 
Genetic m anipulation was carried out to in vestigate th e trans -AT dom ains and som e 
modification domains in the pks gene clusters. In addition to these three pks gene clusters, six 
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giant gene clusters directing synthesis of pe ptides were identified. Except for four gene 
clusters present in BS168, b acillomycin D and a hypo thetical tripeptide are unique in the 
genome of FZB42. A remarkable feature of the FZB42 genome is that it does not produce any 
known ribosomally synthesized bacteriocin, whereas  a gene cluster probably responsible for 
production of a new bacteriocin was identified in this work. In total, FZB42 utilizes more than 
8.5% of its whole genom ic capacity to synthe size antimicrobial substances. The impressive 
genetic capacity to produce antagonistic acting secondary metabolites not only enables FZB42 
to cope successfully with com peting or ganisms within its  natura l env ironment, but also  to 
protect plants from pathogenic bacteria and fungi. 
Schlagwörter:  
Bacillus amyloliquefaciens FZB42, Genome, Polyketide, Lipopeptide, Antibiotikum 
Keywords:  
Bacillus amyloliquefaciens FZB42, genome, polyketide, lipopeptide, antibiotic 
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A adenylation domain 
aa amino acid 
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MT/M methylase 
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NMR-MS nuclear magnetic resonance mass spectrometry 
NRPS nonribosomal peptide synthetase 
OD optical density 
ORF open reading frame 
PCP peptide carrier protein 
PCR polymerase chain reaction 
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1 Introduction 
Microbial genome sequencing and analysis is a rapidly expanding and increasingly important 
trend in microbiology. Before whole genome analysis became available, life science based on 
a reductionism principle, dissec ting cells and system s into thei r fundamental com ponents for 
further study. Recent studies on whole genomes and whole genome comparisons in particular 
give us a p ossibility to  rece ive m ore inf ormation leading  to be tter u nderstanding of  the 
general feature of the life.  
The explosion of the world population and the dem and of high quality of life require a higher 
productivity of agricultu re leading to the enhan ced use of chem ical fertilizers and p esticides.  
Nowadays alternative p ossibilities are exp lored to overcom e the problem s of environm ental 
pollution and nutritional deficiency caused by a rapidly growing world population. Utilization 
of environmental m icroorganisms, which can support plant growth and suppress growth of 
variable plant pathogens, seems to be one of th e most feasible approaches. Recently, different 
Bacilli, which show benefit for plant growth, were isolated worldwide from  nature. Bacillus 
amyloliquefaciens FZB42 (abbreviated as FZB42 in this work), isolated by ABITEP  Berlin 
(former FZB Berlin), belongs to this category . Bioform ulations containing spores m akes 
Bacilli m ore convenient for storage and transpor tation than Gram -negative bacteria like 
Pseudomonas.  Unfortunately , knowledge about the m echanisms of plant growth prom otion 
induced by  Gram -positive ba cteria is r ather scarc e co mpared to their Gram -negative 
counterparts.  
Genomic sequencing Bacillus amylolique faciens FZB42 allows us now to understand 
comprehensively th e mechanism s of plant growth promotion exer ted by Gram-positive 
rhizobacteria on the molecular level. 
1.1 The Genus of Bacillus 
Bacillus is a Gram -positive and r od-shaped bact erium with low GC-content,  which is 
ubiquitous and broadly adapted to grow in divers e environments, either terrestrial or aquatic. 
Bacillus can form highly resistant dorm ant endospores in response to nutrient deprivation or 
other environmental stress conditions [1].  Spor es can rem ain viable for extended periods of  
time. Under favourable conditions, the spore star ts to germ inate and co nverts to a vegetative 
cell again [2]. 
The genus Bacillus can be divided in at least five different groups based on 16S rRNA  
sequence analysis [3, 4]. Bacillus subtilis 168 (abbreviated as BS168 in this work), obtained 
from Bacillus subtilis Marburg strain after X-ray irradiation [5], is one of the best-understood 
prokaryotes in term s of molecular biology a nd cell biology [6]. It s whole genom e sequence 
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[7] and superb genetic a menability  provide the powerf ul tools requ ired to inve stigate a  
bacterium from  di fferent possib le aspects. The or ganism is a m odel for inv estigating 
differentiation, gene/protein regulation and ce ll cycle ev ents in Gram -positive bacteria.  
However, random mutations introduced in past in BS168 by X-ray irradiation led to silencing 
of numerous genes that are activ e in environmental strains. For this reason, it is nece ssary to 
investigate its closes t relatives for understanding the role of these genes and the relationship 
between Bacillus and its environm ent.  Extensive work has been already ca rried out in these 
areas, but one of the m ost dif ficult challen ges is that the majority of  the investig ated 
environmental strains are highly recalcitrant to transformation hindering applying of genetic 
approaches. 
A.           B.  
 
Figure 1. Gfp labelled Bacillus amyloliquefaciens FZB42 colonizes on a root of Lemna minor: 
A. The whole r oot (red) is cover ed by a shield of  B. am yloliquefaciens FZB42 (green). B. T wo 
colonies of B. amyloliquefaciens F ZB42 migra ted into the inter -cellular space in the leaves.  
(Kindly provided by Ben Fan, Bacterial Genetics, Humboldt University of Berlin) 
 
B. amyloliquefaciens, discovered first tim e by Fukumoto (1943), was named according to its  
capability to produce alpha am ylase. The debate  abou t its nom enclature had con tinued for 
some decades, after B. amyloliquefaciens  was separated from  the species B. subtilis  in 1988 
due to its dif ferent 16s ribosom al RNA  seque nce [4].  Bacillus amyloliquefaciens  FZB42  
(Figure 1 ), isolated from soil, dif fers from the model strain BS168, by its ability to enhance 
plant growth and to produce various secondary metabolites with antibio tic activity [8, 9].  
Until to th e last decade, m olecular and cell biological knowledge  about m echanisms 
underlying plant growth prom otion and biosynthesis of these secondary metabolites is poorly 
understood.  
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1.2 Plant growth-promoting rhizobacteria 
Plant growth-prom oting rhizobacteria (PGPR) were first defined by Kloepper and Schroth 
[10] to describe soil bacteria that colonize th e roots of plants and exert beneficial ef fects on 
plant grow th by acting as bio-fertilizers,  bio-pesticides, phyto- stimulators and bio-
remediators.  
In general, colonization of rhiz obacteria is the most essen tial and primary step in the process  
of plant growth prom otion. Rhizobacteria live on  plant roots or reside in the rhizosphere, a 
soil zone sp anning a few m illimeters around roots,  where they fed by root exudates. The 
following steps are im plicit in colo nization pro cess: (1 ) pr oliferating in the spermosphere  
(region su rrounding the seed), (2 ) attaching  the root surface, an d (3) colo nizing the 
developing root system in presence of seed/root exudates [11]. However, a variety of bacterial 
features like quorum  sensing, motility , chem otaxis, production of specific cell surface 
components and ability to use specific com ponents of root exudates, wh ich could contribute 
to this process, were analyzed and a few gene s have been id entified. Most of this work was  
focused on Gram-negative strains belonging to Pseudomonas spp. [12, 13]. 
PGPR can directly enhance plant growth by num erous m echanisms: (1) Fixation of 
atmospheric nitrogen that is tr ansferred to the plan t [14], (2) production of  siderophores that 
chelate iron  and m ake it availab le to the plan t root, (3) solubilization of m inerals such as 
phosphorus [15, 16], (4) Productio n of phytohorm ones by rhiz obacteria [15, 17, 18]. (5) 
Secretion of antibiotics into the rhizosphere can protect plants directly from  pathogenic 
microorganisms or competitively suppress them by colonization [9, 19, 20].  
Since Kloepper and Schroth [10] have intr oduced the concept of PGPR in 1978, the m ost 
investigated subjects for PGPR have been Gram-negative strains like Pseudomonas [13]. Also 
at pr esent, m any m echanisms of  PGPR in Gram-positive and spore  f orming bacteria,  lik e 
Bacillus, remain poorly understood. 
1.3 Secondary metabolites  
Secondary m etabolites are tho se chem ical com pounds in or ganisms that are no t directly  
involved in norm al growth, developm ent or reproduction of or ganisms. They are often 
species-specific or found in only a sm all set of species in a narrow phylogenetic group. Many 
important secondary m etabolites produced by PG PR are involved in plant growth prom otion 
[9, 13, 21- 24]. One  of the m ost interesting as pects in the m echanisms of plant growth 
promotion is bio-control. Many secondary m etabolites show activities against pathogenic 
microorganisms and parasites. Discovering new antibiotics and unraveling the mechanisms of 
antibiotic resistance are interesting research fields, not only because of their utilization in bio-
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control practices [24, 25] but al so in keeping down increase d opportunities for developm ent 
of infections and m ulti-resistance against known antibiotics in clinics [26, 27]. The potential 
of Bacilli to produce antibiotics is know n for more than 50 years. In average, 4-5% of the 
Bacillus subtilis genom e contributes to the production of antibiotics [28]. Anti biotics are 
divided into two groups depending on their biosyn thesis pathway: 1) ribosomally synthesized 
peptides that are norm ally m odified post-tran slationally, lik e bacterio cins; 2) nonribosom al 
synthesis via mega-enzyme complexes, like polyketides and lipopeptides.  
1.3.1 Ribosomally synthesized antibiotics: bacteriocins 
Bacteriocins are ribosomally synthesized peptide antibiotics. Both, Gram-negative and Gram-
positive bacteria can p roduce and export bacterio cins in to the env ironment in order to 
antagonize their competitors. Bacteriocins are d ivided into two classes d epending on whether 
they possess modified amino acids. Bacteriocins  with modified amino acids belong to class I 
and the ones without modification belong to class II [29-31]. 
1.3.1.1 Modified bacteriocins (class I) 
Bacteriocins with m odified amino acids are de signated lantibiotics because of the thioether 
amino acids lanthionine and m ethyllanthionine [32]. The pre-pept ide contains an N-term inal 
leader sequ ence, which  seem s to be required fo r m odification of the C-term inal structural  
region and is rem oved by proteolysis to produce the m ature lan tibiotic. Lantib iotics wer e 
divided into two subgroups based on their structure [33]: Type A are elongated, screw-shaped 
and amphiphic;  Type B are m ore globular in stru cture. Type A lantibiotics interact with the 
membrane of susceptible cells and form transient voltage-dependent pores [34], whereas some 
of type B lantibiotics inhibit functions of some enzymes.  
Lantibiotics were al ready found in m any Bacilli (Figure 2 ). As a ty pe A lantibiotic , subtilin  
(32 aa) was  first identified in  B. subtilis ATCC6633. Its structure is sim ilar to nisin [35, 36].  
Ericin A (32 aa) and eric in S (29 aa), identif ied from B. subtilis A1/3, belong to type A. The  
structural genes for ericin A/S are  similar to sub tilin, but ericin A shows a high er antibiotic 
activity than ericin S [ 37]. The gene clus ter for biosynthesis of sublan cin (type A lantibiotic 
with 37 aa) is in the region of prophage sp β2 [38]. Mersacidin inhibiting biosynthesis of 
peptidoglycan and transglycosylation [39-41] is a rep resentative of type B lantib iotics. Based 
on the structural analysis, s ubtilosin (35 aa) is the only kno wn circular lantibiotic in Bacilli 
[42]. The t hree post-transcriptional thioethe r linkages between Cys and Phe/Thr lead to 
classify subtilosin to the class of lantibiotics . However, oxidative linkage between the sulphur 
of the cysteine and the α-carbon of another am ino acid re sidue is a novel type of post-
transcriptional modification, allowing to classify subtilosin in an own group I [42]. 
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Type A lantibiotics
Type B lantibiotics
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Figure 2. Summary of lantibiotics produced by Bacilli (modified after T. Stein [28]). 
 
1.3.1.2 Unmodified bacteriocins (class II) 
Unmodified bacteriocins do not  contain m odified amino acids, are cationic and hydrophobic 
peptides with a length of 20 to 60 am ino acids. Class II bacteriocins are mainly active against 
low GC-content Gram -positive bacteria. The inhibition spe ctrum is rather  narrow, limited to  
species or strains related to its producer [43].  
Bacteriocins are div ided into  th ree subclass es, IIa, IIb  and  IIc,  ac cording to  the ir prim ary 
structures. Am ong the subclass IIa (antilisterial pediocin-like bacteriocins), m any of the m 
share high similarities in their primary structure. Particularly, they have a highly conserved N-
terminal part including the YGNGV  consensus mo tif [44 ]. Bacteriocins  of the subclass IIb 
(two-peptide bacteriocins) contain heterodimer peptides that show no significant similarity in 
their prim ary structu re. The single peptid e has norm ally no activity . The subclass IIc 
represents leaderless peptide-bacteriocins and the subclass IId circular bacteriocins [45].  
Class II bacteriocin has not been identified in any Bacillus strain so far. 
1.3.2 Non-ribosomally synthesized antibiotics: Lipopeptides and polyketides 
Non-ribosomally synthesized peptides and pol yketides show a broad range of structural 
diversity and bioactivity. They inclu de many important antibiotics [46-48], antitumor agents 
[49-52], immunosuppressive agents [53] and si derophores [54, 55]. In spite of their structural 
heterogeneity, polyke tides and non ribosomal p eptides r epresent two f amilies of  natura l 
products biosynthesized by si milar m ulti-modular enzym es acting in assem bly line arrays.  
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PK-NRP hybrids are compounds biosynthesize d by m ega-enzyme complexes that contain 
both PKS and NRPS modules.   
1.3.2.1 Nonribosomal lipopeptides 
1.3.2.1.1 Mega enzyme complex of NRPS 
The nonribosom al peptide antibiotics share a co mmon mode of synthesis, the m ulticarrier 
thiotemplate mechanism. The assembly of the multifunctional proteins of peptide synthetases 
involved in nonribosom al peptide biosynthesis is reflected by its genetic  organization 
following the co-linear ity ru le. This m echanism resem bles the am ino-acylation of tRNA  
synthetases during ribosom al peptide biosynthe sis. Each elongation cycle in non-ribosom al 
peptide b iosynthesis n eeds at leas t three core domains: adenylation do main (A), peptidy l 
carrier protein (PCP) dom ain (also known as thiolation (T ) dom ain) and condensation (C ) 
domain ( Figure 3 ). Adenylation dom ains select appropr iate a mino acid m onomers from the 
cellular pool, activate it with  A TP to am inoacyl-AMPs and transfer it to the phospho 
pantetheinyl group of PCP  domain. The adenylated am ino acid substrate is connected to the 
PCP domain in thioester bound. Condensation do mains (C) catalyze the for mation of a ne w 
peptide bond between the aminoacyl thioester attached to the PCP domain of the same module 
and that of the preced ing m odule. The C domai n can  be substituted  by a Cy do main that  
catalyses both condensation and the intra-m olecular hetero-cyclization of  serine, cysteine or 
threonine [56, 57] ( Figure 3). The initiation m odule of NRPS nor mally lacks a C dom ain and 
the last module usually contains an extra thioesterase (TE) domain (or an alternative domain, 
such as a reductase) to  release the fully assembled peptide f rom the PCP domain of the final 
module (Figure 3). The TE domain cleaves the covalently tethered peptide from the NRPS by 
catalyzing the nucleop hilic attack  of  water ( resulting in  a linear p eptide) or a n interna l 
nucleophile (resulting in a cyclic peptide).  
A T C
Cy
A T C A T TE
Elongation
module
Initiation
module
Termination
module
MT E
 
Figure 3. Module organization of NRPS: the initiation module contains normally only domain A 
and T. The number of elongation modules is dependent on the number of amino acids assembled 
in the lipopeptide. The TE domain exists at th e end of the termination module. The C domai n 
can be substituted by a Cy domain. The epi merisation domain (E) and the me thyltransferase 
domain (MT) are involved in the modification of amino acids. 
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Except these essential domains, some extra enzymes exist in some modules. An epimerization 
(E) domain, following a PCP  domain and located at  the C-term inus of a m odule, catalyses 
racemization or epimerization (L- to D-configured amino acids), either before or after peptide 
bond for mation [58, 59] ( Figure 3 ). Methylation of the nitrogen of the a mino group is 
achieved by a methyltransferase (MT) domain, which is inserted into the A domain (Figure 3). 
NRPS m odules can function as monom ers or dimers. Di meric structure is im portant for 
synthesis to proceed in trans as well as in cis [60, 61]. 
1.3.2.1.2 Features of nonribosomal lipopeptides and their representatives in Bacilli 
Cyclic lipopeptides such as surfactin, fengycin, and iturin-like antibiotics are widely produced 
by Bacillus subtilis and related strains (Figure 4). 
Surfactin is a cyclic hep tapeptide with an LLDLLDL chiral sequence lin ked to a β-hydroxy 
fatty acid with 13 to 15 carbon atom s via a lactone bond. Surfactins exist widely in Bacilli. 
The srfA operon is required for the nonribosom al biosynthesis surfactin. Itis composed of the 
four genes, srfAA (three m odules), srfAB (three m odules), srfAC (one m odule), and srfAD 
(Figure 4 ). Surf actin e xerts its an timicrobial and antiv iral ef fect by alte ring m embrane 
integrity [62].  
Fengycin and the closely rela ted plipastatin are cyclic lipodecapeptides con taining a β-
hydroxy fatty acid with a side chain length of 16 to 19 carbon atoms. Four D-amino acids and 
ornithine (a nonproteinogenic residue) have been  identified in the pep tide portion of fengycin 
(Figure 4 ). The operon fenABCDE is responsible for the biosynthesis of fengycin. FenA, 
FenB and FenC encode two m odules, FenD en codes three modules an d FenE encodes only 
one module (Figure 4). Fengycin is specifically active agai nst filamentous fungi and inhibits  
phospholipase A [63].  
The m embers of the itu rin fam ily are am phiphilic com pounds that are com posed of seven  
amino acid residues including an invariable D- Tyr2, with the constant chiral sequence  
LDDLLDL connected to a C14-C1 7 aliphatic beta-am ino acid ( Figure 4). The iturins, the 
mycosubtilin and the bacillom ycins belong to th is family. The gene or ganization of the iturin 
family is very similar: malonyl-CoA transacylase is the first gene in the gene cluster, followed 
by three genes containing 1, 4 a nd 2 m odules for the assembly of the growing peptide chain  
of a mino a cids respectively ( Figure 4) [8, 64-66]. They exhibit strong hem olytic and 
antifungal activities against a wide variety of fungi, but their antibact erial activities are 
restricted. The antifungal activity is related to the interaction of the lipopeptides with the 
cytoplasma membrane and change of its permeability [8].  
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Figure 4. Summary of sfp-dependent nonribosomally synthesized peptides in Bacilli. D-amino 
acids are underlined (modified after T. Stein [28]).  
 
Bacitracin is a cyclic dodecalpep tide antib iotic. It can be found in B. lichen iformis and B. 
subtilis [67]. BceA contains f ive modules, with an intern al epimerization domain attached to 
the fourth; BceB contains tw o modules and a carboxy-term inal epimerization domain; BceC 
contains five m odules with addi tional internal epim erization domains attached to the second 
and fourth. A  carboxy-term inal putative thioeste rase dom ain was also detected in BceC. A  
putative cyclization dom ain wa s found in BceA  that m ay be involved in thiazoline ring 
formation [68]. Bacitracin binds tightly to  undecaprenyl pyrophosphate (UPP) and prevents 
the dephosphorylation  of UPP  nece ssary for the recycling of the lipid carrier , thereby 
ultimately inhibiting cell wall polymer biosynthesis [69]. 
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Iron is a co factor of essential cellu lar pro cesses in nearly all m icroorganisms. Because the 
bioavailability of iron is extrem ely lim ited in most of the biospheres, a great number of 
bacteria including im portant pathogens produ ce ferric iron-chelati ng compounds known as  
siderophores to gain access to various iron sources. Three m ain siderophore groups can be 
classified: catecholate, hydroxamate and carboxylate siderophores. The catecholic siderophore 
bacillibactin is produced by dif ferent Bacillus strains such as B. subtilis , B. anthracis , 
B. cereus and B. thuringiensis. Gene cluster dhbACEBF encodes genes for the biosynthesis of 
bacillibactin.  Its precursor 2,3-dihy droxybenzoate (DHB) was synthesized by dhbAC and 
ligase with glycin and threonine to form a tri-peptide intermediate by utilizing the tri-modular 
NRPS system DhbEF (Figure 5). DhbB is responsible for circulating three tri-peptides to form 
the bacillibactin (Figure 5) [55]. 
 
Figure 5.  Model for  the assembly of bacillibactin: (amino) acids are activated and are bound 
as acyl-S-Ppant interme diates on the corr esponding carrier  pr oteins. Condensation r esults in  
formation of the DHB- Gly-Thr unit on the la st PCP  domain. The peptide chain is then 
transferred to a conser ved serin e residue of  t he ter minal Te domain. Te catalyzes th e 
condensation of thr ee DHBGly-Thr units and fi nally r eleases bacillibactin by intramolecular  
cyclization. ICL is isochorismate lyase [55]. 
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The detailed knowledge about the bi osynthesis of surfactin [70], fengycin [63] and iturins [8, 
66] allows bioengineering of novel lipopeptides. 
1.3.2.2 Polyketides 
1.3.2.2.1 Mega enzyme complex of PKS 
PKSs can be class ified into th ree types based on their pro tein architectures. Type I PKSs are  
multi-domain proteins that m odularly or itera tively prolong the polyketide chain by using an 
acyl carrier protein (ACP) [71], whi le type II PKSs  are comprised of a  set of iteratively used 
enzymes, each expressed from a distinct gene [7 2]. The aromatic polyketides are sy nthesized 
by eithe r th e ite rative type I or ty pe II. T ype III PKSs a re hom odimeric p roteins that are 
similar to th e large family of plant c halcone synthase-like proteins. Here the chain growth is 
not dependent on the phosphopantetheinyl group of  ACP [73]. 
methyltransferaseSACPR
O
KR
DH
ER
MT
ACPKS
TE
ATAT
TE
 
Figure 6. Roles of various domains in the biosynthesis of polyketides in comparison with fatty 
acid biosynthesis [76]. 
 
Similar to NRPS, modular type I PKSs follow an assembly-line mechanism. Every module is 
responsible for one round of condensation and reduction. The “mini module” consists of acyl  
transferase (AT) dom ain, acyl car rier protein (ACP) dom ain and β-acyl-ketosynthase (KS) 
domain.  The m ajority of the A T domains disp lay tigh t substrate selectivity. They c an load 
specifically substrates like malonyl-CoA, methlymalonyl-CoA, ethylmalonyl-CoA, and so on. 
These substrates direct biosynt hesis of polyketides in a stepwi se manner from si mple 2-, 3-, 
and 4-carbon building blocks [74, 75]. The A T dom ain tran sfers the substrate to the 
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phosphopantetheinyl group of ACP  and the KS domain catalyzes a d ecarboxylative Claisen 
condensation to connect the extender unit to  the growing polyketide chain. Finally , a 
thioesterase (TE) dom ain relea ses the polyketi de f rom the last ACP  domain and catalyses 
cyclization of the polyketide (Figure 6) [76]. 
Unlike s aturated f atty acid b iosynthesis, PKSs disp lay d ifferent lev el of  ke to thioes ter 
reduction by select ively utiliz ing β-keto-acyl reductase (KR) dom ain, hydroxyacyl 
dehydratase (DH) domain and enoyl reductase (ER) domain (Figure 6). KR domain carries out 
the first reduction to an alcohol. D H domain can further elim inate a water to form a doubl e 
bond. ER dom ain catalyses the final reduc tion to form  fully saturated single bond. 
Additionally, PKSs can perform a m ethylation on carbon and oxygen with S-adenosyl-
methionine (SAM)-dependent m ethyltransferases (MT). Carbon-specific m ethyltransferases 
couple the methyl group onto the activated α-carbon of the β-ketothioester intermediate, either 
during or after assembling the natural product (Figure 6) [77]. 
trans-AT PKSs are a s pecial architecture for ty pe I PKSs, where A T domains are not pres ent 
in every module. Iteratively operating discrete AT(s) load the extender units to A T-less type I 
PKS(s). Such trans-ATs have been already identified in lein amycin, pederin and chivosazol 
biosynthetic assemblies [78-80]. 
1.3.2.2.2 Features of polyketides and their representatives in Bacilli 
Polyketides exist widely in living ce lls, from bacteria to mammalians, but can exert dif ferent 
functions in living processe s. Many polyketides are well -known com pounds as antibiotics 
such as erythromycin A (a broad spectral antibiotic). In addition to the field of antim icrobials, 
further compounds have been approved as imm uno suppressants (rapamycin, ascomycin) [81, 
82], as anticancer compounds (bleomycin, dactinomycin) [83, 84] and as antihelm intic agents 
(milbemycin) [85].  
OO
OPO3H2
O
OH
O
CH3
HO
HO
Difficidin
Macrolactin
 
Figure 7.  the structures of difficidin and macrolactin 
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All these polyketides are produced by Streptomyces, a representative for polyketide producer . 
Meanwhile  there are only three known polyketi des (bacillaene [86], di fficidin [87, 88] and 
macrolactin [89, 90]) produced by Bacilli.  From these three polyketides, only the structures 
of difficidin [87] and macrolactin [90] have been determined (Figure 7). No information about 
their genetic or ganization of PKS a nd biosynthesis pathway was available. The gene cluster 
pksX in Bacillus subtilis  168 [7] has been thought to be responsible for the production of 
difficidin, however no polyketide could be detected in B. subtilis 168. The reason why BS168 
does not produce any polyketides is not explained yet, but one of the most possible hypothesis 
is that some important genes involved in the biosynthesis are dysfunctional because of X-ray 
irradiation [91, 92].  
1.3.2.3 4′-phosphopantetheinyl transferase (PPTase) 
 
Figure 8. Activity of PPTases to convert apo- ACP/PCP to holo-ACp/PCP by transferrin g the 
4-PPant moity of CoA on the conserved serine residue of apo-ACP/PCP [94] 
 
Nonribosomal peptide syntheta ses, polyketide synthases and fatty acid synthases require 
posttranslational modification of  their constituent peptidyl carrier prot ein (PCP) dom ains or  
acyl carrier protein (ACP) dom ains to b ecome catalytically active. The inactiv e apo-proteins 
are converted to active holo-proteins by phosphopantetheinyl (P pant) transferases that can 
transfer the 4 ′-phosphopantetheinyl moiety of coenzym e A to the side chain hydroxyl of a 
conserved serine residue in each apo-protein domain (Figure 8) [93] . The newly introduced -
SH of the Ppant prosthetic group acts as a nucle ophile for acyl-CoA or its derivates for fatty 
acids and polyketides, or aminoacyl-AMPs for peptide biosynthesis [94].  
The first Ppant transferase being  cloned and ch aracterized was AcpS fro m Escherichia coli , 
responsible for apo to holo conversion of fatty acid syntha se. Not AcpS, but EntD (another 
phosphopantetheinyl transferase in E. coli) can m odify the in active apo-PCPs in EntF to th e 
holo-PCPs, which ind icates that AcpS has substrate specificity . By searching in the database  
and by func tional analysis, W alsh´s group coul d identify som e new phospho pantetheinyl 
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transferases, which include Sfp ( Bacillus subtilis ), EntD ( E. coli) and G sp (Bacillus brevis) 
[95].  Surpr isingly, initial searches of seque nce databases did not re veal any protein with 
significant peptide sequence similarity with AcpS [95]. 
Phosphopantetheinyl transferases are grouped into  three families. The first group is the AcpS 
type of E. c oli. PPTases of this type com prise about 120 aa. They are found in almost all 
microorganisms and are involved in the m odification of fatty acid ACP. They were shown to 
activate ACP of PKS type II [96].  Sfp like PPTases, the second group, are 240 aa length and 
possess an extrem ely wide substrate specific ity, like PCPs of NRPS an d ACPs o f FAS and  
PKS [95]. The third group is form ed by integr ated PPT ases that ca n be found as the C-
terminal domain of the multifunctional FAS2 [97]. 
The choice  of one carrier protein over a nother as substrate by a certain  PPTase is probably 
determined by differences in charge and hydrophobic nature of the helices of PCPs and ACPs. 
Additionally, the overall charge of the whole carrier protein as well as steric reasons m ay also 
play a role in protein-protein recognition [98]. 
BS168 contains three gene clusters devoted to nonribosomal synthesis of  surfactin, fengycin, 
the siderophore bacillibactin a nd an unknown polyketide from the pksX gene cluster , but is 
deficient in their synthesis due to a  f rame shif t m utation o n the sfp gene [99]. Restoring a 
functional S fp in such strains led to the production of surfactin, however production of a 
polyketide by PksX was not detected [65]. 
1.3.2.4 4′-phosphopantetheinyl transferase independent nonribosomal synthesized 
antibiotics 
Bacilysin is one of the simplest antibiotics, which contains only two amino acids, namely a L-
alanine at the N-term inus and a non-protei nogenic am ino acid, L -anticapsin, at the C-
terminus[100]. This antibiotic is widely spread in dif ferent Bacilli, like B. subtilis, B. pumilus 
and B. amyloliquefaciens [101]. The  antibiotically active part of bacilysi n is anticapsin that 
can be released after importing susceptible cells by p eptidases and afterwards in hibits the 
activity of glucosam ine synthetase [102]. The gene cluster bacABCDE (formerly designated 
ywfABCDE) was found in B. subtilis  168, which is involved in the biosynthesis of bacilysin 
[101]. The mutation and over-expression of these genes showed that BacABC are responsible 
for the biosynthesis of L-anti capsin, BacD ligates L-alanin e with L-an ticapsin and  BacE 
seems to be involved in the self protection from bacilysin [101]. 
1.4 Aim of this work 
Although it is known that PGPR en hance plant growth by direct and indirect means (detailed 
in 1.2), specific m echanisms have not been well characterized, especially for Gram -positive 
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bacteria like Bacilli.  Sequencing of the whole genome of B. amyloliquefaciens FZB42 allows 
comparing the genom e of the plant growth prom otion strain FZB42 with the m odel s train 
BS168 to find out genes that could be invol ved in plant growth prom otion. Generating 
mutants altered in expression of the respective genes helps to unde rstand their precise role in 
the process of the plant growth prom otion, especially in the pr oduction of secondary 
metabolites. 
Two dozens of antibiotics produced by Bacilli have been already identified and characterized. 
To find out the capacity in producing secondary  m etabolites in FZB42, genes involved in 
secondary metabolism, especially in antibiotic s production, are analyzed by using the whole 
genome sequence of FZB42. Because the m ajority of th ese already id entified antibiotics are 
lipopeptides and bacteriocins and only little knowledge exists about the polyketide production 
in Bacilli, analysis of polyketide synt hesis is the major objective of this work. Gen e clusters 
involved in polyketide s ynthesis will be iden tified and their biosynthes is pathways will be 
illuminated by using the inf ormation f rom the genom e sequence of  FZB42 and genetic 
manipulations. The Ppant transferase Sfp is essential for lipopeptide production in Bacilli. 
This work evidenced for the first time the role of Sfp in biosynthesis of polyketides in Bacilli.  
We already know that Bacillus a myloliquefaciens FZB42 is naturally com petent, but the 
timing and duration of com petence in FZB42 are s till unclear [8, 16]. The FZB42 cells 
become competent under laboratory conditions  using a m inimal m edium ac cording to 
Rapoport´s method [103]. The Spizizen´s protoc ol was used to obtain com petent cells of B. 
subtilis 168 [104]. Therefore, it is difficult to com pare the com petence event of FZB42 t o 
BS168 in two dif ferent m edium s ystems. Fo r this reason, duration and tim ing of the 
competence was investigated in this wo rk with both FZB42 and BS168 according to  
Rapoport´s method [103]. The pos sible reasons for di fferent competence behaviors between 
FZB42 and BS168 were analyzed by comparing both genomes. 
Many of the results obtained in course of my PhD wor k have been already published. 
Therefore, these results are only sho rtly summarized here and the main space in th is thesis is  
given to the results still unpublished. The papers, in which I contributed, are cited with the tag 
“Lit”:  
Lit. 1  Chen XH , Koum outsi A, Scholz R, Borriss R.  Genom e analysis  of  Bacillu s 
amyloliquefaciens FZB42 reveals its potentia l for biocontrol of plant pathogens . accepted J 
Biotechnol. 2009. 
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Lit. 2  Chen XH , Scholz R, Borriss M, Junge H, Mögel G, Kunz S, Borriss R. Dif ficidin 
and bacilysin produced by plant-associated Bacillus amylolique faciens are ef ficient in  
controlling fire blight disease. accepted J. Biotechnol. 2009. 
Lit. 3  Moldenhauer J, Chen XH , Borriss R, Piel J. Biosynt hesis of the ant ibiotic 
bacillaene, the product of a giant polyketide synt hase complex of the trans-AT family. Angew 
Chem Int Ed Engl. 2007; 46(43):8195-7. 
Lit. 4  Schneider K*, Chen XH*, Vater J, Franke P, Nicholson G, Borriss R, Süssmuth RD. 
Macrolactin is the po lyketide biosynthesi s product of the pks2  cluster of Bacillu s 
amyloliquefaciens FZB42. J Nat Prod. 2007 Sep; 70(9):1417-23. Epub 2007 Sep 1 1. * These  
authors contributed equally. 
Lit. 5  Koumoutsi A, Chen XH, Vater J, Borriss R. DegU and YczE positively regulate the 
synthesis of bacillom ycin D by Bacillus am yloliquefaciens strain F ZB42. Appl  Environ 
Microbiol. 2007 Nov;73(21):6953-64. Epub 2007 Sep 7. 
Lit. 6  Chen XH , Koumoutsi A, Scholz R, Eisenreich A, Schneider K, Heine meyer I, 
Morgenstern B, Voss B, Hess WR, Reva O, Junge H, Voigt B, Jungblut PR, Vater J, Süssmuth 
R, Liesegang H, Strittmatter A, Gottschalk G, Borriss R. Comparative analysis of the complete 
genome sequence of the plant growth-prom oting bacterium  Bacillus  a myloliquefaciens 
FZB42. Nat Biotechnol. 2007 Sep; 25(9):1007-14. Epub 2007 Aug 19.) 
Lit. 7  Chen XH, Vater J, Piel J, Franke P, Scholz R, Schneider K, Koumoutsi A, Hitzeroth 
G, Gra mmel N, S trittmatter A W, Gottschalk G , Süss muth RD, Borriss R. S tructural and 
functional charac terization of  thr ee polyke tide synthas e gene c lusters in Bacillu s 
amyloliquefaciens FZB 42. J Bacteriol. 2006 Jun; 188(11):4024-36. 
Lit. 8  Koumoutsi A, Chen XH , Henne A, Liesegang H, Hitzer oth G, Franke P, Vater J, 
Borriss R. S tructural and functional characteriza tion of gene clusters directing nonribosom al 
synthesis of bioactive cyclic lipop eptides in  Bacillu s am yloliquefaciens strain FZB42. J 
Bacteriol. 2004 Feb;186(4):1084-96. 
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2 Materials and Methods 
2.1 Materials 
2.1.1 Chemicals 
Manufacturer  Products 
Bio-Rad Low-Melt agarose gel 
Fluka CaCl 2, EDTA 
Promega BCIP (50 mg/ml), NBT (50 mg/ml) 
Roth Agarose, acetonitrile, citric  ac id, CuSO 4,DEPC, FeCl 2, FeCl 3, 
Fe2(SO4)3,  for maldehyde, form ic aci d, L-glutam ic acid, glycerol, 
IPTG, KCl, K 2HPO4, H2KPO4, maleic acid,  m ethanol, MgSO 4, 
MnCl2, MnSO 4, Na-ac etate, Na-c itrate, Na 2CO3, NaCl, NaOH,  
(NH4)2SO4, peptone, Pipes, SDS, Prot einase K, T ris, T ween 20, 
XGal, yeast extract, ZnCl2  
Roche Anti-DIG AP, blocking reagent, DIG-dUTP 
Serva Agar, casamino acids, EGTA, glucose, N-lauroylsarcosine-sodium, 
MgCl2, MOPS, NaN3, Na2SO4, ONPG, L-tryptophan 
Sigma-Aldrich Chrome azurol S (C AS), hexadecyltrimethylammoniumbromid  
(HDTMA)  
2.1.2 Buffers, mediums and other supplements 
a. Generally used buffers: 
Buffer Compositio ns 
6x Loading 
buffer 
2 mM EDTA (pH8.0), 15% Glycerol, 0.1% Bromophenyl blue 
10x TAE buffer 400 mM Tris, 200  acetic acid, 1 mM EDTA-Na , pH 8 
10x TBE buffer 890 mM TRIS, 890 mM boric acid, 20 mM EDTA-Na, pH 8 
10x TE buffer 100mM Tris-Cl (pH = 7.4), 10mM EDTA,  pH 7.4 adjusted by acetic 
acid 
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b. Generally used mediums: 
Medium Compositio ns 
Landy medium 2% glucose, 0.5% Na-glutam ate (pH = 7.4), 0.05% MgSO 4,0.05% 
KCl, 0.1% KH 2PO4, 15µg% Fe 2(SO4)3.6H2O, 500µg%  
MnSO4.H2O, 16µg% CuSO4.5H2O 
LB medium 1% pepton, 0.5% yeast extract, 0.5% NaCl, adjust to pH 7 
Malt medium 3% malt 
Potato medium   4% potato puree (without milk), 2% glucose 
SOB medium 0.5% yeast extract, 2% tr ypton, 10 m M  NaCl, 2.5 m M KCl, 10 
mM MgCl2 0.5%, 10 mM MgSO4 
Wachsman 
medium 
0.5% peptone, 1% glucose, 0.3% yeast extract, 85 mM NaCl 
1.5% Agar was added to obtain solid mediums. 
c. Supplements used in mediums 
Supplement (manufacturer) Final concentrations 
Amplicillin, Roth 100 µg/ml 
Chloramphenicol, Roth 20 μg/ml (for E. coli), 5 μg/ml (for Bacilli) 
Erythromycin, Serva 1 μg/ml (for Bacilli) 
IPTG, Roche 1 mM 
Kanamycin, Roche 20 μg/ml (for E. coli), 5 μg/ml (for Bacilli) 
Lincomycin, Serva 25 μg/ml (for Bacilli) 
XGal, Roche 40 μg/ml 
2.1.3 Enzymes  
Vent Polymerase and β-Agarase I was supplied by Ne w England Biolabs. T aKaRa and 
Eppendorf, repectively, provided TaKaRa LA Taq and Triple Master Enzyme. Taq Polymerase 
was perchased from Bioron, and dNTPs were from Bioron or Fermentas.  
Fermentas or New England Biolabs supplied rest riction endonucleases. CIAP (Calf intestinal 
alkaline phosphatases), DNA  markers, dNTPs, Klenow Fragm ent, RevertAid M-MuL V 
reverse tran scriptase (2 00U/μl), restriction endonucleases, RiboLock ribonuclease inhibitor 
(40U/ μl), T4 DNA ligase, T4 Polynucleotide kinase were provided by Fermentas. 
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2.1.4 Equipments 
ABI PRISM model 3730XL  Applied Biosystems, Darmstadt, 
Germany 
ABI PRISM model 377-96 Applied Biosystems, Darmstadt, 
Germany 
Agagel Mini agaros e gel electrophorese 
chamber  
Biometra, Göttingen, Germany 
agarose gel electrophorese chamber Biorad, München, germany 
Agilent 1100 HPLC system  Agilent, Waldbronn, Germany 
Agilent 1200 HPLC system  Agilent, Waldbronn, Germany 
APEX II FTICR mass spectrometer 4.7 T Bruker-Daltonics, Bremen, Germany 
Applied Biosystems QTrap 2000  Applied Biosystems, Darmstadt, 
Germany 
Centrifuge MIKRO 200 Classic Sprinter Buckinghamshire, GB 
Centrifuge MIKRO 200R Cool Sprinter Buckinghamshire, GB 
Centrifuge Sorvall RC 5B; Rotor GS3 &  
SS34 
Du Pont/ Sorvall Instrum ents, 
Wilmington, US 
CHEF Mapper XA System Bio-Rad, Munich 
DRX 500 NMR spectrometer  Bruker, Karlsruhe, Germany 
Gene Genius UV imager  Syngene, Cambridge, UK 
Gene Quant II photometer  Pharmacia, Jena, Germany 
GeneAmp PCR system 2700 Applied Biosystems, Darmstadt, 
Germany 
Luna 3 μ C18 column (100 A, 50 × 1.0 mm ) 
for LC-ESI MS 
Phenomenex, Aschaffenburg, Germany 
Luna 5 μ C18 column (100 A, 100 × 4.6 mm) 
for preparative HPLC 
Phenomenex, Aschaffenburg, Germany 
MegaBace1000 sequencers GE Healthcare 
MegaBace4000 sequencers GE Healthcare 
Peltier Thermal Cycler PTC-200 Biozym, Hamburg, Germany 
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pH meter 761 Calimatic  Knick, Berlin, Germany 
rotary evaporator Heidolph VV2000 Heidolph, Schwabach, Germany 
Ultraspec 2000 UV/visible photometer  Pharmacia, Jena, Germany 
Vacuum blotter model 785 Bio-Rad, Munich 
ZORBAX Eclipse XDB-C18 (5 µ m, 4.6 x 
150 mm) 
Agilent, Waldbronn, Germany 
2.1.5 Kits and others 
Manufacturer Products 
Amersham Ready to Go DNA labelled Beads 
Epicentre MasterPure™ DNA  & RNA  Purification Kit, CopyControl™ 
fosmid library production kit and Lambda Packaging Extract 
Qiagen QIAEX II gel extraction kit,  QIAprep Spin m ini prep kit, 
Qiaquick PCR purification k it, R.E.A.L. Prep Kit and 
Polypropylene Column (5 ml) 
Macherey-Nagel Nucleo Spin ® Extract II, Nucleo Spin RNA  L, Nucleospin 
plasmid kit, and Porablot NY plus 
Merck HPTLC aluminium sheet with Sillica gel 60 F254 
Millipore  Micron YM-100 Column 
Sigma Am berlite XAD-16 
Invitrogen Nebulizer 
 
2.2 Strains, plasmids and oligonucleotides 
2.2.1 Strains 
a. Strains used generally in this work: 
Strain Genotype Reference 
Bacillus amyloliquefaciens FZB 
42 
Wild type ABiTEP GmBH, Berlin, 
Germany 
AK1 FZB42 bmyA::emR [8] 
AK2 FZB42 fenA::cmR [8] 
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Strain Genotype Reference 
AK3 FZB42 bmyA::emR 
fenA::cmR 
[8] 
AK15  FZB42 bmyA-His 6 -
Taq::cmR 
[105] 
AK36 FZB42 ΔsigW::cmR [106] 
TF1 FZB42 ΔdegU::emR Tzu-Fang Huang, unpublished 
Bacillus subtilis 168 trpC2 Laboratory stock 
Bacillus subtilis OKB105 JH642; pheA1, sfp [65] 
E. coli DH5α ΔlacU169 hsdR17 
relA1 
Laboratory stock 
E. coli Stbl2 JM109; ΔrecA1, ΔmcrA Invitrogen, Karlsruhe, Germany 
E. coli GM2163 K-12; Δdam,  Δdcm Fermentas, St.Leon-Rot, 
Germany 
 
b. Strains as indicators for antibiotics screening: 
Strain Genotype Reference 
Fusarium oxysporum Wild type Laboratory stock 
Saccharomyces cerevisiae Wild type Laboratory stock 
Bacillus megaterium Wild type Laboratory stock 
 
c. Strains constructed in this work: 
Strain Genotype 
CH1 FZB42 ∆srfAA::emR 
CH2 FZB42 fenA::cmR ∆srfA::emR 
CH3 FZB42 ∆sfp::emR 
CH4 FZB42 ∆yczE::emR 
CH5 FZB42 ∆sfpyczE::cmR 
CH6 FZB42 ∆bae::cmR 
Materials and Methods 
 
  21  
Strain Genotype 
CH7 FZB42 ∆mln::cmR 
CH8 FZB42 ∆dfn::emR 
CH9 FZB42 ∆dfnAT::emR 
CH10 FZB42 ∆dfnTE::cmR 
CH11 FZB42 ∆bae::cmR ∆dfn::emR 
CH12 FZB42 ∆mln::cmR ∆dfn::emR 
CH13 FZB42  ∆mln::neoR 
CH14 FZB42 ∆bae::cmR ∆mln::neoR 
CH15 FZB42 ∆ dfnK::cmR   
CH16 FZB42 ∆ dfnL::emR  
CH17 FZB42 ∆ dfnM::emR 
CH18 FZB42 ∆bmyA::emR ∆mln::neoR 
CH19 FZB42 ∆bmyA::emR ∆bae::cmR ∆mln::neoR 
CH20 FZB42 ∆bmyA-His 6 -Taq::neom
R 
CH21 FZB42 ∆bae::cmR ∆dfn::emR ∆bmyA-His 6 -Taq::neom
R 
CH22 FZB42 ∆mln::cmR ∆dfn::emR   ∆bmyD::cmR 
CH23 FZB42 ∆comA::emR 
CH24 FZB42 ∆bae1ATcmR:: 
CH25 FZB42 ∆bae2AT::emR 
CH26 FZB42 ∆bae3AT::emR 
CH27 FZB42 ∆mlnAT::emR 
CH28 FZB42 ∆pksA::emR 
CH29 FZB42 ∆ganA::emR 
CH30 FZB42 ∆sigV::emR 
CH31 FZB42 ∆ganA::cmR 
CH32 FZB42 ∆sigB::emR 
CH33 FZB42 ∆bae::neoR ∆dfn::emR 
CH34 FZB42 ∆mln::neomR ∆dfn::emR 
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Strain Genotype 
CH35 FZB42 ∆sigV::emR ∆sigW::cmR 
CH36 FZB42 ∆nrsC::cmR 
CH37 FZB42 ∆nrs::cmR 
CH38 FZB42 ∆dhb::emR 
CH39 FZB42 ∆dhb::emR 
CH40 lacI cmR, pSpac as promotor for the bmy gene cluster  
CH41 lacI cmR, pSpac as promotor for bmy gene cluster, ∆yczE::emR 
CH42 lacI cmR, pSpac as promotor for bmy gene cluster,  ∆degU::emR 
 
d. Strains for antibiotics screening 
Strain Refer ence 
Bacillus amyloliquefaciens BE 20-2 laboratory stock 
Bacillus subtilis subtilis INR 937 Joseph Kloepper, Auburn, AL, US 
Bacillus subtilis subtilis FZB 37 ABiTEP GmBH, Berlin, Germany 
Bacillus subtilis spizenii UCMB-5014 Oleg Reva, Ukranian Collection of 
Microorganisms, Kyiv, Ukraine 
Bacillus subtilis spizenii At3 Oleg Reva, Ukranian Collection of 
Microorganisms, Kyiv, Ukraine 
Bacillus amyloliquefaciens  UCMB-
5044 
Oleg Reva, Ukranian Collection of 
Microorganisms, Kyiv, Ukraine 
Bacillus amyloliquefaciens QST713 
(Serenade) 
Serenade, Agraquest Inc., Davis, CA, US 
Bacillus amyloliquefaciens FDK21 ABiTEP GmBH, Berlin, Germany 
Bacillus amyloliquefaciens B9601-Y2  He, Yueqiu, Yunnan agriculture university, China 
Bacillus amyloliquefaciens UCMB-
5113 
Oleg Reva, Ukranian Collection of 
Microorganisms, Kyiv, Ukraine 
Bacillus amyloliquefaciens INR-7 Joseph Kloepper, Auburn, AL, US 
Bacillus amyloliquefaciens FZB 24 ABiTEP GmBH, Berlin, Germany 
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Strain Refer ence 
Bacillus amyloliquefaciens FZB 113 ABiTEP GmBH, Berlin, Germany 
Bacillus amyloliquefaciens FZB 111 
(Kodiak) 
ABiTEP GmBH, Berlin, Germany 
Bacillus amyloliquefaciens FZB 109 
(A1/3) 
ABiTEP GmBH, Berlin, Germany 
Bacillus amyloliquefaciens GB 03 
(Kodiak) 
Kodiak, Gustafson Biologicals, Plano, TX, US 
Bacillus amyloliquefaciens DSM7  laboratory stock 
Bacilus licheniformis S175 (NCIMB 
7724) 
Fergus Priest, Edinburgh, Great Britain 
Bacilus licheniformis ATCC 9789 
(B27)  
Fergus Priest, Edinburgh, Great Britain 
Bacilus licheniformis S167 (9945A) Fergus Priest, Edinburgh, Great Britain 
Bacilus licheniformis S173 (Gibson 
1158) 
Fergus Priest, Edinburgh, Great Britain 
Bacilus licheniformis (B37) laboratory stock 
Bacillus amyloliquefaciens1 FZB 45 ABiTEP GmBH, Berlin, Germany 
Bacillus mojavensis UCMB-5075 Oleg Reva, Ukranian Collection of 
Microorganisms, Kyiv, Ukraine 
Bacillus mojavensis MB2 ABiTEP GmBH, Berlin, Germany 
Bacillus amyloliquefaciens GaoB2 Gao, Xuewen, Nanjing agriculture university, China 
Bacillus amyloliquefaciens GaoB3 Gao, Xuewen, Nanjing agriculture university, China 
Bacillus amyloliquefaciens Gao55 Gao, Xuewen, Nanjing agriculture university, China 
Bacillus amyloliquefaciens Gao85 Gao, Xuewen, Nanjing agriculture university, China 
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2.2.2 Plasmids 
a. Genernally used plasmids: 
plasmid description 
pDG148 [107] E. coli  and B. subtilis  shuttle vector , IPTG-inducible P spac promoter, 
ApR KmR 
pDG268 [108] pBR322 de rivarive with prom oterless lacZ, integrative vector for 
recombination into B. subtilis amyE, ApR CmR 
pMX39  [109] E. coli and B. subtilis shuttle vector base d on pBR322 and PDB101, 
ApR EmR 
ECE73 [110] CmR to NeomR exchange vector, ApR 
ECE149 [111] Protein fusion vector f or Bacillus, Gfp with IPTG-inducible P spac 
promoter, ApR EmR 
pGEM-T 
(Promega, 
Mannheim) 
Cloning vector, ApR  
pCR2.2 T OPO 
(Invitrogen, 
Karlsruhe) 
Cloning vector, ApR 
pTZ19R (GE 
Healthcare, 
Munich) 
Cloning vector, ApR 
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b. Plasmids constructed in this work: 
plasmid Description 
pGEM-TcmR 992 bp PCR fragment containing cmR was ligated in pGEM-T 
pUCemR 1791 bp fragm ent containing emR from  pMX39 cut by HindIII, inse rting in  
pUC18 at HindIII 
pUCcmR 1861 bp fragm ent containing cmR from  pDG268 cut by SphI and HindIII, 
inserting in pUC18 at SalI and HindIII 
pCH01a 2285 bp PCR fragment containing srfAA was ligated in pGEM-T  
PCH01 1798 bp containing emR from pUCemR cut by HindIII was inserted in pCH01a  
cut by HindIII 
pCH03a 2281 bp fragment containing sfp was ligated in pGEM-T   
pCH03 1152 bp containing emR f rom pUCemR was inserted in pCH03a cut by MunI  
and Kpn2I (101 bp  of sfp was deleted) 
pCH04a 2517 bp fragment containing yczE was ligated in pGEM-T   
pCH04 1152 bp containing emR from pUCemR was inserted in pCH04a cut by Sm aI 
and EcoRI (386 bp of yczE was deleted) 
pCH05a 2090 bp fragment containing sfp and yczE was ligated in pGEM-T   
pCH05 1333 bp containing cmR from pUCcmR was inserted in pCH05a cut by Hindlll 
and Aval (783 bp of sfp and yczE was deleted) 
pCH06a 3318 bp fragment containing KS2 of baeJ was ligated in pGEM-T   
pCH06 1333 bp containing cmR from pUCcmR was inserted in pC H06a cut by EcoRI  
and Hpal (1360 bp of baeJ was deleted) 
pCH07a 2984 bp fragment containing mlnBKS0 was ligated in pGEM-T   
pCH07 1333 bp containing cmR from pUCcmR was inserted  in pCH07a cut by EcoRl 
and Kpnl (1257 bp was deleted) 
pCH08a 2128 bp fragment containing KS1of dfnD was ligated in pGEM-T   
pCH08 1791 bp containing emR from pUCemR was inserted  in pCH08a cut by EcoRl 
and EcoR72l (376 bp of dfnD was deleted) 
pCH09a 2973 bp fragment containing dfnAT was ligated in pGEM-T   
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plasmid Description 
pCH09 1524 bp containing emR from pUCemR was inserted in pC H09a cut tw ice by 
Aval (781 bp of dfnAT was deleted) 
pCH10a 2565 bp fragment containing TE dom ain of the dfn gene cluster was ligated in 
pGEM-T   
pCH10 1345 bp containing cmR from pUCcmR was inserted  in pCH10a cut by EcoRl 
and BamHl (523 bp of TE domain was deleted) 
PCH15a 1498 bp fragment containing dfnK was ligated in pGEM-T   
pCH15 992 bp containing cmR from pUCcmR was inserted in pCH15a cut by Kpnl and 
Eco91l (771 bp of dfnK was deleted) 
pCH16a 2076 bp fragment containing dfnLM was ligated in pGEM-T   
pCH16 1126 bp PCR fragm ent containing emR was inserted in pC H16a cut by Hindlll 
and BamHl (28 bp of dfnL was deleted) 
pCH17 1220 bp containing emR from pUCemR was inserted  in pC H16a cut by Kpn2 
and Bpu1102l (197 bp of dfnM was deleted) 
pCH23a 2092 bp fragment containing comA was ligated in pGEM-T   
pCH23 1152 bp containing emR from pUCemR was ins erted in pCH23a cut by KspAI  
and Eco72I (104 bp was deleted) 
pCH24a 2741 bp fragment containing baeAT1 was ligated in pGEM-T   
pCH24 1333 bp containing cmR from pUCcmR was inserted in pC H24a cut by HindIII 
and HpaI (462 bp of baeAT1was deleted) 
pCH25a 2741 bp fragment containing baeAT2 was ligated in pGEM-T   
pCH25 1 152 bp containing emR from pUCemR was inserted in pCH25a cut by HindIII 
and Eco47III (928 bp of baeAT2 was deleted) 
pCH26a 1401 bp PCR fragm ent cut by NdeI a nd NaeI was inserted in pUCe mR cut by 
NdeI and EheI 
pCH26 1842 bp PCR fragment cut by SphI was inserted in pCH26a cut by HhpaI  and 
SphI (193 bp of the baeAT3 was deleted) 
pCH27a 2466 bp fragment containing mlnAT was ligated in pGEM-T   
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plasmid Description 
pCH27 1 152 bp containing emR from pUCemR was inserted in pCH27a cut by HindIII 
and EcoRI (472 bp of mlnAT was deleted) 
pCH28a 2532 bp fragment containing baeA was ligated in pGEM-T   
pCH28 1152 bp PCR fragm ent containing emR was inserted in pCH28a cut twice by 
BgllI (306 bp of baeA was deleted) 
pCH29a 1971 bp fragment containing ganA was ligated in pGEM-T   
pCH29 1152 bp containing emR from pUCemR was inserted in pCH29a cut by SnaBI 
pCH30a 1286 bp PCR fragment cut by EcoRI was inserted in pUCemR cut by HpaI und 
EcoRI 
pCH30 1892 bp PCR fragm ent of cut by PvuII und NdeII was inserted in pCH30a cut 
by NdeI and EheI (sigV was deleted) 
pCH31 992 bp containing cmR from pUCcmR was inserted in pCH29a cut by SnaBI 
pCH32a 3064 bp PCR fragm ent cut by NdeI a nd SmiI was inserted in pUCe mR cut by 
NdeI and EheI 
pCH32 3064 bp PCR fragment of cut by Ps tI was inserted in pUCe mR cut by PstI and 
SmaI (sigB was deleted) 
pCH37a 2742 bp fragment containing nrsC was ligated in pGEM-T   
pCH37 1232 bp containing cmR from pUCcmR was inserted in pC H37a cut tw ice by 
EcoR and HindIII (706 bp of nrsC was deleted) 
pCH38a 1360 bp PCR fragm ent cut by Bam HI was inserted in pUCcmR cut by Ba mHI 
and NaeI 
pCH38 2167 bp PCR fragm ent cut by Hind III was inserted in pCH38a  cut by  HindIII 
and EheI (deletion of whole nrs gene cluster) 
pCH39a 1993 bp PCR fragm ent cut by EheI a nd NdeI was inserted in pUCe mR cut by 
EheI and NdeI  
pCH39 13045 bp PCR fragment of cut by HpaI and PstI was inserted in pCH39a cut by 
PstI and PvuII (deletion of whole dhb gene cluster) 
pCH41a 1296 bp containing LacI of ECE149/BamHI and SmiI was inserted in pUCcmR 
cut by Eco47III and BamHI 
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plasmid Description 
pCH41b 1322 bp PCR fragm ent was inserted in pCH41 between E co72I and HindIII 
cutting site 
pCH41c 1536 bp PCR fragm ent cut by SacI a nd BamhI was inserted in pCH41b cut by 
SacI and BamHI, exchange Pbmy with Pspac 
 
2.2.3 Oligonucleotides 
Over 900 prim ers were designed during Bacillus amyloliquefaciens  FZB42 sequencing 
project. 16 prim ers were designed for long ra nge PCR, and 38 prim ers were designed for 
multiplex PCR (see lists below). Oligonucleotides were provided from Sigma Aldrich, Operon 
or Eurogentec. 
a. Oligonucleotides used  in genomic project for long range PCR  
Primer Sequence 5´-> 3´ Contig name 
babg57x1993 AATGTTAATGCGACTTCGCCCGCTTTCGTCTCC gbacg30f  
back95x1995 TGCCTCTGCTCTCAGGCTTCCTTATCAACAACCAC abald13r   
babg57x1993 AATGTTAATGCGACTTCGCCCGCTTTCGTCTCC gbacg30f  
baey96x1996 AGCGTCAATCCGACATTCCCCTTATACATCGCAGC abald13r   
bajh39x1994 GATGTCCGTCTTTTACCATACGTTCAACCGTGTCCG gbacg30f  
back95x1995 TGCCTCTGCTCTCAGGCTTCCTTATCAACAACCAC abald13r   
bajh39x1994 GATGTCCGTCTTTTACCATACGTTCAACCGTGTCCG gbacg30f  
baey96x1996 AGCGTCAATCCGACATTCCCCTTATACATCGCAGC abald13r   
badu60x1840  TGCTCCGTCAGACTTTCGTCCATTG on 16S rRNA   
baqi14x1876 AACAACAGAGCTTTACGATCCG on 16S rRNA  
baqi14x1873  TATCTAATCCTGTTCGCTCCCC on 16S rRNA 
baqi14x1855  AGAGTGCCCAACTGAATGCTGGCAAC on 16S rRNA  
badu60x1840  TGCTCCGTCAGACTTTCGTCCATTG on 16S rRNA  
baqi14x1876 AACAACAGAGCTTTACGATCCG on 16S rRNA  
baqi14x1873  TATCTAATCCTGTTCGCTCCCC on 16S rRNA 
baqi14x1855  AGAGTGCCCAACTGAATGCTGGCAAC on 16S rRNA  
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b. Oligonucleotides used for multiplex PCR 
Primer Sequence 5´-> 3´ Contig name 
badh62x1859 GTACTGGGTTTGAAGGCACTCG abald13r 
bafk72x1953 TCAGCGGCAAGGACATTCCTTATGACAGAC aba1876pcr0960  
bajo94x2059  TTTGGCTTTGCCACATCCCTAC aba1954pcr0872  
bagf09x1810 ACACTGGATGAGCTGACATACG ababy33x1809w2  
baby33x1966 ATCATCGGCAATGTGCTTGGTG ababy33x1809w2  
baeb27x2085 AACGAGATCGGCGAAAACAGC abaeb27f   
baeb27x2084 TGGACGAACGCCAGAAGATCAC abaeb27f   
baaw06x2082 AACCATTAACCTGTGCCAGCCC gbaaw06f  
baaw06x2083 ATCGCCATTACACCGCAGATTC gbaaw06f  
baaw25x2074 TAATAACGCTGCACCCACTGCC gbaaw25f  
baaw25x2075 TGCTGGCGACCAAAATCACCAC gbaaw25f  
baji93x1860 ACATCGCACGCTTCAGCTTCAC gbafh19f  
badv31x2036 TTCGTTCAGCCTTTGCCGTCAC gbafh19f  
bafy85x2073 TCCCTCAGCGGTTAGCAAGAAG gbafy85f  
bafy85x2072 TTTACCCGTAACGACTGACCCC gbafy85f  
banc82x2062  ACTCATGGGGTGTTCGTACATC gbagm27r  
bajg64x2061  TGAATGAAGAGAAGGTGTCCCG gbagm27r  
baid72x2066  AACTTCGACCTCCATACAAGCC gbaid72f  
baid72x2067  ACGTGGTCACCCTTCTTTACGC gbaid72f  
babt35x0767 ACCTATTGGACGTTAAAGGAC gbakj78r  
babp88x2063  TCGGTTATGACGGCACTGAAAC gbakj78r  
bakk20x2078 TCCACTTTTGTGCTTCGTGCCC gbakk20f  
bakk20x2079 TGTTCTGAGGAGTCCCTGATGG gbakk20f  
baks42x2068  AGAGTAGGGCTTCGGGTGTTTG gbaks42f  
baks42x2069  TGTTGAACGTGTCGTTACCGTG gbaks42f  
bakt57x2064  TTCAACTGCTTGCCCGTAATGG gbakt57f  
bakt80x2065  TTTCGGAACTTGAGGATGTCGC gbakt57f  
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Primer Sequence 5´-> 3´ Contig name 
baah04x1961 AGAGGTGGATACATAATGCCGAC gbakv75r  
balm29x2071  TTGTGCCGACCTGGTACGAATC gbalm29f   
balm29x2070  TATACCGACGAAGCCGCATTGG gbalm29f   
bacj30x2077 AAACTGCTGCGGAATAACGCTC gbanf96f  
banf23x2076 TTTCATCGGAATCTGCGGCATC gbanf96f  
bagh57x2060  AGGACGATGTTGGAAGTAGAG gbanz86f  
banz86x1967 TCAATGACTTCAAGCGGCTGGC gbanz86f  
bapr63x2080 ATTCACACTGGCACGGACAAGG gbapr63f  
bapr63x2081 TATACCTTTGCTTCCACGGCAG gbapr63f  
baqs37x1988 TGCAAACAGCCTAGATAAAGATATATGGTG gbaqs37f  
 
 
c. Oligonucleotides designed for secondary metabolites  
Primer Sequence 5´Æ 3´ Applications 
srfAAkn3-1 AGCCGTCCTGTCTGACGACG pCH01a 
srfAAkn3-2 GACTATGCGGTATGGCAGCAGA pCH01a 
sfp-n1 ATCTGATGGTGGAGCAGCTTG pCH03a 
sfp-n2 TTGTAGGAGCGGGAGAAGAAGC pCH03a 
yczE-n1 ACTCAACGTGTCCAACGTCAAG pCH04a 
yczE-n2 AAGGATACATCTCTCGCGTCAC pCH04a 
sfp1 TCAACGTGTCCAACGTCAAG pCH05a 
ycz2 TTGGCGGTTATGCTACAATG pCH05a 
pks1Up AAAGGAGCGGAGTGCAACATC pCH06a 
pks1Dw TGAGATGATGCCGTCCTCTTC pCH06a 
pks2Up AGCTCATTGACAGCGATGCTGC pCH07a 
pks2Dw ATGATCGCCGCTTCCTCATCAG pCH07a 
pks3Up ACATTGACCGCATCCTCAATCTG pCH08a 
pks3Dw TCAGCTGCTGTTCGGAATGTG pCH08a 
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Primer Sequence 5´Æ 3´ Applications 
pks3AT-1 TGTGATTTTGCTTCATGGACGC pCH09a 
pks3AT-2 TTTCGCATAACCGTGCTTCTCC pCH09a 
pks3TE-1 TTGCAGAGGGTATGATCTTCC pCH10a 
pks3TE-2 TGCATGAAGTATCCGATCATC pCH10a 
pks3Enoyl-1 TCTCAGTCTCAAGGAGTTCCC PCH15a 
pks3Enoyl-2 TTCTGGAAACAATCGGAGAAG PCH15a 
pks3cyp-1 ACCGTTGAGTCAATCGTCATGC pCH16a 
pks3cyp-2 TATCCGTTCCGATGATGAGCG pCH16a 
comA-1 TCTGATGGGATCGCTGATCTG pCH23a 
comA-2 TCTGCATGATTCAGTGCTGCAG pCH23a 
pks1AT1-1 ACAGAAGGGTGCGGTATATGTGGG pCH24a 
pks1AT1-2 TGAGGGCATTGACGACATAGAGC pCH24a 
pks1AT2-1 AGCAGGCTGATGAAACACTCGG pCH25a 
pks1AT2-2 TCTGTTATCGGCTCCGCTTCAG pCH25a 
pks1AT3-1 TCGTCTGTCTGATCCATTTGACCG pCH26a 
pks1AT3-2 TCCTTCGCTTCCAGCATGTATCTG pCH26a 
pks1AT3-3 ATGGCAGCGGTGATCGGCCTG pCH26b 
pks1AT3-4 TCAGAAGCGAGGCCGTCTCTTCC pCH26b 
pks2AT-1 TCTGAGCAATGCAAATCAGCG pCH27a 
pks2AT-2 TGTGTGTTTCCATCATTTCATCCC pCH27a 
pksR-1 AGCTGAGAATGCACATCACGGC pCH28a 
pksR-2 AAGCGTTCCTGACCCGCTCC pCH28a 
araB-1 AGACGAAACCGTCAGCATCATC pCH29a 
araB-2 TCCCTGAAATCCGTGAGGAGC pCH29a 
sigVL-1 AGCTAAAGCGCAGCCGAGAAG pCH30 
sigVL-2 AAGAAATCGCAGACATCACGGG pCH30 
sigVR-1 TCCTTGCGCTCAGTTATGCAC pCH30a 
sigVR-2 AATGAAAGCGGCAAGATGGCAC pCH30a 
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Primer Sequence 5´Æ 3´ Applications 
sigB-1 AGAACGCAGCGACATTCAGCG pCH33a, pCH33 
sigB-2 TCTCGTCATCTGCGGCTGACTTG pCH33a, pCH33 
nrs-1 TTTGCTAGTTTCTCAATGGTAC CH37a 
nrs-2 AGCAGATGGAGCTAGTATCCAG CH37a 
nrsWR-1 TCTGTCGGTGTGCTTACATTGC CH38a 
nrsWRbamHI-2 ACTCGACCTAGGATCCAGCATCTTAGGTAAGGCG CH38a 
nrswL-1 TTCATCAGCTCATTGGCGTAAG pCH38 
nrswL-2 TGAGGCTACAGTTGCTGTTAGTG pCH38 
dhbR-1 AATCATGTACCGGCTTACAGC CH39a 
dhbR-2 TATCAAAGCCTTTCCTGAAGCC CH39a 
dhbL-1 AGGACAGAAAGCAAGTATGGG CH39 
dhbL-2 AAATGCTGTGTGAGCTGTTCG CH39 
bmyDR-1-HindIII AAAGTAAAGCTTCTATTGAGCGGTATACCCG pCH41a 
bmyDR-2 AGGCAAAGTGACGATTGCAGAGG pCH41a 
pspac-1-BamHI TTTGAGGATCCCCTTGCCTACCTAGC pCH41b/SOE PCR 
pspac-2 TCCTCCGATCAATAGCGCTGGTACCCTC pCH41b/SOE PCR 
bmyDL-1 ACCAGCGCTATTGATCGGAGGAATCTCATG pCH41b/SOE PCR 
bmyDL-2-sacI TTATCCCGAGCTCAGAGATATTGCTTC pCH41b/SOE PCR 
pks2AT-3 TGTGGTGCTCATCCAGTCCGATC check pCH25 and 
CH25 
pks3-1up ACTCTTGGCGTGACGTCTCTC check CH08 , CH11, 
CH12 and pCH08 
pks3-1dw TGAGGAAACCTTCTTCGTGTG check CH08, CH11, 
CH12 and pCH08  
pks2-1dw AATCATGGAGAAACAGACATG check pCH07 and 
CH07, CH12, 
dhbL-M TGGCCTTCAGCATTGACGAG check pCH39, CH39 
and CH40 
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Primer Sequence 5´Æ 3´ Applications 
dhbR-M AGGAGGCCGTACGTATCGTATC check pCH39a, pCH39, 
CH39 and CH40 
bmyDR-M ACACTCAGCTTGTCCGCAATC check pCH41b, 
pCH41c, pCH41, 
CH41, CH42, CH42 
baeC-ATc-1 TCCGTATTCCAACCTTCACAAG Examining the 
conserved AT domain 
in baeC 
baeC-ATc-2 AGATAGCGGATGCTGTCGTTCC Examining the 
conserved AT domain 
in baeC 
baeD-ATc-1 TCGTCTGTCTGATCCATTTGAC Examining the 
conserved AT domain 
in baeD 
baeD-ATc-2 TATATCGGTCTCAGCCTCTCC Examining the 
conserved AT domain 
in baeD 
baeE-ATc-1 AGGCTCGCAAAGAATAGGGATG Examining the 
conserved AT domain 
in baeE 
baeE-ATc-2 TGCCGTCACATTTGAAATGACC Examining the 
conserved AT domain 
in baeE 
pks2AT-c1/mln-c1 ATGCTGTTGCAGGACATAGTC Examining the 
conserved AT domain 
in mlnA 
pks2AT-c2/mln-c2 TAGTCAGAATGTTTCCAGGACC Examining the 
conserved AT domain 
in mlnA 
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Primer Sequence 5´Æ 3´ Applications 
difA-ATc-1 AGATCGACATGCCTGTTTCTCC Examining the 
conserved AT domain 
in dfnA 
difA-ATc-2 AATGCCTGCCATGATCAGACTC Examining the 
conserved AT domain 
in dfnA 
nrs-1f TGCTCTTCCTTGACACTCAATC examining the repeats 
in nrs gene cluster 
nrs-1r AGAAAGAGACAGAACATCACATC examining the repeats 
in nrs gene cluster 
   
nrs-2f TGGTATGCTAACATATAATCTC examining the repeats 
in nrs gene cluster 
nrs-2r TCAAGATGTGTTATATGCGTAC examining the repeats 
in nrs gene cluster 
nrs-PCP2 TCTCTCTCTAAACCCAGGTTGC examining the repeats 
in nrs gene cluster 
nrs-CD2 AGTGTTGTCGAAGTGGAGTAACC examining the repeats 
in nrs gene cluster 
nrs-PCP1 TTCCATTCGGAAGAATGACCG examining the repeats 
in nrs gene cluster 
nrs-CD1 TTCCTTCAACACCAGCTCTGC examining the repeats 
in nrs gene cluster 
nrs-PCP2 CTCTCTAAACCCAGGTTGC examining the repeats 
in nrs gene cluster 
nrs-CD2 AGTGTTGTCGAAGTGGAGTAACC examining the repeats 
in nrs gene cluster 
nrs-PCP1 TTCCATTCGGAAGAATGACCG examining the repeats 
in nrs  
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Primer Sequence 5´Æ 3´ Applications 
nrs-CD1 TTCCTTCAACACCAGCTCTGC examining the repeats 
in nrs gene cluster 
nrsCwhole-1 TTCTGGGTATCCTGCATCCAATAATGCATG examining the repeats 
in nrs gene cluster by 
long range PCR 
nrsCwhole-2 AGCTGTGATAGAGCGTCAACACATGCTACG examining the repeats 
in nrs gene cluster by 
long range PCR 
nsrSN-1 AATGCTGGTCCATTCAGCCTTG Southern blot 
nsrSN-2 TCGAGACAATCGCCAGTATCC Southern blot 
cmRup AATAACCTAACTCTCCGTCG check plasmids and 
mutant containing cmR 
emRdw TGGGTCAATCGAGAATATCGTC check plasmids and 
mutant containing emR 
kmRup AGAGAGCCATAAACACCAATAGCC check plasmids and 
mutant containing 
NeoR 
cmBstEII-3 ATGTTTGACAGGTAACCATCGGCAATAGTTACCC pGEMTcmR 
cmKpnl-3 ACCGACGGTACCAAGTACAGTCGGCATTATCTC pGEMTcmR 
emBamHI ATCATGAGTAGGATCCGAGAGTGATTGGTC pCH16 
emHindIII TTAATTGGTAAAGCTTAGAGGTGCCCTATACC pCH16 
emRbglII-1 TTAGAAGAGATCTTAAGAGTGTGTTGATAGTGC pCH28 
emRbglII-2 TAATTGAGATCTATTAGAGGTGCCCTATACC pCH28 
The restriction enzyme recognition site within each primer is underlined. 
 
2.3 Methods 
2.3.1 Cell biological methods 
2.3.1.1 Preparation of calcium chloride competent E. coli and transformation 
The calcium  chloride m ethod was used in this work for preparation of com petent E. coli  
according to Sambrook [112]. 
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100 m l LB containing fresh E. coli  cells  was shaken at 3 7°C and 210 rpm , until O.D. 600 
reached 0.3 to 0.5. The culture was chilled on ice for 10 min, and was washed with 25 ml cold 
MgCl2 (0.1 M). Cell pellets were resuspended in 5 ml cold CaCl2 (0.1 M), and kept on ice for 
20 min. After centrifugation under 2500 xg at 4°C for 10 min, the pellet was resuspended in a 
mixture with 4.3 m l CaCl 2 (0.1M) and 0.7 m l glycerol (87 %).  The aliquots (200µl) were 
stored at - 80°C. 
For transformation, an aliquot was thawed on ice for 10 min.  10- to 30-ng plasmid was added 
in the com petent cells. The cells were kep t on ice for 45 m in, and then a heat shock wa s 
performed at 42°C for 30 sec. After adding 800µl LB or SOB (for E. coli Stbl2), the culture 
was shaken under 210 rpm at 37°C or 30°C (for E. coli Stbl2) for 1 hour and spread on plates 
with appropriate antibiotics and other selective compounds. 
2.3.1.2 Preparation of competent Bacillus subtilis and transformation 
According to the m ethod developed by Spizizen [ 104],  fresh cells (not older than 3 days)  
were grown overnight in 10 m l KM1 buffer at 32°C and 150 rpm, and then 1:10 diluted in 50 
ml KM1 buffer. Cells were grown at 37°C and 175 rpm. The cell density was observed every 
30 min at wavelength 600 nm. The culture was diluted 1:10 in 100 m l KM2 buffer during the 
transient ph ase. Incub ation at 37° C and 75 rpm  for further 75 min was necessary . 
Subsequently, the cells were harvested by 10-minute centrifugation at 5000 rpm  and room 
temperature, and the pellet was resuspended in  2-ml supernatant containing 10% glycerol. 0.5 
ml aliquots of the competent cell were stored at - 80°C. 
For transformation, an aliquot  was thawed by short inc ubation at 37°C. 0.5 ng to 1 μg of the 
desired DNA (chromosomal or linearized/cir cular plasmid DNA) was added, and cells were 
incubated at 37°C for 30 m inutes at 50 rpm . Subsequently, 0.5 ml of LB m edium, containing 
sub-lethal c oncentration (1/10 of  the norm ally used concentr ation) of  the appropria te 
antibiotic was added to the ce lls and they were further grown at 37°C and 200 rpm  for 75 
minutes. The culture was spread on agar plates with the appropriate antibiotics. 
Buffer Compositio ns 
KM1 1X SMM, 1 m M MgSO 4, 0.5% glucose, 0.04% casam ino acid, 
0.005% tryptophan 
KM2 1X SMM, 1 m M MgSO 4, 0.3% glucose, 0.005% casam ino acid, 
0.005% tryptophan, 0.001 CaCl2 
SMM (10x) 150 mM (NH4)2SO4, 800 m M K2HPO4, 450 mM KH 2PO4, 34 mM  
Na3citrate 
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2.3.1.3 Preparation of competent Bacillus amyloliquefaciens FZB42 and transformation 
Competent cell preparation for B. amyloliquefaciens FZB42 was modified base on previously 
described [103]. Fresh c ells were grown overni ght in LB m edium at 28°C and 180 rpm . The 
cells were 1:10 diluted in 10 m l GCHE m edium and grown at 200 rpm  and 37°C. When the 
O.D.600 value was near to 1.2, an equal volum e of GC medium was added to the culture and 
grown for another 1 hour at 37°C under 210 rpm. Af ter that, the culture was divided into 2 ml 
tubes, centrifuged at 6000 rpm  and room  te mperature for 5 m in. 100 µl  of the supernatant 
were added into the competent cell pellet and resuspended gently. 1 to 2 µg linearized plasmid 
DNA were added into the tube and m ixed gently for 1 to 2 m in. After adding 1 m l at 37°C 
pre-warmed transformation buffer, the culture was shaken from  time to time under 75 rpm  at 
37°C for 20 min. Before shaking at 37°C and 210 rpm for 90 min, 0.5 ml at 37°C pre-warmed 
LB medium with a sub-lethal concentration of antibiotics (1/10 of the antibiotic concentration 
used for Bacillus) was added. Finally the culture was spread on  LB agar plates with 
appropriate antibiotics. 
Buffer Compositio ns 
GCHE 1x PC, 2%  glucose, 0.0 5% tryptophan,  40 mM FeCl 3/Na3citrat, 3  
mM MgSO4,  0.1% casein hydrolysat, 0.25% sodium glutamate 
GC 1x PC, 2%  glucose, 0.0 5% tryptophan,  40 mM FeCl 3/Na3citrat, 3  
mM MgSO4 
Transformation 
buffer 
1x SMM, 0.5% glucose,  1 mM EGTA, 20 mM MgCl2 
PC (10x) 800 mM K2HPO4, 450 mM KH2PO4, 28 mM Na3citrate 
SMM (10x) 150 m M (NH 4)2SO4, 800 m M K 2HPO4, 450 mM KH 2PO4, 34 mM  
Na3citrate 
2.3.1.4 Agar diffusion test 
For antif ungal tes ts, B. amyloliquefaciens FZB42 and its derivatives were grown in Landy 
medium at 37°C and 210 rpm for 24 hours. The de nsity of the cultures was adjusted to 0.4 at 
O.D.600. 2 μl of these cultures were spotted on Waksman agar together with regularly arranged 
growing fungi. The plates were incubated at 27°C. 
For the  antibacterial tes ts, the indicator strains were grown at 37°C un der vigorous shaking 
until the ir O.D. 600 reached 0.6. 300 μl of  the cultu re was m ixed with 3 m l of LB-agar and 
poured on dishes.  B. amyloliquefaciens FZB42 and its derivatives  were grown in Landy 
medium for 36 hours at 30°C and 210 rpm .  20 to 30 µl of their supern atants were added in 
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the holes o n the p lates with i ndicator s trains. The plates were  incubated at the appropriate 
temperature. 
2.3.1.5 Feeding experiment 
Mutant strain CH1 1 (Δbae, Δdfn) was used to p roduce macrolactin in o rder to elim inate the 
background of the other polyketides, like bacillaene and difficidin. The pre-culture was grown 
in LB broth at 28°C and 180 rpm ove rnight, and was then 1:100 diluted in Landy medium. To 
obtain a high uptake of 1-13C sodium acetate, the Landy medium was modified by using a low 
concentration of glucose (0.25% ). The m ain culture was shaken at 180 rpm  and 28°C. 10 
mg/ml 1- 13C sodium  a cetate was added every hour from the 7th to the 12th hour . The 
supernatant was harvested after further 12-hou r cultivation. The investigated com pound was 
purified by XAD16 and isolated by preparative HPLC. Its structure was determined by NMR-
spectrometry [113]. 
2.3.2 Molecular biological methods 
DNA digestion with restriction endonucleases, 5'-phosphorylation of oligonucleotide or filling 
recessed 5' -termini of double- stranded DNA with T4 polynucleotide kinase, filling  recessed  
3'-termini of double-stranded DNA  by Klenow  Fragm ent, dephosphorylation of DNA  with 
CIAP (Calf intestinal alkali ne phosphatases) and ligation of DNA  with T4 lig ase wer e 
performed according to the instructions supplied by the manufacturer (Fermentas). Ligation of 
PCR products to pGE M-T vector was carried  out following the in structions of the  
manufacturer (Promega).  
Unless otherwise specified, polymerase chain reaction (PCR) was done using the GeneAmp 
PCR system 2700 acco rding to [114], under the a ppropriate conditions in each case.  Plasmid 
DNA isolation was perform ed with the QIAprep Spin m ini prep kit (Qiagen), N ucleospin 
plasmid kit (Macherey-Nagel) or according to  the alkaline m ethod [1 12].  Purification of  
DNA and recovery of DNA  from agarose ge ls were perform ed with the QIAEX II gel 
extraction kit (Qiagen) or Nucleospin Extract II (Macherey-Nagel). 
Agarose gel electrophoresis, fluorescent visual ization of DNA  with ethidium  brom ide, 
spectrophotometric quantitation of DNA or RNA were perform ed as de scribed by S ambrook 
[112]. 
2.3.2.1 Chromosomal DNA isolation from Bacillus amyloliquefaciens FZB42  
10 ml LB medium  inoculated with a fresh colony was shaken at 37°C and 210 rpm  until its  
O.D.600 rea ched 1. The cell pe llet was washed with suspension buf fer. Cell walls were 
destroyed by incubation with 0.7 m l lysis buffer at 37°C for 45 m in. 25 µl L-lauroylsarcosine 
(30%) and 4 µl proteina se K (20mg/ml) were added into th e suspension and incubated for 20 
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min at 70°C in order to degrade cell m embranes and proteins. T o preci pitate proteins and 
extract pure DNA from the su spension, 700-µl phenol was adde d. After centrifugation for 5 
min under 13000 rpm , the aqueous upper layer co ntaining chrom osomal DNA was treated 
with chloroform/ isoamylalcohol (24:1). The aqueous layer was incubated with 5 µl RNAse at 
37°C for 15 m in, then DNA  precipitation was performed with 2.5 to  3 volum es of 96% 
ethanol. The chromosomal DNA was washed with 70% ethanol, and dissolved in 100 µl 1xTE 
Puffer at room temperature over night.  
Buffer Compositions 
suspension buffer 10 mM Tris pH 8.0, 150 mM NaCl, 10 mM EDTA 
lyses buffer 20 mM Tris pH 8.0, 50 mM NaCl, 10 mM EDTA, 4 mg/ml lysozym 
Proteinase K 20 mg/ml in 1xTE buffer 
RNase A 100 mg/ml in 1xTE buffer 
2.3.2.2 Total RNA isolation 
A pre-culture containing 10 ml LB and a fresh colony was shaken at 37°C and 200 rpm for 12 
h. It was diluted 1:100 in Landy m edium with  0.25% glucose and shaken at 37°C and 200 
rpm until its O.D600 reached 0.6. 10 m l of culture was m ixed with 5 m l of Killing buffer, and 
centrifuged and 12000 rpm  at 4°C fo r 10 min. After the pellets were  washed again with 1 m l 
of Killing buf fer, they  were read y f or total RNA  preparation with  NucleoSpin  RNA L  
according to the pro tocol of Mach erey-Nagel. In order to concentrate the RNA, one-ten th 
volume of 1M NaAc (pH 4.5) and 2.5 to 3 volum es of cold 96% ethanol were used for 
precipitation. The pellets were finally dissolved in 50 µl H 2O containing 0.01% DEPC. A  
1.5% agarose denatured gel was used to run RNA samples. 
Buffer Compositions 
Killing Buffer 20 mM Tris/HCl (pH = 7.5), 5 mM MgCl2, 20mM NaN3 
Loading buffer (2x) 356.25 µl deionized fo rmamide, 106.25 µl form aldehyde, 9375 µl  
MEN (10X), 20 µg Ethidium bromide 
MEN (10x) 200 mM MOPS, 50 mM NaAc, 10 mM EDTA, adjust to pH 7.0 with 
HAc/NaOH 
1.5% agarose 
denatured gel  
0.75 g agarose to be melt in 37.5 m l H 2O , 5 m l MEN a nd 8 m l 
formaldehyde  
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2.3.2.3 Southern blot 
Southern blotting is a m ethod to detect the presence of DNA  by using an agarose gel and 
hybridization with a labeled probe . In com parison to PCR, this method is not necessary to 
know the investigated sequence.  
a) Preparing labeled probes 
Two methods were used to label probes. On e was PCR based. Instead of  0.2 mM dTTP, only 
0.18 mM dTTP and 0.01 m M digoxigenin-11-dUTP (DIG-dUTP) (Roche, Mannheim) were 
used. The other way was Klenow fragm ent 3´-labeling using Ready-To-Go labeling Bead (-
dCTP) according to the instruction s of the manufacturer (GE Health care, Freibu rg). The 
labelled p robes were ready for use,  after they were pur ified by a QIA EX II ex traction kit 
(Qiagen) or a Nucleospin Extract II (Macherey-Nagel). 
b) Sample preparation and blotting 
 1-4 µg investigated plasm id or chromosom al DNA was digested overni ght with appropriate 
restriction endonucleases. The DNA was separated on a 0.8% agarose gel in 1x TAE buffer at 
60V. First th e gel was  washed twice in dena turalization buffer for 20 m in, then two tim es in 
neutralization buffer for 20 m in, finally in 2x SSC buf fer for 2 m in. DNA was blotted on a  
Nylon or N ylon+ m embrane (Macherey-Nagel) under 5 mmHg for 1 hour (Biorad vacuum  
blotter model 785). DNA was cross-linked on the membrane under UV for 3 min. 
c) Hybridization and detection 
The m embrane was pre-hybridized in 40 m l hybridization buf fer for 1 hour at room 
temperature. For the hybridization, the labeled probe was denatured at 95°C for 3 t o 5 m in 
before adding 10 ml of fresh hybridization buffer. The hybridization was performed overnight 
at a suitable annealing temperature (in this works it was at 55°C).  
Before detection, the membrane was washed twice in 2x SSC/0.1% SDS at room  temperature 
for 5 m in, twice in 0.5x SSC/0.1% SDS at 55° C for 15 m in, once in P1-Dig solution for 1 
min, and finally in 100 m l blocking solution at room temperature for 30 m in. To detect the 
labeled probe, the m embrane was incubated in  25 ml antibody solution with 3.75 units Anti-
Digoxigenin-AP (Roche, Mannheim) for 30 min.  The unbound antibodies were subsequently 
removed after a 15-m in washing step. The m embrane was neutralized by a 15- min washing 
step with AP  buf fer, then incubated in 10 ml AP  buf fer contai ning 2.25 m g nitroblue 
tetrazolium salt (NBT) and 1.75 mg 5-bromo- 4-chloro-3-indolyl ph osphate (BCIP). The 
hybridized DNA with the labeled probe could be visualized on the membrane by incubating in 
the dark for a while. 
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Buffer Compositions 
Denaturalization buffer 1.5 M NaCl, 0.5 M NaOH 
Neutralization buffer 1.5 M NaCl, 1 M Tris-HCl (pH = 8) 
Hybridization buffer 5x SSC, 0.1% (v/v) N-lauroylsarcosine sodium, 0.02% SDS, 
1% blocking reagent  
SSC (20x) 3 M NaCl, 0.3 M Na-citrate 
P1-DIG buffer 100 mM maleic acid, 150 mM NaCl, 1% blocking reagent 
Wash buffer 150 mM NaCl, 100 mM maleic acid, 0.3% (v/v) Tween-20 
AP buffer 100 mM NaCl, 100 mM Tris-HCl (pH = 9.5), 50 mM MgCl2 
2.3.2.4 Reverse transcription PCR 
Reverse transcription PCR (RT-PCR) is the preferred technique utilized to detect and quanitfy 
mRNA. The RevertAid™ M-MuL V Reverse T ranscriptase (Fermentas, S t. Leon-tot, 
Germany) and the RiboLock™ RNase Inhibitor (Fermentas, St. Leon-tot, Germany) was used 
in this work. The RT-PCR mixture contained 1 to 3 μg of total RNA, 1x reaction buffer, 1 μM 
primer, 1mM dNTPs, 2 units/µl R Nase inhibitor and 10  u nits/µl reverse transcrip tase. The 
total RNA and the pr imer was f irstly incubated at 70°C for 5 m in, then the reaction buf fer, 
RNase inhibitor and dNTPs were added. This mixture was incubated at 37°C for 5 min before 
adding reverse transcrip tase. Th e reverse transcription started with ann ealing at 42 °C f or 1 
min, followed by elongation at 70°C for 10 m in. To visualize the R T-PCR product in 0.8% 
agarose gel, an extra standard PCR step using 5-µl cDNA was performed. As negative control, 
a mixture with 1-µg total RNA was run in parallel.  
2.3.3 Genomic methods 
2.3.3.1 Shotgun library 
The shotgun library was constructed in Göttingen Genomics Laboratory (G2L) in G öttingen. 
Total genomic DNA was sheared ran domly with Nebulizer (Invitrogen), and DNA  fragments 
1 to 3 kb in size were cloned into pTZ19R or pCR2.2 TOPO to establisha shotgun library. The 
inserts of the recom binant plasmids were se quenced from both ends using the MegaBACE 
DNA Seque ncing System s 1000 and 4000 (A mersham-Biosciences) and ABI Prism  377 
sequencers (Applied Biosystems) with dye terminator chemistry.  
2.3.3.2 Long range PCR 
Long range PCR polymerases  can amplify fragm ents longer than  that usually attainable by 
Taq DNA polymerase. Mixtures of two polym erases (one with proofre ading activity and one 
without) allow long fra gment PCR to be carri ed out (over 20kb). The length of the prim ers 
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was between 30 to 36 bp, and their m elting temperature was at 60°C  ± 1.5°C. All prim ers 
were purified by HPLC.  PCR m ixtures were consisted with 3 ng/µl chrom osomal DNA, 0. 5 
mM dNTPs, 1x PCR buf fer containing 2.5 m M MgCl 2 and 0.125 units/µl T aKaRa LA Taq 
(Shiga, Japan). Denaturation wa s perform ed at 94°C for 3 m in. In total 30 cycles were 
performed. The first 10  cycles were done with  20 s of m elting at 94°C, 30 s of ann ealing at 
60°C and 20 m in of elongation at 68°C. The last  20 cycles were carried out with 20 s of 
melting at 94°C, 30 s of annealing at 60°C and elongation at 68°C for 20 min with an increase 
of 20 s/cycle. After the last cycle, the PCR mixture was incubated for f urther 10 minutes at 
68°C to complete the extension of both strands. 
2.3.3.3 Multiplex PCR 
Multiplex PCR [115] is an essential cost-s aving technique for closing a large number of gaps 
in a whole-genome shotgun sequencing project [116, 117]. The method uses a primer-pooling 
strategy to minimize the number of laborator y procedures required to sequence the unknown 
DNA that falls in between contiguous seque nces. There are physical lim its to how m any 
primers can be used in a single te st tube. It was tested that up to 30 prim ers could be used in 
one single tube [117]. 
The prim er design is th e f irst cr itical s tep in the m ultiplex PCR. Prim ers with a  m elting 
temperature at 55°C ± 1.5°C we re designed for all ends of the contigs from  FZB42 genome  
database. Every prim er pool contained ra ndomly 9 pri mers. T wo pools were random ly 
combined for every PCR. T riple Master En zyme (Eppendorf, Ham burg, Germany) was used 
for PCR mixtures that were as follows: 1x tuning buffer with Mg2+, 0.5 mM dNTPs, 1µM per 
primer, 6 ng/µl chromosomal DNA. Cycling conditions were 96°C for 3 m in, 30 cycles of 15 
s of melting at 96°C, 30 s of annealing at 55°C,  5 min of elongation at 6 8° for the fir st cycle, 
the elongation time was  increased for 10 s per cycle until it reached 9 min. 
2.3.3.4 Construction of a fosmid library 
a) Chromosomal DNA preparation 
The LB culture of B. amyloliquifaciens was sh aken at 210  until O.D. 600 was approxim ately 
0.8 for chromosomal DNA isolation. MasterPure™ DNA & RNA Purification Kit (Epicentre, 
Madison, US) was used according the instructions of the manufacturer. DNA pellet was eluted 
in 35 µl at 50° C pre-warm ed H2O by incubation at 37°C for  30 min or at room  temperature 
overnight. 
b) Shearing and End-Repair of the insert DNA 
In order to get DNA  fragm ents with approxim ately 40 kb that are su itable for creating the 
fosmid library, the genom ic DNA was shear ed by up and down pipeting for 150-200 tim es 
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with a 100-µl tip. A  0.8% agarose gel was us ed to exam ine the size of the sheared DNA  
fragments. End-repair of DN A fragm ents could be done accord ing the proto col from  the 
CopyControl™ fosm id library production kit (Epicentre, Madison, US), if suf ficient 
fragments with the desired length were there (o ver 10%).  Af ter this treatment, the fragments 
were ready for blunt-end ligation. 
c) Fragment size selection and recovery from the gel slices 
To isolate DNA fragments with approximately 40 KB for the ligation, the filled up DNA was 
separated by a pulse field gel electrophoresis . 1% Low-m elt agarose gel (Bio-Rad, Munich) 
was solved in 0.5 x TBE, which was used also as running buf fer.  The e lectrophoresis of the 
DNA fragments took p lace in “T wo S tate m ode” of CHEF Mapper X A System  (Bio-Rad, 
Munich) with the following param eter: gradient voltage 6 V/cm ; included angle 120°; switch 
time from  1 to 10 s with linear increasing; temperature at 14°C. The r unning tim e varied 
between 22 and 24 h. 
The DNA  fragm ents between 38 KB and 42 KB were excised from the pulse f ield gel. 
Recovery of the DNA  fragm ents was done using β-Agarase I (N ew England  Biolabs, 
Frankfurt a.M.).  For the optim al digestion of β-agarase I, the gel slices  were incubated twice 
in two volum es of 1x β-Agarase I reaction buf fer for 30 min on ice. The gel slices were 
melted at 65° C for 10 min, subsequently at 42° C for 5 min. 6 μl β-Agarase I was added, after 
one hour another 3 μl was added. The total incubatio n tim e was 90 m in. Micron YM-100 
column (Millipore GmbH, Schwalbach) was u sed to completely remove the agarose residues 
and to concentrate D NA.  The  colum n was washed firstly with 500 µl H 2O under 
centrifugation at 500 xg for 10 min. The digested agarose sample was centrifuged at 16060 xg 
for 4 min, before loading on the colum n. The column loading with a sa mple was centrifuged 
under 500 xg, until the sam ple was concentrated in approximately 20-50 µl. The column was  
washed with 500 µl TE buf fer (pH 8) and then w ith 500 µl H2O. The wash process was done 
by centrifugation under 500 xg and the final wate r volume was approxim ately 20 µl in the  
column. The DNA  fragm ents were gathered b y putting the top side of  the colu mn into a  
cleaning tube and centrifugation at 1000 xg for 3 min. To avoid the loss of DNA, the column 
was eluted with another 5-µl H 2O. The entir e e luate was c ompletely used for the f ollowing 
ligation. 
d) Ligation, Packaging, transfection of fosmids 
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Since the concentration of the available DNA  for ligation was far under guidelines of the 
Epicentre kit, two different attempts were pipetted. The amount of vector pCC1FOS was used 
in one approach according to the protocol and in the other one was 1:1 diluted: 
10 x Fast-Link Ligations buffer 1 μl 2 μl 
10 mM ATP 1 μl 2 μl 
pCC1FOS Vector (0,5 μg/μl) 1 μl 1 μl 
Concentrated  Insert-DNA 6 μl 14 μl 
Fast-Link DNA-Ligase  1 μl 1 μl 
Bidest. H2O  - - 
Total volume 10 μl 20 μl 
The ligation  was accomplished over night at ro om tem perature. 1 µl fresh Fast-Lin k DNA 
Ligase was added to the ligation m ixture on th e next m orning and ligation was extended for 
45-60 min at room tem perature. To inactivate the ligase, the m ixture was kept at 70°C for  10 
min. 
The ligated  DNA  fragm ents were packed in the phage u sing Lam bda Packaging  Extract 
(Epicentre, Madison, US), and th en infected in the EPI300-T1 R E. coli (Epicentre, Madison, 
US). Lam da packagin g and tran sfection in  E. coli  were performed according to the 
instructions of Epicentre.  
e) Induction of a high copy fosmid number and fosimid preparation  
Induction of the CopyControl fosm ids to a high copy num ber was perform ed using the 
standard m ethod of Epicentre. R.E.A.L. Prep  Kit (Qiagen; Hilden) w as used for fos mid 
preparation f ollowing the protoco l of  the m anufacturer. Quality and  concentr ation of  the 
fosmid were determined by running 0.8%  agarose gel and digestion with EcoRI, sequentially 
the fos mid was directly sequenced with pCC1 forward and reverse prim er provided by 
Epicentre. 
2.3.4 Biochemical and chemical methods 
Unless otherwise specified, the investigated strains were grown in Landy medium [118] for 36 
hours at 30°C and 180 rp m. The supernatants we re purified by XAD16 for the analysis with 
bioautography, HPLC and LC-ESI MS. For MALDI-TOF MS, the lyophilized supernatants or 
colonies were examined. 
2.3.4.1 Clean-up the cell culture supernatants 
XAD16 is a nonionic macroreticular resi n for hydrophobic com pounds up to 40,000 MW . 
XAD16 adsorbs and releases ionic species through hydrophobic and polar interactions; 
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usually used under isocratic c onditions. XAD16 resin was washed  with deionized water to 
remove salts before 10 m l of supernatant was added on the m atrix with a 5 beds/m in speed. 
After washing the XAD 16 m atrix colum n with  400 m l deionized water , polyketides and 
lipopeptides could be eluted with 100% methanol. For the qualitative analysis, 6g of XAD 16  
resins and 12 m l 100% m ethanol were use d. In order to analyze the am ount of the 
lipopeptides and the polyketides qua ntitatively, 12 g resins a nd 300 m l 100% m ethanol were 
used. The methanol samples were dried by using a rotary evaporator. To avoid the degradation 
of the antibiotics, all the sample were purified at room temperature and neutral pH value. The 
dried sam ples were dissolved in 1 m l 100% methanol. These mixtures were ready for the 
applications in HPTLC , HPLC  and LC-ESI MS. The used XAD16  was regenerated by  
washing with 400 ml methanol (100%), 400 ml acetone (100%) and 400 ml NaOH (1M). 
2.3.4.2 High performance thin layer chromatography (HPTLC) 
The thin layer chrom atography is  a separation process, by wh ich substances are isolated 
according to their d ifferent m obility in an organic so lvent m ixture. The m obility of a 
substance is dependent on the physical and chem ical character istics of the substance, for 
instance its size and polarity . The migration of one substance in a certain m obile phase has 
always the same RF value which is the ra tio of the migration distance (a) of the substance to 
the simultaneous migration distance (b) of the mobile phase (RF = a/b).  
Samples were concentrated by XAD16. Depending on the sensitivity of the indicator strain, 5-
20 µl sam ple was dropped as point for m on a thin layer Silica gel plate (HPTLC alum inium 
sheet with Silica gel 60 F254, Merck KGaA, Darmstadt, Germany). After plates were run with 
chloroform/methanol/deionized water (65: 25: 4 v/ v/v) in a sealed chamber , the samples had  
to be dried completely. The front was marked and the plate was dried horizontally. 
2.3.4.3 Bioautography 
Bioautography is based on that s ubstances separated on the TLC strips could dif fuse into the 
agar. The active substances that  can suppress the grow th of a bacterial and fungal indicator 
showed a clear inhibition zone.  
A bacterial indicator was grown under appropriate conditions until O.D.600 reached about 0.6. 
Fungus was grown in Erlenm eyer flasks with adequate solid m edium, and its spores were 
gathered through washing with physiological saline solution (0.9% NaCl). The indicator strain 
was m ixed with an appropriate m edium cont aining 1.5% agar . The c oncentration of the  
bacterium was 4x107 cfu/ml and the fungus was 4x106 spores/ml. After the medium was solid, 
the HPTLC strips were put on the plate for 2 ho urs at the ro om temperature. After removing 
the strips, the agar plate was incubated for 8-48 hours at the appropriate temperature.   
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2.3.4.4 High performance liquid chromatography (HPLC) 
HPLC (high perform ance liquid chrom atography) is an analytic m ethod in chem istry, which 
can not only separate substances, but also identify compounds and their amounts.  
According to the stationary phase, there are two methods: normal phas e (NP) and reversed 
phase (RP). A  polar stationary phase (e.g. silica gel) is used  in the NP-HPLC. A  non-polar 
stationary p hase is  used  in a RP-H PLC, where a polar surface of the silica gel pa rticles is 
covered with a non-polar layer of an alkane, so  the polarity of a RP-HPLC is inverted. RP-
HPLC decreases the elution strength by rising polarity in the. As mobile phase, acetone nitrile 
and tetrahydrofurane (THF) or methanol diluted in water or buffers is usually used. With iso-
ionic s trength separa tion, the com position of  the  mobile phase rem ains the sam e during the  
entire time. With gradient separ ation, the pola rity of the m obile phase is changed during the 
analysis.  
In this work, RP-HPLC was perform ed with  an Agilent apparatus HPLC 1200. ZORB AX 
Eclipse XDB-C18 was used as th e column. The column temperature was kept at 30°C during 
the experiment. Briefly, a 10-µl sample was injected into the colum n. The f low rate was 1.5 
ml/min solvent A  was water containing 0.1% (v/v) formic acid and B was 100% (v/v) 
acetonitrile containing 0.1% (v/v) form ic. The a cetonitrile concentration was increased from  
10% to 100% within 10 m inutes and hold furt her two m inutes at 100%. The colum n wa s 
equilibrated at 5% ac etonitrile for 3 m inutes after runn ing every sample. A  diode-array 
detector in the range from 190 nm  to 550 nm was used for detecting peaks. Polyketides were 
detected at 280 nm; bacilysin was detected at 230 nm. For the quantitative determ ination, the 
area of the peaks was calculated by the auto integrate software of Chemstation from Agilent. 
2.3.4.5 HPLC-ESI MS 
Liquid chromatography electrospray (HPLC-ESI) mass spectrometry (MS) is able to separate 
a sample firstly by HPLC. Subsequently , the compounds are vaporized  and ionized under a 
high pressure. HPLC 1 100 Agilent and a Luna 3 μ C18 colum n were used to perform ance 
HPLC. The  running  conditions  w ere d escribed in 2.3.4.4.  Details about ESI MS was 
described previously [119]. 
2.3.4.6 MALDI-TOF MS 
Matrix-assisted las er de sorption/ionization-time of flight (MALD I-TOF) m ass spectrom etry 
(MS) is based on ionization of com pounds by a la ser beam. A matrix is used to protect the 
compounds from being destroyed by ionization and facilitate vaporization. 
To prepare sam ples for  MALDI-TOF MS, supern atants of cultures in Landy m edium were  
lyophilized at 4°C. Those were dissolved in 70% aceton itrile/0.1% trifluoroacetic acid and  
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mixed with an equal volum e of m atrix solu tion. T o investigate the com pounds that are 
attached to the outer cell wall, whole cell extr action was performed. Cell material was picked 
into 100 µl solvent used for di ssolving supernatants. Sam ples were shaken vigorously . After 
centrifugation, the extracted solutions from supernatants or whole cells mixed with the solvent 
were spotted on the tar get and air -dried fo r the MALDI-T OF MS analysis. Details about 
MALDI-TOF MS were described in previous publication [120]. 
2.3.4.7 CAS liquid assay for determining siderophores 
The dependency of the cell growth on dif ferent iron concentrations is an  indirect indicator to 
know whether bacteria can pr oduce siderophores. This m ethod is not sensitive enough to 
detect the amount of siderophor es. Chrome azurol S (CAS) can form a blue colored com plex 
with iron, which is stabilized by the cationic surfactant hexa decyltrimethylammoniumbromid 
(HDTMA). Siderophores can deprive iron from the CAS com plex, which leads to 
decolorizing chrome azurol S. The s pectrometric measurement of the color alteration  is used  
to determine the siderophore concentration   [121].   
500µl CAS solution was added to 500µl supernat ant from the strains grown in m odified 
Landy m edium with 0.1 µM Fe 2O3. The m ixture was incubated for two hours at room 
temperature in the dark and then O. D. was measured at 630 nm .  The ratio of the absorption 
values from the supernatant/CAS mixture to  the one from  the Landy medium /CAS mixture 
reflects the amount of the siderophore in the supernatant [121]. 
Buffer Compositions 
CAS Buffer I (10x) 0.605 % C rome Azurol S, 1 m M FeCl 3, 10 m M HCl, 
0.729% HDTMA 
CAS solution 1x CAS buf fer I,  3.024%  Pipes, adjust pH to 7.4 with 
NaOH 
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3 Result s 
3.1 Whole genome B. amyloliquefaciens FZB42 sequencing project  
Bacillus amyloliquefaciens FZB42, a Gram-positive rhizospher e bacterium, is applied world-
wide in farming and gardening, and shows a significant ef fect on enhancing plant growth.  In 
order to identify the genes involved in this pr ocess, the genome of FZB42 was sequenced and 
compared to the genome sequence of Bacillus subtilis  168, a well-known laboratory m odel 
strain that is not endued with plant growth promotion capabilities [7].  In this chapter,   I will 
present the results that I got in the process of genome sequencing. 
3.1.1 Shotgun sequencing  
The shotgun m ethod m akes it possible to get th e m ain part of the inform ation from  the 
genome sequence in a very short time. Göttingen Genome Laboratorium (G2L) performed the 
Shotgun sequencing and assembling of the reads. 39,175 reads were generated by the shotgun 
approach. Af ter the  f irst autom atically ass embling by  Phrap ( http://www.phrap.org/), 814 
contigs were generated in the genome database, which covered 3,836 kb.  
3.1.2 Editing contigs 
Contig editing was supported by G AP4 (http://staden.sourceforge.net/).  The m ajor tasks f or 
editing contigs were solving problems of m isassembling and si ngle nucleotide base error in 
contigs.   
 
Figure 9. An example of misassembly in the gap4 Contig Editor window: The disagreement of 
base between the consensus and individual reads are shown in green. The confidence of a base in 
a consensus is described by the grey scale value. The confidence reduces from light to dark. 
 
Misassembling is due to repeats in the genomic DNA, unclonable sequences, chimeric clones, 
etc. (Figure 9).  All of the misassembled sequences were identified by checking the contigs in 
the Contig Editor . Thes e read s were m anually disassem bled and th en reassem bled into  a 
correct contig.  
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Single nucleotide base error existed very freque ntly in contigs. These tiny widely spr ead 
errors might result in fram eshift in a n open r eading frame and af fect protein pred iction. The 
point m utation, bad quality  of read s and low cove rage of reads were the reasons for this  
problem. To avoid the spontaneous point m utation in the genome sequence, the chromosomal 
DNA was isolated  always from a bacterial sto ck kept in -80 °C. T o fish mistakes of bases in 
contigs, the  contig con taining the whole genome sequenc e was checked m anually from 
beginning to end; regions with insuf ficient sequence quality (b ase co nfidence lo wer than  
65%) were identified and improved through re-sequencing. 
3.1.3 Gap closure 
The most challenging step in the sequencing pr oject was gap closure, especially a sequence 
with a big span of repeats like rRNA  operon. In order to close these gaps, several strategies  
were used in this work. 
3.1.3.1 Gap closure by Gap4  
Gap4 (http://staden.sourceforge.net/) is no t only useful for editing sequences but also one of  
the most convenient tools as a first step to conquer the problem of gap closure.  
 
Figure 10. Gap closur e by using Gap4 softwar e: Two contigs were shown in Contig Editor . 
Arrows r epresent r eads (blue for  r everse r eads and orange for forward). Red line is for  the  
forward and the r everse read from one plasmid co nnected in a same contig, yellow for  the two 
relative reads belonging t o two differ ent contigs with an a ppropriate distance (< 3.5 kb) , green 
for the one with hypothetical distance bigger  th an 4 kb, blu e line for  mi ssing complementary  
read. 
 
Gap4 could find two neighbor contigs, if a forw ard read and its reverse read cam e from the  
same plasmid and were located in two dif ferent contigs. It was i mportant that the expected  
distance between these two reads should be sm aller than 3.5 kb, because an insertion of a 
chromosomal DNA fragment in a plasm id from the shotgun library was about 3 kb. Prim ers 
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could be designed on the related plasm id and PCR walking was perform ed. If the  assumed 
distance of these two reads was bigger than 4 kb, it indicated that at least one of the reads was 
in a wrong contig, nam ely m isassembling ( Figure 10 ) which had to be corrected by 
reassembling.  
3.1.3.2 Gap closure by comparison with B. subtilis 168 
The phylogenetic tree analysis (Figure 11) indicated that Bacillus amyloliquefaciens FZB42 is 
the closest one to Bacillus subtilis 168 and followed by Bacillus licheniformis ATCC14580. 
Therefore, it was presumed that th e organization of the genetic inform ation from FZB42 was 
similar to BS168. All the proteins from  BS 168 were com pared by tblastn against the 
nucleotide database of FZB42 containing all contigs. If one or two ge nes in the neighborhood 
of the B. subtilis 168 genome found their sim ilar counterpart locating in the dif ferent ends of 
two contigs,  at leas t two pairs of  the prim ers were designed on the two ends of the related 
contigs. If the PCR-product existed, the primers were used for further sequencing. 
B.cereus_ATCC14579
B.thuringiensis_serovar_konkukian_97-27
B.l icheniformis_ATCC14580
B.amyloliquefaciens_FZB42
B.subti lis_subsp.subtil is_168
0.010
0.033
0.017
B.halodurans_C125
B.clausii_KSM-K16
0.022
0.041
0.005
 
Figure 1 1. Phylogenetic tree of some memb ers of the genus Bacillus based on 16s rRNA  
sequence analysis 
 
3.1.3.3 Primer walking 
If an interesting sequence obtained from PCR was bigger than 1.5 kb, which is common in the 
case of long range PCR, it was too long to be  sequenced at one tim e by using prim ers from 
both ends of a fragm ent. In this case, prim er walking was used, where new prim ers were  
designed by using the inform ation from the prior end of sequences. This process was  
repeated, until the information from the whole DNA fragment was obtained.  
After the first round of gap cl osure using the methods describe d above, the total number of 
contigs reduced to 228, among which 71 were bigger than 3 kb. 
3.1.3.4 Gap closure by software MUMmer 
Comparison with the closest related  species Bacillus subtilis 168 accelerated the pro gress of 
gap closure. T o exploit this method for gap closure, the ge nomes of other closely related 
species ( B. lich eniformis A TCC14580, B. cer eus A TCC14579, B. clausii  KSM-K16, B. 
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halodurans C125, B. thuringiensis serovar konkukian 97-27) were compared with the one of  
FZB42.  
 
 
Figure 12. Alignment of the whole genome se quences by using MUMmer:  the X -axis stands 
for the whole genome sequence of Bacillus am yloliquefaciens F ZB42 and the Y -axis for the 
compared genome seque nce. A dot is  a sequence th at is matched in both  of the genomes. Th e 
sequences can be matched on the forward (red dots) or the reverse (green dots) strand.  
 
It would have been very tim e consuming, if the comparison had been done manually. For this 
purpose, the whole genom e alignment program MUM mer ( http://mummer.sourceforge.net/) 
was applied, which can find all m aximal, unique, matching sequences (MUMs). The longest 
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possible set of m atches that occur in the sam e order ( Figure 12 ) was extracted. This 
information was used for contigs ordering th at was confirm ed subsequently by prim er 
walking.  After this ro und of gap closure, 179 contigs re mained in the Gap4 database, which 
contained 48 contigs longer than 3 kb and 2 contigs longer than 400 kb. 
This comparison confirmed the conservation of organization of genetic inform ation in very 
closely re lated s trains (lik e B. su btilis and B. lichen iformis) and indicated “hot-spot” 
rearrangement loci, where gene transfer could have occurred. These “hot-spot” rearrangement 
loci exist mainly at the end of the replication fork (Figure 12). 
3.1.3.5 Gap closure by using fosmid library 
To conquer the problem  with a lar ge scale of ga ps between the contigs,  it was necessary to 
establish a clone library that cont ains fragments about 30 kb in si ze. At first, a cosm id library 
was tried, but no clone was obtained after several attempts, probably due to instability of the 
cosmids. In contrast to cosm ids, fosm ids have a lower copy num ber and higher stability . 
Using fosmids, a genome library containing 96 clones with fragm ents larger than 25 kb wa s 
established. 249 reads were obtained directly from the fos mid library; one of the fosmids was 
sub-cloned to get a shotgun library for further sequencing.  
3.1.3.6 Gap closure by multiplex PCR and long range PCR 
After exploiting the fosmid library, the number of the contigs larger than 1000 bp was reduced 
to 31. For the rem aining contigs, there was no evidence for contig  ordering. All these contigs 
had to b e tested randomly by PCR to assess  contig order. In this case, multiplex PCR was a  
powerful method, which enabled simultaneous am plification of m any inte resting tar gets in 
one reaction by using more than one set of primers [122].  
 
Figure 13. Strategy for gap closure containing at least two rRNA operons 
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After using multiplex P CR there were still thre e gaps remaining among the contigs that were 
larger than 400 kb, from  which four ends contained rRNA  ope rons. Two of the gaps were 
closed by long range PCR using a unique primer at the end of  one contig and a non-unique 
primer at the end of another contig containing rRNA operon in the end . The last g ap in th e 
genome sequence was the m ost difficult one, because both ends contained rRNA operon, one 
of the contigs contained two rRNA operons and the total number of rRNA operons in this gap 
was unknown.  The sequence around this gap wa s found conserved very well in comparison 
with BS168. It could be hypothesized, that the number of r RNA operons in FZB42 was the 
same as in Bacillus subtilis 168. To confirm this assumption, three primer pairs were designed 
according to the s equence of B. subtilis 168 . Primer pairs 1 and 2 we re used to am plify two 
specific PCR-products on FZB42 chrom osomal DNA, whose size were sim ilar to that of B. 
subtilis 168 (Figure 13). It ruled out that  three rRNA operons exist in this region. Primer pairs 
3, 4 and 5 were used to check the direction of the operons ( Figure 13). PCR and sequencing 
with these five primers confirmed that the number of rRNA operons and their organization are 
identical to that of B. subtilis 168. 
3.1.4 Sequence analysis of the genome of B. amyloliquefaciens FZB42 
The process of identifying location and functio n of open r eading frames (ORFs) is called 
annotation. ORFs of FZB42 were identified fi rstly by direct m anual comparison of the DNA  
sequence against the ge nome database of B. subtilis 168 ( genolist.pasteur.fr/SubtiList). This 
result was then com bined with the autom atic ORF prediction done by G2L  using Y ACOP 
program which contains the ORF-finding programs Glimmer, Critica and Z-curve [123]. 3984 
ORFs were identified in FZB42 after autom atic searching. All predicti ons were verified and 
modified manually by confirming the presence  of ribosom al binding site, codon usage 
analysis and sequence hom ology analysis by the software GeneSOAP  [124]. The sequence 
homology analysis was done by co mparing coding sequences agai nst public databases, like 
SwissProt, GenBank, ProDom, COG, Prosite and KEGG.  
During the annotation, frameshifts were detected mainly due to sequencing mistakes and point 
mutations. Sequencing m istakes occurred because of bad quality of s equences or contigs, 
while point mutations happen spontaneously in na ture, which often lead to gene silence. T o 
rule out the frameshifts that did not be caused by arti ficial sequencing mistakes, all frameshift 
regions were exam ined again by sequencing.  After completing the annotation, the final 
number of coding sequences (CDS) is 3693. Three types of prot ein annotation were assigned: 
1) 2340 (63.3%) were proteins with putativ e functions; 2) 1 141 ( 30.9%) were conserved 
hypothetical proteins w hose hom ologues were f ound in other genom es, but their functions 
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were still unknown; 3) 214 (5.8%) were hypothetic al proteins that were unique for FZB42. 
The genomic information of B. amyloliquefaciens FZB42 is availab le in the NCBI databas e 
under the accession number gi|154350369. 
The m anual annotation provides a great am ount of genetic, biochemical and physiological 
data, e.g. metabolism  pathway, enzym e activit y and dom ain or ganization, which gives the 
hints about the functions of the genes. However , their exact functions should be investigated 
by further experiments. 
3.2 Genomic analysis 
Genome analysis of FZB42 has been extensivel y described in several previous publications 
[Lit. 1, Lit. 6, Lit. 7 and Lit. 8] Here I will present a short summary and stress some additional 
aspects of my genome analysis.  
Table 1. Gen omic features of B.  am yloliquefaciens in  com parison with  the  genomes of other 
Bacillus strains: 
 B.  
amyloli-
quefaciens 
FZB42 
B. sub tilis 
168 
B. l icheni-
formis 
ATCC 
14580 
B. cla usii 
KSM-K16 
B. 
halodurans 
C-125 
B. cer eus 
ATCC 
14579 
B. 
thuringiensis 
serovar konku-
kian 97-27 
Genome size 
(bp) 
3,918,589 4, 214,630 4, 222,645 4, 303,871 4,202,352 5, 426,909 5,237,628
G+C content 
(mol%) 
46.4 43 .5 46 .2 44 43.7 35 .4 35.4
Protein coding 
sequences 
3,693 4, 106 4, 196 4, 096 4,066 5, 366 5,263
Average CDS 
size (bp) 
933 89 5 87 7 90 0 879 83 5 826
Percent of 
coding region 
88.0 87 .2 87 .2 85 .0 85.0 84 .0 83
Ribosomal 
RNA operons 
10 10 7 7 8 13 13
Number of 
tRNAs  
89 86 72 74 78 108 105
Phage-
associated 
genes 
44 268 71 18 42 124 11
Transposase 
genes of IS 
elements 
9 0 10 22 93 10 60
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Table 2. Substitution of prophages in the genome of FZB42 in comparison with B. subtilis 168 [Lit. 
6]: 
From 
(BS1) 
To (BS1) Siz e 
(BS1) 
RBAM DR 2 phage tRN A remark 
200263 
glmS 
228161 
csgA 
28898 RBAM183 
RBAM206 
+ Prophage 1 - RR/HK, detoxification (export antimicrobial 
peptides), KDPG reductase, RR/HK, ABC 
transporter; substitution of prophage 
1(deletion 1: 24492 bp) 
502777 
ydcK 
521213 
cspC 
31118 RBAM460 
RBAM482 
+ Prophage 2 Leu ester cyclase, transporter, MarR regulator (2), 
NAD dependent dehydrogenase, NADP 
quinone reductase, TetR, regulator, oxido 
reductase (3), fatty acid desaturase, 
substitution of prophage 2 (deletion 2: 19208 
bp) 
524801 
yrkE 
560664 
ydeR 
35863 RBAM485 
RBAM525 
+ Prophage 3 - rhodanase, aspartate racemase, PadR 
regulator, Mannose-6-phosphate isomerase, 
dihydrodipicolinate synthase, Fe-S-cluster 
redox enzyme, pyrimidine kinase, sugar 
phosphatase, arsenite efflux pump, Na+H+ 
antiporter, GntR regulator, PaiB regulator, 
methyl transferase, RR/HK, substitution of 
prophage 3 (deletion 3: 30805 bp) 
1164638 
yjcJ 
1193383 
yjfB 
28745 RBAM1106 
RBAM1135 
+ Prophage 4 Val sugar transporter, galR, ganA, galT, galE, 
galK, ptsIIBC, ptsIIA, P-ß-gal, deoR regulator, 
phosphohexomutase, substitution of 
prophage 4 (deletion 4: 28412 bp) 
1317799 
xlyB 
1347491 
xlyA 
28786 RBAM1158 
RBAM1177 
+ PBSX - rearrangement of prophage related genes 
yomR and yomQ  (deletion 5: 19751 bp) 
1793935 
glnA 
1796733 
xynP 
2798 RBAM1630 
RBAM1636 
+ phi105 - phage integrase, gluconolactonase 
2050542 
pps 
1916851 
lexA 
133691 RBAM1641 
RBAM1669 
+ Prophage 5 - homing endonuclease, nuclease inhibitor, 
dehydrogenase, protein acetyltransferase, 
chitin  binding, transporter, regulator, 
substitution of prophage 5 (deletion 6: 24681 
bp) 
2078498 
yodU 
2095572 
yokA 
134777 RBAM1863 
RBAM1881 
+ SPßC2 - Replication terminator yodN, phage proteins 
but lacking major SPßc2, RR/HK, site specific 
recombinase YokA, , partial substitution of 
SPßC2 (deletion 7:134777 bp) 
2652600 
spoIVCB 
2700977 
spoIIIC 
48377   + skin element - insertion of putative polysaccharide 
deacetylase RBAM02462 and unknown gene 
RBAM02464 (deletion 8:48377 bp ) 
3767647 
yxdJ 
3772893 
fba 
5246 RBAM3511 
RBAM3517 
- Imo828 - Detoxification: mersacidin export and 
regulation, mrsK, mrsR, mrsF, mrsG, mrsE 
1. BS: Bacillus subtilis 168 
2. DR: direct repeats 
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Figure 14. The whole g enome of Bacillus amylo liquefaciens F ZB42: Genes and gen e clusters 
involved in synthesis and export (detoxification) of secondary metabolites l ie in the most outside  
of the cir cle. 1st cir cle: all genes in color  code  ac cording to their  functions: cell enve lope and 
cellular processes, green; information pathways, orange; intermediary met abolism, pink; other  
functions, r ed; unknown, black. 2nd circle: Gene s not conserved in B. subtilis including four  
giant gene clusters invol ved in synthesis of secondary metabolites (orange); 3rd ci rcle: the  
numbered 17 DNA islands (green), 4th circle: GC-content profile, 5th circle: rRNAs (green), 6th 
circle: tRNAs (cyan), 7th circle:prophages (black), transposons, and IS elements (red), 8th circle: 
scale (bp) [Lit. 6]. 
 
3.2.1 General features of FZB42 genome 
FZB42 possesses an AT-rich genome with 3,916,653 bp. General properties of its sequence in 
comparison to other genom e sequences of related Bacilli are shown in Table 1. Addition al 
genomic information of other Bacilli is available from the NCBI  genomics projects database 
(http://www.ncbi.nlm.nih.gov/genomes/lproks.cgi).   
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The majority of the FZB42 CDS are conserved in the closely related B. subtilis (3,181) and B. 
licheniformis (2,857), and most of them are arranged in  a collinear manner in all three strains 
(Table 1, Figure 12  and Figure 14 ).  These three strains shar e 2494 conserved genes totally . 
Genes involved in signal transduction, sigma factors, com petence, transporter system s, 
secretion systems and extracellular proteins were summarized in [Lit. 6].  
3.2.1.1 Absence of prophage related genes 
Unlike Bacillus subtilis 168, the total am ount of A (26.7%) and T (26.8%), G (23.3%) and C  
(23.2%) is similar in FZB42. In comparison to BS168, the genome of FZB42 is about 300 kb 
smaller, mainly due to absence of A +T-rich prophage related genes. In  total, BS168 contains 
four known prophages (PBSX, SPβ, skin element and phi105) and six prophage-like elements 
[7]. In FZB42 330503 bp were absent, compared to BS168.  The prophages, skin element (48 
kb) and SPβC2 (134 kb), were deleted alm ost completely in the genome of FZB42 ( Table 2). 
Notably, loss of production of th e anti-listerial bacteriocin s ubtilosin in FZB42 is due to 
deletion of the corresponding genes within th e SPßC2 region; however , FZB42 contains the 
genes for four extra non-ribosomally synthesized compounds (see 3.2.1.2).  
3.2.1.2 Numerous secondary metabolites produced by B. amyloliquefaciens FZB42 
A remarkable feature of FZB42 is its  capacity to produce a high diversity  of antibiotics. Nine 
giant gene clusters, which are responsible  for non-ribosom ally synthesized secondary 
metabolites, are  pres ent in  the  B. amyloliqu efaciens FZ B42 genome: three lipopeptides  
(surfactin, fengycin and bacillo mycin D), three polyketides ( pks1, pks2 and pks3), on e 
dipeptide (b acilysin), on e sideropho re (b acillibactin) and two unknown com pounds ( Figure 
14). One of the unknown compounds is a PKS/NRPS hybrid; the other is Sfp-independent and 
was detected by antibiotic resistance gene analysis [125].  
3.2.2 Genomic analysis of gene clusters involved in production of secondary 
metabolites by B. amyloliquefaciens FZB42 
3.2.2.1 Lantibiotics and other ribosomally synthesized antibiotics produced by B. 
amyloliquefaciens FZB42 
Despite that Bacilli produce a series of lantibiotics (for details see 1.3.1), no structure genes of 
known lantibiotics are presen t in the genom e of FZB42 ( Table 3). However , som e of the 
transporters, regulator s and imm unity genes  f or lantibio tics were id entified ( Table 3). For 
example, the signal transduction genes mrsK2R2 involved in regulation of biosynthesis of  
mersacidin and their immunity genes mrsEFG are present ( Table 3). A  similar gene cluster 
containing the signal transduction genes spaKR and the im munity genes spaEFG of subtilin 
exists. In case of subtilosin A, only a putat ive transpo rter, AlbG, was found, whilst the 
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immunity g enes albBCD are no t p resent. The immunity and regulation gene s of sublancin 
were not characterized until now. However, the immunity genes of sublancin are thought to be 
localized in the region o f the sp β2 prophage [126, 127] which is  completely missing in the 
genome of FZB42 indicating that it does no t con tain specif ic im munity gen es aga inst 
sublancin (Table 3). No signal transduc tion genes, transporters and immunity genes directed 
against ericin are present in FZB42 (Table 3). 
A ribosom ally synthesized unknown com pound that shows antibiotic activity against B. 
subtilis HB0042 (sigW) was detected by screening of sigW-dependent resistance genes [125]. 
ydbST and fosB were identified as the resistance  genes for the nove l antibiotic in B. subtilis. 
Homologues of the ydbST genes have been identified in a plasm id of Staphylococcus aureus, 
they are involved in production of, and imm unity to, the bacteriocin aureocin A53 [125]. fosB 
is a known immunity gene for fosfo mycin. Analyzing the whole genome sequence of FZB42,  
no genes were detected, which could be involve d in the biosynthesis of aureocin-like or 
fosfomycin-like antibiotics. 
Table 3. Presence of lantibiotics and related genes in B. amyloliquefaciens FZB42: 
Genes involved in biosynthesis of the lantibiotics presented in their producers 
Name of the 
lantibiotics 
Genes 
Structure 
gene 
Post-
transcriptional 
modification 
Transporter regulatior imm unnity 
 Lantibiotics 
related gene s 
presented i n 
FZB42 
mersacidin 
mrsK2R2 
EFGADMT mrsA mrsMD mrsT mrsK2R2  mrsFEG 
mrsk2R2 
mrsEGF 
subitilosin A 
sboAX 
albABCDEFG 
sboA/ 
spoX? albA albFG   albBCD albG 
sublancin 
sunAT/bdbA 
yolJ/dbdB sunA bdbAB sunT      - 
subtilin 
spaBTCS 
FEGRK spaS spaBC spaT spaRK  spaFEG 
spaFEG 
spaRK 
ericin 
eriBTCAS 
FEGRK eriAS eriBC eriT eriRK eriFEG  - 
 
The data from  the transposon library of CH5 ( sfp- and yczE-) showed that a unique gene  
cluster in F ZB42 is involved in production of  this antibiotic (Zhiyuan W ang and Ant o 
Budiharjo, unpublished). This gene cluster is inserted between guaC and yutM counter -
clockwise to the DNA replication (Figure 15).  
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B. amyloliquefaciens FZB42
Paenibacillus larvae subsp. larvae BRL-230010 
abaps1238pcr0109
6077 bp
guaC yjcKRBAM 029240RBAM 029230RBAM 029220RBAM 029210
RBAM 029200
RBAM 029190RBAM_029190
RBAM_029200
AM_029210 RBAM_029220
RBAM_029230
RBAM_029240 yjcK
GuaC
abaps1238pcr0109
6554 bp
Plarl 010100002023 Plarl 010100002058Plarl 010100002028
Plarl 010100002033
Plarl 010100002038
Plarl 010100002043
Plarl 010100002048
Plarl 010100002053Plarl_010100002023
Plarl_010100002028
Plarl_010100002033
Plarl_010100002038
Plarl_010100002043
Plarl_010100002048
Plarl_010100002053 Plarl_010100002058
Plarl-2043
RBAM_029230
A.
B.
 
Figure 15.  The gene cluster  related to a  novel  antibiotic in F ZB42 is very sim ilar to  a gene 
cluster involved in the genome of Paenibacillu s larvae subsp. larvae BRL-2300: A. Gene 
organization in FZB42 and BRL-2300. The green marked genes are related to production of this 
novel antibi otic, the br own-labelled genes ar e in the neighbourhood to this gene cl uster. B.  
Alignment o f RBAM_029230 and Pl arl_2043 shows that this gene is highly conserved in both 
strains. 
 
This operon contains six genes a nd its organization is similar to that of a gene cluster present 
in Paenibacillus lar vae subsp. larva e BRL-230010 [128], an endospore-form ing bacterium 
causing American foulbrood disease in honeybee ( Figure 15A). The similarity of these genes 
on the am ino acid level is ranging from  46% (RBAM_029240 to Plarl_2053) to 80% 
(RBAM_029230 to Plarl_2043) ( Table 4). Notably , the C-term ini of RBAM_029230 and 
Plarl_2043 are almost identical (Figure 15B). 
Table 4 Features of the proteins involved in production of this novel antibiotic: 
 
length 
(bp) 
MW 
Dalton 
Conserved 
domains sign alP1 secretomeP2 
No. of 
TMH3 
similarity 
to Plarl4 
protein 
in Plarl4 
RBAM_029240 57 0 21138 n. d.5 30/316 Yes 5 46% 2053 
RBAM_029230 33 6 11350 n. d.5 39/40 Y es 2 80% 2048 
RBAM_029220 16 53 62891 n. d.5 n. d.5 Y es 12 51% 2043 
RBAM_029210 70 2 25971 ABC-transporter n. d.5 no 0 72% 2038 
RBAM_029200 44 7 16290 
integral membrane 
protein n. d.5 no 3 56% 2033 
RBAM_029190 21 9 8311 n. d.5 n. d.5 Y es 3 55% 2028 
1. signalP predicts whether there is signal peptide in the protein sequence and its possible cutting position. 
2. secretomP predicts whether the protein can be secreted without signal peptide. 
3. TMH: transmembrane helix 
4. Plarl: Paenibacillus larvae subsp. larvae BRL-230010 
5. n. d.: not detected 
6. Probable cleavage site in the position of the amino acids 
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To predict the structural gene of this unknown antibiotic, conserved domains were analyzed in 
this unique gene cluster . The results s howed that RBAM_029200 contained an integral 
membrane protein domain with unknown f unction and R BAM_29210 contained an ABC-
transporter dom ain belonging to the BcrA  superfam ily ( Table 4 ). This im plied that 
RBAM_029200 and RBAM_29210 could not be the structural gene whose product is secreted 
out of the cell or anchor to the outer of the cell membrane. The rest proteins in this cluster did 
not contain any known conserved do mains. Prediction software for signal peptides (SignalP), 
extracellular proteins wit hout signal peptide (Secretom P) and transm embrane helix 
(TMHMM) (CBS Pre diction Servers, Denmark)  were used to an alyze th ese proteins. 
RBAM_029230 and RBAM_029240 were predicted to contain a signal peptide or a signal 
anchor ( Table 4). The p robability th at RBAM_02940 had a signal anch or was 0.43 3 and a 
signal peptide 0.559, while the probability that RBAM_029230 contained a signal peptide 
was one, which m eant that RBAM_029230 contained a signal peptide with a possibility of 
100% ( Table 4). The results from secretomP  analysis im plied that RBAM_29220 and 
RBAM_29190 belong to the secretom e protein, despite that signalP  prediction gave no 
evidence for presence of signal p eptides and signal anchors in  these proteins ( Table 4). 
However, RBAM_29220 and RBAM_29190 cannot be a secreted protein, because the m ain 
parts of these proteins are transmembrane helices (Table 4). 
A. RBAM_029230 B. RBAM_029190 
35 aa 71 aa 23 aa25 aa 73 aa
transmembrane inside outside  
Figure 16. Transmembrane helix analysis of RBAM_029230 and RBAM_029190 
 
The results from signalP  and secretom P showed that RBAM_029230 and RBAM_29190 
could be candidates for struct ure genes. RBAM_29190 contained two tiny extracellular parts 
(Figure 16 B), which implied that RBAM_29190 was un likely a structural gene for this 
unknown antibiotic. In comparison to it, transmembrane helix (TMH) analysis illustrated that 
RBAM_029230 contains two TMHs, between which there are abou t 36 am ino acids outside 
of the cytoplasm (Figure 16A). It seems that RBAM_029230 could be the structural gene for 
this antibiotic and would be cut  at the positi on of the 36th aa of the N-term inus and the 41th 
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aa of the C-term inus to for m a hypothetical m ature protein, before it  is released from  cells 
(Figure 16A). Features of the mature protein were investigated by Protein Calculator v3.3 (the 
Scripps Research Institute, La  Jolla, USA): it would have a molecular weight of 3455.8601 
Da and pI 5.69. Cysteine, the characteristic am ino acid for lantibiotics, is not present in the 
mature protein. Because of lacking tryptoph an, tyrosin e and disulfide bond, it has 
theoretically no absorbance at wavelength 278 nm to 282 nm. 
HPLC, HPLC-ESI MS a nd MALDI-TOF MS analysis yielded no peaks corresponding to the 
predicted size of this unknown an tibiotic in the supernatant a nd/or on the surface of the 
cytoplasm membrane.  
3.2.2.2 Nonribosomally synthesized lipopeptides produced by B. amyloliquefaciens 
FZB42 
Three lipopeptide synthetases cover 101,077 bp of the genom e of B. amyloliquefaciens  
FZB42. The  bmy gene cluster  lies 1.8 Mbp and the fen gene cluster  1.9 Mbp distant to the 
DNA replication s tart point in coun terclockwise orientation; the srf gene cluster locates 0.3 
Mbp clockwise to the replication start point.  
The 26.1-kb srf operon  present in the B. amyloliquefaciens  FZB42 genom e is or ganized 
similarly as in B. subtilis  168. The corresponding genes of thes e two strains ex hibit identity 
between 72% (srfAA) and 83% (srfAC) at the amino acid level. Like B. subtilis 168, the genes 
present at the left flan king region of the operon are hxlBAR, while the genes at the right 
flanking region of the srf gene cluster differ slightly to the ones from B. subtilis 168. The two 
genes ycxAB with unkown functions in BS168 ar e substituted by two O RFs (RBAM_003700 
and RBAM_003710) with unknown function in FZB42. RBAM_003700 contains a conserved 
domain, belonging to am inotransferase class I and II, and exists in other Bacilli, while 
RBAM_003710 did not show any similarity to known genes in the database. 
The fen gene cluster is about 37.6 kb and contains five genes ( fenABCDE). It lo cates in B. 
amyloliquefaciens FZB42 at the sam e locus as the pps operon in B. subtilis  168. The  
homology of fenABCDE to ppsABCDE is between 61% and 66% and this region is 
conserved well in both Bacillus species. 
The 37.2-kb bmy gene cluster ( bmyABCD) does not exist in BS 168, and is inserted between 
xynD and yngA with a rearrangem ent of the biotin synt hesis gene cluster. Notably, the genes 
in the neighborhood of the bmy operon are the sam e as in the itu rin A gene clus ter in B. 
subtilis RB14  [64] and t he bmyL gene cluster in B. subtilis A1/3 [129].  BmyA shows a high 
level of homology  to ItuA (98%) of B. subtilis  RB14, BmyB to ItuB (81%) of B. subtilis  
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RB14 and BmyC to MycC (74%) of B. subtilis ATCC6633. A more detailed description of the 
lipopeptide gene clusters in FZB42 has been given elsewhere [Lit. 8 and Lit. 1]. 
3.2.2.3 Polyketides produced by B. amyloliquefaciens FZB42 
Three PKS gene clusters covering 196,340 bp  are localized at the positions around 1.4 Mbp 
(pks2), 1.7 Mbp ( pks1) and  2.3 Mbp ( pks3) in  clockwise direc tion to  the DNA  replic ation 
origin of the B. amyloliquefaciens FZB42 genome.  
Table 5. List of pks1 ORFs and their homologous proteins: 
Protein/Gene Size (Da/bp) 
Similar to 
strain 
Similarity 
[%] 
Homolog 
protein Domain 
BaeB/baeB 25875/678 BS 168 64 PksB GloB 
BaeC/baeC 32317/870 BS 168 72 PksC AT1 
BaeD/baeD 36425/975 BS 168 52 PksD AT2 
BaeE/baeE 82426/2241 BS 168 69 PksE AT3, oxidoreductase 
AcpK/acpK 9306/249 BS 168 69 AcpK ACP 
BaeG/baeG 46539/1263 BS 168 83 PksG ACP 
BaeH/baeH 29202/774 BS 168 65 PksH ECH (enoyl-CoA hydratase) 
BaeI/baeI 27788/750 BS 168 75 PksI ECH (enoyl-CoA hydratase) 
BaeJ/baeJ 551392/14949 BS 168 62 PksJ 
[AL0, ACP0], [C1,A1,PCP1], [KS2,DH2, KR2, 
ACP2,ACP2], [KS3, KR3,ACP3], [KS40 
BaeL/baeL 495437/13428 BS 168 63 PksL 
DH4,ACP4], [KS5,DH5,KR5,ACP5], [KS6, 
ACP6-1, ACP6-2], [KS7,KR7, ACP7], [KS80 
BaeM/baeM 389407/10536 BS 168 62 PksM 
DH8,ACP8], [KS9,DH9,KR9, MT9, ACP9], 
[KS10,KR10,ACP10] 
BaeN/baeN 599995/16302 BS 168 63 PksN 
[C11,A11,PCP11], [KS12,DH12, KR12, 
ACP12], [KS13, DH13,KR13, ACP13], 
[KS14,DH14,KR14 
BaeR/baeR 276050/7449 BS 168 57 PksR 
MT14,ACP14], [KS15, DH15, ACP15],  
[KS16, ACP16,TE] 
BaeS/baeS 46296/1212 BS 168    PksS P450 
Grey KS0 stands for KS that cannot elongate the polyketide chain. Grey ACP6-1 contains only the N-terminus of 
ACP.  
The location and the m odule organization of pks1 (724 kb) is similar to that of the pksX from 
Bacillus subtilis  168. The ORFs of pks1 show sim ilarity between 52% and 83% to pksX, 
except two genes ( pksA and pksG). pksA, a hypothetical transcrip tional regulator , which 
locates directly at the beginning of the gene cluster in Bacillus subtilis  168, lies 730 kb 
upstream of the pks1 gene cluster in FZB42. pksG, encoding a β-ketoacyl synthase, is absent 
in the pks1 gene cluster . The total 17 m odules (Table 5) for PKS and NRPS begin with the 
gene baeJ: three ORFs (baeL, baeM and baeR) encode PKS type I modules; two ORFs (baeJ, 
baeN) encode NRPS/PKS hybrid modules.  14 KS domains, 16 ACPs, 9 DHs, 9 KRs, 2 MT  s 
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and 1 TE ar e involved in the 15 PKS m odules of the pks1 gene cluster ( Table 5). No AT was 
found in any PKS m odule, except that three A T dom ains stand freely in front of the gene 
cluster (BaeCDE).  Module 2 an d 6 contain tw o ACPs. The firs t ACP of m odule 6 contains 
only the N-term inal part in cluding the serine for connecting to PPant m oiety ( Table 5).  
Except the C-terminus of BaeM and the N-terminus of BaeN, the PKS modules stand separate 
in two neighbouring proteins. The adenylation domain of the first NRPS module in BaeJ can 
specifically recognize th e am ino acid glycine, and the on e of the second NRPS module in 
BaeN can recognize alanine as a specific substrate [130].  
Table 6. List of pks2 ORFs and their homologous proteins: 
Protein/Gene Size (Da/bp) 
Similar 
to 
strain 
Similarity 
[%] 
Homolog 
protein Domain 
MlnA/mlnA 86329/2307 FZB42 53 DfnA (pks3) AT 
MlnB/mlnB 457737/12261 
CC 
H10 38
beta-ketoacyl 
synthase 
[KS0,KR0,ACP0], [KS1,DH1,KR1, 
ACP1-1, ACP1-1], [KS2,DH2 
MlnC/mlnC 179074/4773 
CC 
H10 42
beta-ketoacyl 
synthase KR2,ACP2], [KS3,DH3 
MlnD/mlnD 323718/8709 
CC 
H10 39
beta-ketoacyl 
synthase 
KR3,ACP3], [KS4,KR4,ACP4], [KS5, 
ACP5-1 
MlnE/mlnE 258599/7005 
BS 
B11 96 PksB KR5,ACP5-2], [KS6,KR6,ACP6], [KS7 
MlnF/mlnF 214038/5712 
BS 
B11 97 PksC DH7,ACP7-1,ACP7-2,KR7], [KS8 
MlnG/mlnG 275495/7383 
BS 
B11 97 PksD 
KR8,ACP8], [KS9,ACP9-1,KR9, ACP9-
2], [KS10 
MlnH/mlnH 144480/3852 
BS 
B11 96 PksE DH10,ACP10, KR10, TE] 
CC H10 = Clostridium cellulolyticum H10; Grey KS0 stands for KS that cannot elongate the polyketide chain. Grey 
ACPs are ACPs without serine to connect the PPant moiety.  
 
The pks2 gene cluster with 53 kb is the sm allest pks gene cluster in the genom e of FZB42. It  
contains eight ORFs, and no sim ilar gene cluster was found in the genom e of B. subtilis 168. 
The pks2 gene cluster is inserted between ykyA and pdhA. Except the insertion of the pks2 
gene cluster, the genome sequences of FZB42 and BS 168 are highly conserved in this region.  
The first gene ( mlnA) shows 53% s imilarity to the f irst gene of  pks3 (dfnA), mlnBCD have 
low similarities to the p olyketide synthases of Clostridium cellulolyticum H10, the other four 
ORFs of pks2 are alm ost identical to the genes  present in Bacillus subtilis  B11 (Table 6). In 
total, 11 PKS m odules are involved in the gene  cluster, which include 1 1 KSs, 15 ACPs, 1 1 
KRs, 5 DHs and 1 TE. Methylase transferas e domain could not be detected in the pks2 gene 
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cluster (Table 6). Only one A T domain is present in front of the pks2 gene cluster (MlnA ). 
Modules 1, 5, 7 and 9 contain two ACPs, respec tively. One of the ACPs in m odule 5 and 9 
does not provide the serine for connecting to a PPant moiety, so these ACPs cannot convert to 
the active ACP  for ms. Except the last m odule, the PKS modules stand separately in two 
neighbouring proteins. A  unique feature of the pks2 gene cluster in com parison to the pks1 
and pks3 is that no cytochrome P450 is involved in the gene cluster of pks2 (Table 6).  
Table 7. List of pks3 ORFs and their homologous proteins: 
Protein/Gene Size (Da/bp) 
Similar to 
strain 
Similarity 
[%] 
Homolog 
protein Domain 
DfnA/dfnA 82951/2259 BS 168 60 PksE AT 
DfnY/dfnY 36744/981 n.d.  n.d. n.d.  n.d. 
DfnX/dfnX 10026/273 n.d.  n.d. n.d.  n.d. 
DfnB/dfnB 49460/1332 
Chloroflexus 
aurantiacus J-
10-fl 50
AMP-
dependent 
synthetase 
and ligase [AL0 
DfnC/dfnC 26714/738 
Pseudomonas 
fluorescens 46 MupS  3-ketoacyl-(ACP) reductase  
DfnD/dfnD 464004/12591 
BAM FZB42 
/BS 168 60/46 DfnG/PksP 
ACP0],[KS1,DH1,KR1,MT1, 
ACP1-1,ACP1-2],[KS2, DH2, KR2, 
ACP2],[KS3 
DfnE/dfnE 232861/6297 BS 168 48 PksJ 
DH3, ACP3],[KS4,KR4, ACP4], 
[KS05 
DfnF/dfnF 212483/5727 
Bacillus 
subtilis A1/3 96 PksM 
DH5,ACP5],[KS6,ACP6-1,DH6,  
KR6 
DfnG/dfnG 573635/15615 
BAM 
FZB42/BS 168 60/38 DfnD/PksN 
MT6,ACP6-2,ACP6-3],[KS7,DH7, 
KR7,ACP7],[KS8,DH8,KR8, ACP8], 
[KS9,KR9,ACP9], [KS010 
DfnH/dfnH 286026/7719 
Geobacter 
uraniireducens 
Rf4 50
beta-
ketoacyl 
synthase 
DH10,ACP10,DH10],[KS11, 
KR11, ACP11],[KS12 
DfnI/dfnI 225736/6153 BS 168 43 PksN 
DH12, ACP12,DH12],[KS13, DH13, 
KR13 
DfnJ/dfnJ 230391/6216 
Sorangium 
cellulosum 'So 
ce 56' 47
polyketide 
synthase 
MT13,ACP13,ER13],[KS14, 
ACP14,ACP14,TE] 
DfnK/dfnK 44385/1155 
Arthrobacter 
sp. FB24 42
cytochrome 
P450  P450 cytochrome 
DfnL/dfnL 46216/1248 BAM FZB42 72 BaeG 
3-hydroxy-3-methylglutaryl CoA 
synthase 
DfnM/dfnM 27475/747 BS168 55 PksI ECH 
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Grey KS0 stands for KS that cannot elongate the polyketide chain. Grey ACPs are ACPs without serine to connect 
a PPant moiety.  
n.d. = Not detected in the NCBI database 
 
The pks3 gene cluster spans over 195 kb with 15 ORFs and is the lar gest pks gene cluster in 
the genome of FZB42. The pks3 gene cluster is inserted b etween yqjM and proI of BS168 by 
deletion of yqjN.  Three unique genes, RBA M_022090, RBAM_022100 and RBAM_022110, 
are inserted upstream of the pks3 promotor region. RBAM_022090 is  a putative transcription 
anti-terminator, RBAM_022100 is a putative transcription regulator , w hile RBAM_0221 10 
has not been assigned with any functi on. Except for RBAM_022100, the other two unique 
genes are transcribed in  opposite direction to pks3. The ORFs in the pks3 gene cluster show 
very low similarities to pks genes in other species (Table 7). DfnXY did not match any known 
protein in the NCBI database  and did not contain any puta tive conserved dom ain. Fifteen 
modules are involved in the pks3 gene cluster containing 15 KS s, 18 ACPs, 11 DHs, 10 KRs, 
3MTs, 1 ER and 1 TE ( Table 7). L ike pks2, dfnA contains only one A T domain in the whole 
gene cluster. Module 1, 6 and 14 contain two ACPs, respectively. One of the ACPs in m odule 
6 does not provide the serine fo r connecting to a PPant m oiety. Except the last m odule, the 
PKS modules stand separated in tw o neighbouring proteins. There are three genes dfnKLM 
following the main modules of the pks3 gene cluster. DfnK contains a conserved dom ain for 
cytochrome P450, DfnL  contains a putative 3- hydroxy-3-methylglutaryl-CoA synthase, and 
DfnM has a hypothetic enoyl-CoA hydratase (Table 7). 
A m ore detailed description of  the polyketides gene clusters  in FZB42 has been published 
elsewhere [Lit. 7, Lit. 1 and Lit. 2]. 
3.2.2.4 Other genes related to nonribosomal synthesis of secondary metabolites 
Besides lipopeptides and polyketides, three gene clusters, involved in non-ribosomal synthesis 
of peptides (bacillibactin, bacilysin and a putative peptide), were detected in the genome of B. 
amyloliquefaciens FZB42.  
A gene cluster hom ologous to Bacillus subtilis  168 dhbACEBF assigned for the synthesis of 
the siderophore bacillibactin, was detected in the genome of FZB42. Similarities were ranking 
from 64% to 80% on the am ino a cid level. T he region inclusive this ge ne cluster is well 
conserved [55]. DhbF encodes a dimodular pep tide synthetase, which contains two modules  
composed of C, A and PCP domain and a terminal T domain. The substrate specificity of A1 
in DhbF is glycine and A2 is threonine. 
 
Results 
 
  66  
Table 8. Organisation of the genes in nrs gene cluster: 
Protein/Gene Size (Da/bp) Similar to strain 
Similarity 
[%] Homolog protein Domain 
NrsA/nrsA 26505/705 Bacillus cereus E33L 42 thioesterase TE 
NrsB/nrsB 38665/984 
Clostridium beijerinckii
NCIMB 8052 38 
conserved 
hypothetical 
protein mcbC-like_oxidoreductase1 
NrsC/nrsC 392167/10236 
Clostridium beijerinckii
NCIMB 8052 45 
amino acid 
adenylation 
domain 
C1,A1,PCP1,C2,A2,PCP2, C3, 
A3,PCP3 
NrsD/nrsD 104199/2760 
Clostridium beijerinckii
NCIMB 8052 37 
Predicted hybrid 
NRPS/ PKS KS, GloB 
NrsE/nrsE 42983/1098 
Eubacterium dolichum 
DSM 3991 27 
hypothetical 
protein 
HTH_ARSR, Arsenical 
Resistance Operon Repressor 
NrsF/nrsF 62320/1650 
Clostridium beijerinckii
NCIMB 8052 48 
Predicted NRPS 
adenylation 
domain  Not detected 
1. mcbC-lik e_oxidoreductase is  the ox ydase do main of NRPS (non-ribosomal peptid e synthetase) and  other  pr oteins that 
modify polypeptides by cyclizing a thioester to form a ring. 
 
During annotation, one unique gene cluster was identified, encoding domains for lipopeptide 
synthetases and polyketide synthases.  This gene cluster was nam ed nrs. It is located 2,868 kb 
downstream from  the replication origin in co unter-clockwise orienta tion, and is inserted 
between ytzC and ytqA. RBAM_027480, located direc tly in front of the nrs gene cluster , is 
transcribed in its opposite direction. Acco rding to the conserved dom ain analysis, 
RBAM_027480 is a putative m ulti-drug resis tance gene.   The nrs gene clus ter involves s ix 
ORFs and has some unusual features: 1) the thioesterase is not located at the end, but in front  
of the gene cluster ( Table 8); 2) NrsC contains three m odules for NRPS. Notably , there are 
three repeats ranging from  the end of C1 up to  the m iddle of T3 spanning a total length of 
8982 bp. These repeats show 98% to 100% identity on nucleic acid s level. C1 and T3 show a 
low homology (around 70%) to C2/C3 and T1/T2, respectively (Table 8); 3) three adenylation 
domains (A1, A2 and A3) possess the sam e substrate specificity , namely cysteine ( Table 8). 
Until now, the function of this gene cluster could not be elucidated (see later section 3.3.4). 
bacABCDE is responsible for the biosynthesis of bacilysin in dif ferent Bacilli [101] and is 
also present in the genome of FZB42, displaying a high similarity (between 84% and 93%) on 
the protein level to the corresponding gene cluster in B. subtilis  168. In com parison with 
Bacillus su btilis 168, the genes in the neighborhood of the bac g ene clus ter are well 
conserved. A recently published paper claimed that yvfI is essential for bacilysin biosynthesis 
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as a transcription regulator [131].  Co rresponding to its localization in BS168, yvfI was found 
about 339 kb upstream of the bac gene cluster. LacR, another transcription regulator, which is 
located ups tream of the bac gene cluster , is rearranged in  the genom e of FZB42 and is  
replaced at its original position by the unique gene RBAM _031480. Analysis of conserved 
domains revealed that RBAM _031480 contains an aminotransferase. Recently, we found that 
bacilysin inhibits grow th of phytopathogenic E. amylovara, the caus e of fire bligh t diseas e 
[Lit. 2].  
3.2.3 Whole genome screening of drug efflux proteins 
Drug efflux proteins can contribut e to na tural insensitivity to antibio tics and a re one of  the 
most important tools used for antibiotics resistance. These pr oteins are widely distributed in 
the genom e of FZB42 (Supplem entary table 1). T otal 59 genes, in another words 42 
transporter system s, are invo lved in m ultidrug transporti ng, thereof six belong to ABC-
transporter system s. Except the A BC-transporter for bacitracin, m ersacidin and subtilin, 
YfiLMN1 i s partially sim ilar to BS168, whilst the other two ABC-transporter system s are  
unique in FZB42 (Supplementary table 1). 
Table 9. Features of the proteins belong to SMR (small multidrug resistance) family: 
 Gene TMHMM Protein length [aa] MW (Da) 
ykkC 4 1 12 11894
ykkD 3 10 4 11236
ebrA 4 10 4 11289
ebrB  3 1 17 12406
yvaE 3 12 1 13368
yvaD  4 13 5 16288
yvdS 4 10 9 12004
yvdR  3 10 4 11105
 
SMR (sm all m ultidrug resis tance) f amily proteins are the sm allest anti-por ters th at expel 
various toxicants f rom bacterial cells to conf er multidrug re sistance to the cell. The y consist 
of proteins with only 100 to  120 am ino acid  residues and four transmembrane spanning α-
helices [132]. YkkCD a nd ErbAB, m embers of the SMR f amily, could  be de tected in the  
FZB42 genome. According to the protein leng th, two further candidates were found, Y vaED 
and Y vdSR.  T ransmembrane helix analysis showed that YkkC, EbrA, Y vaD a nd Y vdS 
possess four TMHs, but YkkD, EbrB, YvaE and yvdR have only three (Table 9). According to 
the work from Saiers´ group [133, 134], there is a TMH in the beginning of the N-terminus of 
EbrB and YkkD, whe re YkkD, EbrB, Y vaE a nd Y vdR share highly conserved sequence 
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(Figure 17). This indicates that YvaE and YvdR have also four TMHs.  It was reported that the 
conserved m embrane-embedded glutam ate in th e f irst tr ansmembrane helix is a bsolutely 
conserved in all SMR fa mily m embers [135, 136]. Except Y vaD, the other seven proteins 
contain glu tamate resid ues in  the first transm embrane helix ( Figure 1 7). The am ino acid  
sequence of the first transm embrane helix from  YkkC and YvdS is almost the same, and its 
glutamate residues are located in the same positions (Figure 17).  
3 aa 20 aa 26 aa 45 aa 52 aa 74 aa
84 aa 101 aa
A. Helix 1 Helix 2 Helix 3
Helix 4  
 
31 aa 53 aa 57 aa 79 aa
86 aa 103 aa
B. Helix 1 Helix 2
Helix 4
Helix 3
 
Figure 17 Multiple sequence alignment of p utative members of th e SMR fa mily: putative  
transmembrane helix are represented by the lines with the start and stop position on the protein. 
The solid line stands for the TMH detected by the software TMHMM; the dashed line stands for 
the TMH prediction by comparison with the wo rk of Saiers`  group. A. Pr oteins with 4 TMHs 
(YkkC, ErbA, YvaD and YvdS) were aligned. B. Proteins with 3 TMHs (YkkD, ErbB, Y vaE and 
YvdR) were aligned. 
 
3.3 Functional analysis of B. amyloliquefaciens FZB42 genome 
3.3.1 Analyzing polyketides produced in B. amyloliquefaciens FZB42 
In this part, I ana lyzed genetically the three polyketide gene clusters toge ther with ch emical 
detection methods, like HPLC, LC-ESI MS and MALDI-TOF MS. The results of this analysis 
have been published in pa rt in several papers ( Lit. 1, Lit. 2, Lit. 3, Lit. 4, and Lit. 7). Here I 
will summarize the most important results and present some additional aspects of my analysis. 
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3.3.1.1 Identification of three polyketides produced by B. amyloliquefaciens FZB42 
In antibiotic activity tests,  our lipopeptide synthetases knoc kout m utants showed decreased 
antifungal activities at dif ferent levels, but the antibacterial activ ity of FZB42 a gainst B. 
megaterium was not affected (Figure 18). This indicates that antibacterial activity of FZB42 is 
not due to lipopeptides, but m ight be cau sed by polyketides, bac ilysin or other unknown 
bacteriocins [8]. In order to inv estigate whether the pks1, pks2 and pks3 gene clusters can 
produce antibacterial polyketid es, knockout m utants CH6 ( ∆pks1::cmR), CH7 ( ∆pks2::cmR) 
and CH8 ( ∆pks3::emR) were analyzed by bioautography as well as by chem ical detection 
methods. 
A
B C FZB42
AK1
AK2
CH1
AK3
 
Figure 18. Lipopeptides ar e responsible for antifungal activity: the indicator  strain in A  and B  
was Fusarium oxysporum f. sp. cucum erinum DSMZ 62313. In the single m utants, AK1 (bmy-) 
shows weak activity ag ainst F. oxysporum , whereas CH1 (srf-) and AK2 (fen-) have the same 
effect like wild type FZ B42 on  inhi biting growth of  F. oxysporum. The double m utant (bm y-, 
fen-) shows loss of almost all of this activity. None of the  mutants does suppr ess the gr owth of 
Bacillus megaterium (C). [Lit. 8] 
 
Bioautography dem onstrated, that in com parison to the wild typ e, in each of  the sing le 
mutants CH6 (pks1-), CH7 (pks2-) and CH8 (pks3-) one of the four inhibition zones produced 
by FZB42 against B. megaterium was missing (Figure 19). The double mutants CH1 1, CH12 
and CH14 c orroborated this finding [ Lit. 7]. The pks3 product m igrated slowest among the 
three polyketides and was located closest to th e start front on the TLC-p late, suggesting that 
pks3 is m ost hydrophilic. In contrast, pks1 is the m ost hydrophobic com pound due to its 
fastest migration in the running buf fer (Figure 19). The high est antibacterial activity agains t 
B. megaterium  was caused by pks3, displaying the bi ggest and clearest inhibition zone on 
bioautographs (Figure 19).  The antibiotic halo produced by pks1 was stronger and more clear 
than that of pks2, but it seem ed that pks2  did more diffuse into the agar due to its bigger size 
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of the inhibition  zone  ( Figure 19 ).  Am ong the lipopeptides  produced by FZ B42, only 
surfactin showed a weak antibacterial effect (Figure 19). 
mln (pks2)
FZB42   CH6    CH7 CH8
bae(pks1)
dfn (pks3)
srf
A. B.
D.C.
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Figure 19 Bioautography of wild type FZB42, CH6, CH7 and CH8 and UV spectrum of the three 
polyketides: A. Bacillus megateriu m was u sed as  the indicator  strain; B. UV  sp ectrum of 
bacillaene; C. UV spectrum of macrolactin; D. UV spectrum of difficidin. The UV spectrum was 
obtained from190 nm to 550nm. 
 
In cooperation with Professor Süßmuth´s group and Dr . Vater, the three com pounds were 
identified as  bacillaene (bae), m acrolactin (mln) and dif ficidin (dfn) using LC-ESI MS and 
MALDI-TOF MS [113, 119]. This was for the firs t time that three giant polyketide synthases 
responsible for biosynthesis of bacillaene, m acrolactin and dif ficidin have been assigned 
genetically [Lit. 4 and Lit. 7]. The genomic information of these three polyketides allowed to 
elucidate their biosyn thesis pathways (Supplementary figure 1, Supplementary figure 2 and 
Supplementary figure 3) and to determine the structure of bae [130]. LC-ESI MS allowed us to 
identify dif ferent der ivatives of  these th ree polyketides:  six ba cillaenes (b acillaene, 
dihydrobacillaence and another four derivates with unknown modification), four macrolactins 
(macrolactin A, O- malonyl-macrolactin A, 7- O-succinyl-macrolactin A and m acrolactin D) 
and two molecular forms of difficidins (difficidin and oxydifficidin) were identified in FZB42 
( 
Table 10). In the following, I will u se the term s difficidin, macrolactin and bacillaene for all 
their derivatives. The retention tim es and molecular m asses of these com pounds are 
summarized in  
Table 10. 
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Table 10 Bacillaene, m acrolactin and dif ficidin and their deriva tives produced in B. 
amyloliquefaciens FZB42: 
Polyketide R t (LC-ESI)
1 Rt (HPLC)
2 Mass3 Modification  
Bacillaene (bae 3-A) n.m.4 6.2 (?) 842.41 unknown modification 
dihydrobacillaence (bae 3-B) n.m.4 6.3 (?) 844.42 unknown modification 
bacillaene (bae 2-A) 6.53 6.5  742.4 hypothetical sugar 
dihydrobacillaence (bae 2-B) 6.53 6.5  744.41 hypothetical sugar 
Bacillaene (bae 1-A) 7.61 7.40 580.34 basic structure 
Dihydrobacillaence (bae 1-B) 7.71 7.51 582.3 basic structure 
macrolactin A (mln 1) 7.2 7.26 402.4 basic structure 
O-malonyl-macrolactin A (mln 1) 7.39 7.26 488.3 malnoyl-group 
7- O-succinyl-macrolactin A (mln 1) 7.43 7.26  502.4 succinyl-group 
macrolactin D (mln 2) 6.27 6.011 664.2 
succinic acid as a half-
ester connected with 
glucose 
difficidin (dfn 1) 10.91 9.041 544.4 basic structure 
oxydifficidin (dfn 2) 8.54 8.401 560.3 oxidation 
1. Retention time obtained from LC-ESI MS (from the thesis of K. Schneider) 
2. Retention time obtained from HPLC 
3. Mass obtained from LC-ESI MS (from the thesis of K. Schneider) 
4. Not mentioned in the thesis of K. Schneider 
5. “?” stands Rt that was not available from LC-ESI MS (from the thesis of K. Schneider) 
 
The HPLC method is commonly used in detecting compounds with UV absorption because of 
its rapid application, high reproducibility of re sults and possibility for sem i-quantitative 
determination. Analyzin g the wild  type and  th e m utants, at leas t four bacillaene, two 
macrolactin and three d ifficidin isoforms were detec ted in th e supernatant of FZB42 ( Figure 
20). Because HPLC does not allow the determ ination of the m asses of polyketides, their 
unique UV spectrum was used to identify these polyketides ( Figure 19B, C and D). However , 
the different derivatives could not  be distinguished in HPLC wit hout their masses. In order to 
overcome this problem, the retention time was applied in combination with the UV spectrum, 
because the reten tion tim e of these com pounds was constant under s ame conditions. The 
sample preparation and running condition of HPLC and LC-ESI MS were the same, so masses 
of the compounds in HPLC were deduced from LC-ESI MS by comparing their retention time 
( 
Table 10). The retention time of di fferent forms of bacillaene was determ ined as 6.2, 6.5, 7.4 
and 7.5 ( Figure 20 ). T he peak  at R t = 6.2 was attributed to b ae 3A  and bae 3B. Their  
modification is unknown. The peak at R t = 6.5 probably corresponds to bae 2A  and bae 2B, 
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whose modification could be cau sed by a sugar re sidue according to their empirical formula. 
Subject to the area of these peaks, bae 2 is the main bacillaene product of FZB42. The peak at 
Rt = 7.4 could be assign to bae 1A and Rt = 7.5 to bae 1B. Their structures were determined by 
Butcher et al. [130]. The retention time of macrolactins was 6 and 7.3 minutes, which indicate 
that the  tw o isof orms are d ifferent in  the ir p olarity ( Figure 20 ). The peak R t = 6 was 
ascertained for m ln 2 and R t = 7.3 for m ln 1. The retention times of dif ficidins were 
determined with 7.7, 7.9, 8.4 and 9.0 m in (Figure 20). Rt = 9.01 was supposed to be dfn1 and 
Rt = 8.4, dfn2.  R t = 7.7 and 7.9 could not be found in LE-ESI MS, so no m ass could be 
assigned to these dfn isoforms. 
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Figure 20 HPLC of the knockout m utants CH6, CH7 a nd CH8: Four  peaks which wer e 
disappeared in the HPLC fr om the su pernatants of the mutant  CH6 (bae-).  In the mln--mutant 
CH7 two pe aks were not  present. Four peaks we re disappeared in the df n- -mutant CH8. The 
chromatographs were selected by the wavelength at 280 nm. 
 
3.3.1.2 Analyzing the roles of trans-AT in the synthesis of FZB42 polyketides  
One of the most im pressed feat ures of the m odule or ganization in these three polyketide  
synthases is absence of A Ts in every m odule. In to tal, five acyl-transf erases (A T) were 
ascertained within the three gene c lusters.  Three ATs (Bae1AT in Ba eC, Bae2AT in BaeD, 
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Bae3AT in BaeE) are in front of the bae gene cluster, one is upstream of dfn (DfnAT in DfnA) 
and mln (MlnAT in MlnA).  
To examine the role of these acyl- transferases, the mutants CH24 (Bae1AT-), CH25 (Bae2AT-
), CH26 (Bae3A T-), CH27 (MlnA T-) and CH9 (DfnA T-) were con structed by com plete 
deletion of the AT domains. In this work, two approaches were applied in order to analyze the 
effect of deleting AT domains on biosynthesis of these polyketides.  
One of them  was to co mpare the s ize of the inhibition zones via bioa utography. The size of  
the inhibition activity of a give n compound is only dependent on its concentration: the higher 
the concentration, the bigger the inhibition zone. Deletion of one of the AT domains in the bae 
gene cluster did cause not only disappearance of the respective bae inhibition zone, but also a 
dramatic reduction of the inhibition zone of dfn. Inhibition of mln was only slightly reduced . 
On the contrary, knockout of the A T-domain of the mln or dfn gene cluster did not af fect the 
inhibition zone of bae, only its own inhibition zone was reduced or disappeared (Figure 21). 
 
Figure 21 Bioautograph analysis for FZB42 and its AT deletion mutants 
 
Inhibition zones from  the bi oautography are corresponding roughly to the amount of 
antibiotic, but this m ethod is quite insensit ive. T o overcom e this disadvantage, a sem i-
quantitative method coupled with HPLC was al so used in analyzing polyketide production. 
HPLC chromatography of FZB42 and its AT deletion mutants is shown in Supplementary figure 
4. The area of a peak  in a ch romatograph was determined by integration. Because more than 
one peak ex ists for all three polyk etides, all peaks from one polyketide  were added together . 
Destruction of BaeA T1, BaeA T2 or BaeA T3 ge nes with  an antib iotic res istance casse tte 
caused: 1) almost complete loss of its ability  to produce bacillaenes; 2) strong im pact on the 
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production of dif ficidins (5-fol d reduction in com parison with FZB42 wild type); 3) less 
effect on the production of m acrolactins (1- to 2.5-fo ld reduction in com parison with FZB42 
wild type) ( Table 1 1). Knockout of the A T-domain of the mln syntha se led to in ability to 
produce m acrolactins, whilst the production of di fficidins and bacillae nes was not af fected 
(Table 11).  Interestingly , deletion of the df n AT-domain did not only interrupt synthesis of 
difficidins, but also reduced 2-fold the production of bacillaenes and m acrolactins (Table 11). 
The resu lts from  se mi-quantitative HPLC analysis corroborated  the resu lts from  
bioautography. 
Table 11 Quantification of bae, mln and dfn peaks in FZB42 and their mutants by HPLC: 
0
2000
4000
6000
8000
10000
12000
Strain
In
te
gr
at
ed
 A
re
a 
fo
r t
he
 P
ea
ks
dfn
mln
bae
dfn 76,7 97,8 86,60 4663,96 73,4 3975,9
mln 2273,5 2716,7 4392,40 0,00 3430,2 7153,4
bae 32 0 0,00 9713,88 5266 10216
CH24 
(∆bae1AT)
CH25 
(∆bae2AT)
CH26 
(∆bae3AT)
CH27 
(∆mlnAT) CH9 (∆dfnAT) wt
 
3.3.1.3 Analysis of proteins involved in difficidin synthesis 
In this work, we have demonstrated f or the first time that difficidin is synthesized by the pks3 
(dfn) operon. Polyketide synthase of dif ficidin belongs to type I PKSs. Its biosynthesis 
pathway follows the co-linearity rule, which allowed to construct a model for the synthesis of  
difficidin ( Supplementary figure 3, [ Lit. 7]). Som e genes bel ong to this operon, but do not 
encode any module. These are dfnK, dfnL and  dfnM.  T o find out whet her these genes are 
essential for biosynthesis of difficidin, knockout mutants were constructed (Figure 22). 
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dfnM dfnL dfnK dfnJ (partial)
BamHI
HindIII
emR
BamHI
EcoRITE
BlpI
BspEI
emR
BstEII
KpnI
cmR cmR
CH17 CH16Mutant: CH15 CH10  
Figure 22 Construction of the mutants in dfn operon. 
 
Protein s equence analy sis showed that DfnK  possesses a conserved dom ain (cytochrom e 
P450). Interestingly, BaeS contains also a cy tochrome P450 dom ain, but these two proteins 
share very low si milarity on the a mino acids level (about 30%). In the mln operon, such a 
conserved dom ain does not exis t. Com paring the supernatan ts from  FZB42 with CH15, a  
dfnK deletion m utant, revealed that not only difficidin but also m acrolactin production 
decreased almost completely (Figure 23). In the case of bac illaene, the results appeared more 
complex. The production of bae 3 and bae 1 redu ced dramatically, however the production of 
bae 2 increased ( Figure 23 ). Interestingly, som e new HPLC peaks could be detected in the 
area between the fourth  and sixth m inute in the supernatant of CH15 ( Figure 23 ), and these 
peaks did show UV -spectra dif ferent from  the three polyketides produced by wild-type 
FZB42.  
DfnL contains a conserved 3-hydroxy-3-m ethylglutaryl CoA synthase  dom ain. Its deletion 
mutant CH16 was unable to produce dif ficidins. Production of bacillaenes and m acrolactins 
was not altered.  No new peaks could be found in the HPLC from  the supernatant of CH16 
(Figure 23). 
The conserved domain in DfnM is an enoyl-CoA hydratase. Deleting dfnM (CH17) abolished 
dfn production completely. The amount of mln 2 (macrolactin D), a dominant m acrolactin in 
the supernatant of FZB42, was reduced in CH 17, whilst the production of m acrolactin A and 
its derivatives rem ained unchanged. The produc tion of bae 1A, 2 and 3 decreased in the 
supernatant from CH17, whereas the production of bae 1B r emained at the sam e level as in 
FZB42 (Figure 23). 
It is already known that a thioesterase is esse ntial for the release of  the fully synthesized 
polyketides from PKS [137, 138]. In this work, the function of the TE domain of the dfn gene 
cluster was analyzed by  comparison with the T E deletion mutant (CH10). No dif ficidin was 
detected in the supernatant of  CH10. No interm ediates of dif ficidins could be detected 
probably due to low sensitivity of our HPLC  equipm ent. The am ount of m acrolactins 
remained at the same level as in FZB42, but the bacillaenes production was affected partially, 
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especially the dom inant product bae 2 was reduced  dramatically in the supernatant of CH10 
(Figure 23).  
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Figure 23. HPLC analysis of CH15 (dfnK-), CH16 (dfnL-), CH17 (dfnM-) and CH10 (TE 
domain knockout): the polyketides were detected 280 nm; t he black cir cle shows th e ar ea of   
peaks that differ between FZB42 and CH15. 
 
3.3.1.4 Identifying the precursor for the starter and elongation units for macrolactin 
To know the substrates that can be utilized in the biosynthesis of m acrolactin, a feeding 
experiment with 13C-labelled sodium acetate was performed.  In order to obtain a h igh quality 
of 13C-labelling in the macrolactin backbone, the amount of the carbon source, glucose in case 
of Landy medium , should be kept as low as  possible, but cell growth and production of 
macrolactin should not be strongl y affected. To determine the optim al glucose concentration 
for the grow th of CH11, the growth behavior of CH11 in Landy m edium with four dif ferent 
glucose concentrations (2%, 1%, 0.5% and 0.25%) was compared. The maximal cell densities 
were only slightly reduced in de creasing glucose concentrations (Figure 24). Because of their 
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minor effect on cell growth, Landy medium with the lowest glucose concentration was chosen 
for the feeding experiment. 
0.01
0.1
1
10
100
0 10 20 30 40 50 60
Time [h]
O
.D
. 6
00
2%
1%
0.5%
0.25%
 
Figure 24. Growth of CH11 in Landy medium with different concentrations of glucose 
 
The labeled macrolactin A was purified from the supernatant by extraction with ethyl acetate 
and subsequently concentrating by prepara tive HPLC. The pure compound was analyzed by 
NMR MS. NMR-spectrum  of labeled m acrolactin A revealed an altern ating labeling of the 
carbon skeleton with 13C (Figure 25 ). The p eaks of tw elve 13C-enriched carb on atom s 
including th e sta rter un it showed s imilar inten sities. No s ignificant is otopic d ilution was 
observed ( Figure 25 ), which indicated acetate/m alonate as the exclus ive precu rsor for the 
macrolactin skeleton [Lit. 4].  
 
Figure 25. 13C-NMR spectra of (A) macrolactin A and (B) assignment of signals of 13C-labelled 
macrolactin A derived from [1-13C] acetate feeding experiment: The numbers 1, 3, 5….23 in (B) 
indicated the C atoms that are labelled by 13C [Lit. 4]. 
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3.3.1.5 Production of bacillaene, macrolactin and difficidin in environmental strains 
To understand whether production of the thr ee polyketides is a general feature in Bacilli, 29 
different Bacillus strains were in vestigated by LC  ESI-MS and  PCR analysis. The 
supernatants of these strain s grown for 36-hour in Landy m edium we re extracted by ethyl 
acetate. Because the A T dom ains were essent ial and sp ecific for the production  of these 
compounds (3.3.1.2), five pairs of prim ers were designed according to the sequences of these 
AT domains present in the genome of FZB42.  
The PCR analysis for the mln gene cluster corroborated the LC ESI-MS result, while the 
results for bacillaene and difficidin were not always corresponding (Table 12).  
B. amyloliquefaciens UCMB-5044 and QST713 were found to produce dif ficidin by LC-ESI 
MS, but their PCR fragm ent was bigger than that  of FZB42. This indicated that the dfn A T 
domain is more variable than the one of mln (Table 12).  
The HPLC ESI-MS re sults of  the three B. lichenifo rmis strains (S167, S173 a nd B37) 
indicated that they m ight produc e dif ficidins, but no PCR frag ment of the dfn A T dom ain 
could be amplified using chrom osomal DNA  from  those strains ( Table 12). According to 
database and literature, there is no report that B. licheniformis can produce difficidins. 
The bacillaene gene clus ter in the genome of FZB42 contains three dif ferent trans-ATs. In 14 
strains, bacillaene could be detected by both HPLC ESI-MS a nd PCR with appropriate size, 
corresponding to the re lated FZB42 sequence ( Table 12). In B. amyloliquefaciens  DSM7,  
three bacillaene A T dom ains we re detected by PCR with the sam e size as in FZB42, but  
bacillaene could not be detected in  the supernatant by HPLC ESI-MS ( Table 12). It can be 
speculated that a dy sfunctional PP Tase m ight be the reason for absence of bacillaene in 
DSM7, as i n BS168. In B. amyloliquefaciens UCMB-5044 and QST713, bacillaene could be 
detected by LC-ESI MS, but not all of the three AT domains were amplified by PCR analysis, 
only the second baeAT yielded a PCR fragm ent corresponding to FZB42. The PCR products 
obtained from the first and the third baeAT were bigger than those of F ZB42 (Table 12). In 
INR937, the first AT domain has the same size as that of FZB42, and the PCR products of the 
other AT dom ains were sm aller ( Table 12). In case of Bacillus subtilis  subtilis  FZ B37 and 
Bacillus sub tilis spizen ii UCMB-5014, bacillaene could be detected by LC-ESI MS in the 
supernatants ( Table 12). The BaeA T specific prim ers a mplified in UCMB-5014 fragm ents 
with dif ferent sizes to that of FZB42. No P CR products could be det ected in FZB37 when 
using th e p rimers for BaeA Ts ( Table 12). T aken together , thes e results suggest that the 
sequences of AT domains in the bae gene clusters are highly variable. 
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Table 12. Production of bacillaene, m acrolactin a nd dif ficidin in dif ferent Bacillus strains  
detected by the PCR products of the AT domains and HPLC ESI-MS: 
Macrolactin Bacillaen e Difficidin 
PCR PCR PCR 
strain mlnAT MS
1. 
baeAT 
2. 
baeAT 
3. 
baeAT MS dfnAT MS
Bacillus amyloliquefaciens B9601-Y2  + +  +  +  + +  + + 
Bacillus amyloliquefaciens FZB 24 + +  +  +  + +  + + 
Bacillus amyloliquefaciens FZB 42 + +  +  +  + +  + + 
Bacillus amyloliquefaciens FZB 45 + +  +  +  + +  + + 
Bacillus amyloliquefaciens FZB 109 (A1/3) + +  +  +  + +  + + 
Bacillus amyloliquefaciens FZB 113 (QST 113, 
Serenade) + +  +  +  + +  + + 
Bacillus amyloliquefaciens FZB 111 (GB03, 
Kodiak) + +  +  +  + +  + + 
Bacillus amyloliquefaciens GaoB2 + +  +  +  + +  + + 
Bacillus amyloliquefaciens GaoB3 + +  +  +  + +  + + 
Bacillus amyloliquefaciens Gao55 + +  +  +  + +  + + 
Bacillus amyloliquefaciens Gao85 + +  +  +  + +  + + 
Bacillus amyloliquefaciens GB 03 (Kodiak) + +  +  +  + +  + + 
Bacillus amyloliquefaciens UCMB-5044 + +  +  +  + +  + + 
Bacillus amyloliquefaciens UCMB-5113 + +  +  +  + +  + + 
Bacillus amyloliquefaciens FDK21 + +  >  +  > +  > + 
Bacillus amyloliquefaciens QST713 (Serenade) + +  >  +  > +  > + 
Bacillus amyloliquefaciens DSM7  - -  +  +  + -  - - 
Bacillus amyloliquefaciens BE 20-2 - -  -  -  - -  - - 
Bacilus licheniformis ATCC 9789 (B27)  - -  -  -  > -  - - 
Bacilus licheniformis (B37) - -  -  -  > -  - + 
Bacilus licheniformis S167 (9945A) - -  -  -  - -  - + 
Bacilus licheniformis S173 (Gibson 1158) - -  -  -  > -  - + 
Bacilus licheniformis S175 (NCIMB 7724) - -  -  -  > -  - - 
Bacillus mojavensis UCMB-5075 - -  - <  + -  - - 
Bacillus mojavensis MB2 - -  -  < - +  - - 
Bacillus pumilus INR-7 - -  -  -  - -  - - 
Bacillus subtilis spizenii At3 - -  <  <,>  <,> -  - - 
Bacillus subtilis spizenii UCMB-5014 - -  <  <,>  < +  - - 
Bacillus subtilis subtilis INR 937 - -  +  <  < +  - - 
Bacillus subtilis subtilis FZB 37 - -  -  -  - +  - - 
“+” stands for presentation of the compound in HLC-ESI MS or the PCR fragment with the same size like FZB42; 
“-”stands for absence of the compound in LC-ESI MS or the PCR fragment;  
“>” stands for the PCR fragment was bigger than the one of FZB42; “<” stands for the PCR fragment smaller than the one of FZB42;  
Blue = the result from PCR agreed with the result from LC-ESI MS and the size of the PCR fragment was same to the one from FZB42; 
Yellow = PCR fragment with the size like FZB42, but no corresponding compound in LC-ESI MS; 
Pink = LC-ESI MS could detected the compounds, but the PCR fragment was absent or present in a size differing to that of FZB42. 
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In summ ary,  all plant growth prom oting B. amyloliqu efaciens (16 strains) can produce 
bacillaene, m acrolactin and dif ficidin  [139]. The two B. amyloliquefaciens  without PGPR 
effect can produce none of these polyketides.  The four strains that can only produce 
bacillaene belong to Bacillus subtilis  (three strains) or Bacillus majavensis (one strain), and 
their AT domains varied to the ones from FZB42 strongly (Table 12).   
3.3.2 Role of yczE in production of secondary metabolites 
A.
 
 
1 aa 11 aa 77 aa 82 aa 136 aa 163 aa
B.
 
Figure 26. Com putational analysis of the pr otein YczE: A. YczE contains a possible signal  
peptide; B. YczE is a hypothetical trans-membrane spanning protein. 
 
yczE (215 aa) is located directly downstream of sfp and is transcribed in opposite direction to 
DNA replication and sfp transcription. YczE has a signal pe ptide that could be cleaved of f 
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between 39 aa and 40 aa of the protein with five trans-m embrane helices ( Figure 26). The  
main part of the YczE protein consists of trans-membrane helices whilst cytoplasm ic and 
extracytoplasmic segm ents are very short. No  functional dom ain could be found in this 
protein. 
 
Figure 27. Effect of YczE on pr oduction of po lyketides and lipopeptides: A. HPLC shows 
reduction in pr oduction of bacillaene (bae), macr olactin (mln) and difficidin. B. Loss of 
antibiotic activity of the polyketides and surfactin (srf) again st Bacillus megaterium (right); loss 
of antibi otic activity of  bacillomycin D and  (partially) fe ngycin (fen)  against Fu sarium 
oxysporum (left). 
 
During genome annotation, it was no ticed that YczE hits  to YczE3B (99% sim ilarity at the 
amino acid level). yczE3B is in the  region whe re the  seque nce is quite conserved in m any 
surfactin producing Bacillus strains, so it was thought that yczE3B could be involved in 
production of surfactin, but no experimental evidence was pr ovided [140]. T o ve rify this 
hypothesis, yczE was disrupted in the genom e of FZB42 by insertion with an erythrom ycin 
resistance cassette. The produc tion of lipopeptides and polyketides w as exam ined by bio-
autography, HPLC and MALDI-T OF MS. Surprisi ngly, bioautography dem onstrated that the 
inhibition zone of surfa ctin against B. megaterium  remained in CH4 ( yczE-), but th e activity 
of bacillaen e, dif ficidin and m acrolactin disappeared. Bacillom ycin D , the m ost pr ominent 
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lipopeptide produced by FZB42 i n Landy medium, lost its activity against Fusarium 
oxysporum in CH4, whilst production of fengycin was only slightly reduced in CH4 ( Figure 
27B). Using HPLC, t he am ount of the polyketides w as estim ated. The production of  
macrolactin and dif ficidin was com pletely abolished in CH4. However , production of bae in 
CH4 was only partially af fected: production of b ae 3 remained constant whilst production of 
bae 2 and bae 1 was reduced significantly (Figure 27 A). 
To confirm whether YczE is involved in regulation of lipopeptides and polyketides production 
on transcriptional or translati onal level, the promot er fusion strains of FZB42 (CH41) and 
CH4 (CH42) whose original prom oter of the bmy cluster was replaced by the promoter P spac 
from pECE149. The lacI gene was co-transformed in CH41 and CH42 by insertion in front of 
the Pspac promoter, so th at the expression of  bacillomycin D could b e induced by IPTG and 
became independent of its possib le transcriptional regulators. Saccharomyces cerevisiae was 
sensitive only against bacillom ycin D a mong all an tibiotics produ ced by FZB42, and was 
used as an indicator for the agar-diffusion test indicating the production of Bacillomycin D in 
CH41 and CH42. 30-µl supernatants from  CH41 and CH42, both with or without IP TG, were 
added to ch eck the activity of Bacillom ycin D. CH4 was used as a n egative control and  
FZB42 as a positive control. The bi oassay s howed t hat CH41 could resto re its  a bility to 
produce bacillomycin D after adding IPTG, and implied that the promoter Pspac in front of the 
bmy gene cluster was functional.  In contrast , CH42 did not restore the ability to produce 
bacillomycin D even after addin g IPTG , wh ich indicated that YczE could not be a 
transcriptional regulator of the bmy gene cluster.  
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Figure 28. Bacillomycin D antibiotic activity in the strains whose bmy gene cluster was regulated 
by IPTG: A. Saccharomyces cerevisiae was u sed as an indicator. FZB42 and CH4 were used as 
controls grown in Landy medium without IPTG [Lit. 5]. B. YczE affects bmyD synthesis 
 
To confirm whether YczE is i nvolved in regulation of lipopep tide and polyketide synthesis, 
promoter fusion strains of FZ B42 (CH41) and CH4 (CH42) whose original prom otor of bmy 
cluster was substituted by the Ps pac promoter from pECE149. The lacI gene was integrated 
into CH41 and CH42 in front of the Pspac pr omoter, resulting in IPTG-inducible ex pression 
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of bacillomycin D independently f rom possible tran scriptional reg ulators. Saccharomyces 
cerevisiae was sensitive only against bacillomyci n D a mong all antibiotics produced by 
FZB42, and was chosen as indicato r for production of  Bacillomycin D in CH41 and CH42. 
30-µl supernatants from CH41 and CH42, cultiv ated with or without IPTG , wer e used to 
determine a ctivity of  Bacillom ycin D. CH4 was used as negative control and FZB42 as  
positive control. The ag ar diffusion-test showed that CH41 can res tore its ability to produce 
bacillomycin D by adding IPTG , and im plied that Pspac promotor in front of the bmy gene 
cluster was functional ( Figure 28).   In contras t, CH42 coul d not restore ability  to produce 
bacillomycin D even by adding IP TG, which i ndicated tha t YczE is  n ot a trans criptional 
regulator of the bmy gene cluster promoter (Figure 28, Lit. 5).  
 
3.3.3 Role of sfp in the production of secondary metabolites 
Two 4 ′-phosphopantetheinyl (Ppant) tr ansferase genes are presen t in the genom e of FZB42, 
sfp and acpS.  AcpS is known to be involved in produc tion of fatty acids, and Sfp is essential 
for synthesis of active NRPS. Si milar to BS168, sfp is located downstream from the srf gene 
cluster. However , instead of ycxA and ycxB, two unique genes, RBAM_003700 and 
RBAM_003710 are present between sfp and srf in the genom e of FZB42. RBAM_003700 
contains a conserved dom ain with sim ilarity to am inotransferase, whereas RBAM_003710 
possess no conserved dom ains.  N o other featur es useful to predict a possible function of 
these two unique genes do exist.  
It is known that dif ferent 4′-phosphopantetheinyl transferases share only low sim ilarity (10% 
to 20%) [ 95]. Theref ore, it is very dif ficult to identif y alter native Ppan t transf erase in the 
genome of FZB42 by BLAST . Sfp can convert apo-ACPs to holo-ACPs in vitr o, but no 
investigation has been carried out to  evaluate the function of Sfp in cont ext of a real cellular 
system. In order to investig ate roles of Sfp in FZB42, sfp gene was disrupted in FZB42. The  
supernatant of CH3 ( sfp-) grown in Landy medium  was analyzed by bioautography and 
HPLC. CH3 did not develop in hibitory a ctivity agains t B. megaterium  and F. oxysporum 
(Figure 29B). HPLC confirm ed that neither pol yketides nor lipopeptides were produced by 
the CH3 mutant ( Figure 29A). By contrast, the sfp0 Bacillus subtilis can produce both 
surfactin and bacillaene after restoring the functional Sfp [Lit. 7].  
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Figure 29 Effect of Sfp on pr oduction of  polyk etides and lipopeptides: A. HPLC sh owed no 
production of bacillaen e (bae), macr olactin (mln) and diff icidin. B. Bioautograph y: loss of 
antibiotic activity of polyketides and surfacti n (srf) agai nst Bacillus megaterium (right); loss of 
the antibiotic activity of bacillomycin D and Fengycin (fen) againstFusarium oxysporum (left) 
 
3.3.4 The nrs gene cluster 
It was not known so far whether the nrs gene cluster is expresse d in FZB42. T o find out the 
conditions for the transcription of the nrs gene cluster , reverse tr anscription PCR (R T-PCR) 
was perform ed.  FZB42 cells grown in Landy medium were collected at m id-exponential 
phase for isolation of total RNA. The purity of  RNA was checked by P CR using th e primer 
pair nrs2f and nrs1-r . In order to analyze expression of the nrs gene cluster, the primer nrs2f 
(5´-TGGTATGCTAACATATAATCTC-3´) was  used for reverse R T-PCR. As a negative 
control, the primer nrs2-r was used. To visualize the cDNA product on agarose gel, the cDNA 
was amplified by the p rimer pair  nrs2-f and nrs1-r . A 273-bp fragment was obtained, if the 
primer nrs2-f was used, but no PCR product could be obtained in the case the prim er nrs2-r 
was used. This result demonstrated that the nrs gene cluster is transcribed in m id-exponential 
phase (Figure 30).  
λ DNA
HindIII
EcoRI
nrsr-1        - +                -
nrsf-2        +                  - -
 
Figure 30.  RT-PCR product from the nrs gene cluster 
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The nrs gene cluster involved th ree m odules for the lipopeptide synthesis, which is 
responsible for condensation of three cysteines.  The m odule organization is very sim ilar to 
that of yersiniabactin synthetase [141, 142] . The gene cluster en coding yersiniabactin 
synthetase contains five genes: irp2, the first gene of the operon, contains two m odules of 
NRPS for two cysteines; ipr1 contains one PK S module and one m odule for NRPS for the 
third cy steine, while nrsD contains three NR PS m odules for cysteine; the condensation 
domains of these cys teine can ci rcularize the cyst eine itse lf ( Figure 31 ). A  transcriptional 
regulator an d a transpo rter gene were found adjacen t to  the structu ral genes ( Figure 31 ). 
Similar to yersin iabactin synthetase, the nrs operon contains also th ree cysteine modules and 
their condensation dom ains can circularize cysteines. NrsA  and NrsB contain two 
thioesterases. However, it is unusual in NRPS or PKS systems that thioesterases are located in 
front of the gene cluster ( Figure 31). Unlike yersiniabactin, these three modules are located in 
one protein, NrsC (Figure 31). Instead in the centre of th e NRPS modules, the PKS module is 
located downstream of the NRPS modules. ArCP, the starter unit of yersiniabactin synthetase, 
is not present in the nrs gene cluster. NrsE contains the conserved dom ain CD00090, a m etal 
regulated repressor. RB AM_02748 is located upstream  of the nrs promoter , its N-term inus 
contains a conserved domain for multi-drug efflux (Figure 31). However, at its C-terminus no 
conserved domains could be detect ed. Similarity in organization of the modules suggests that 
nrs might have siderophore function. 
 
22467 bp
ybtUybtTybtE ybtAfyuA irp1(HMWP2) irp2 (HMWP1)
abaps1238pcr0109
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Figure 31. Module org anization of the nrs gene cluster  in com parison with the yersiniabactin 
biosynthesis gene cluster: A=adenylation dom ain A, AL= acyl Co-A  synthetase, Ar CP= aryl 
carrier pr otein, Cy=cycli zation, PCP=peptidyl  carrier  pr otein, KS= β-ketoacyl synthase,  
AT=acyltransferase, M= methyltransferase, KR=ketoreductase, ACP=ac yl carrier pr otein, 
O=Oxidoreductase, R= transcriptionalregulator, T= transporter. 
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As earlier mentioned, a dhb gene cluster exists in the genome of FZB42 and is responsible for 
production of the sider ophore bacillibactin ( 3.2.2.4). The mutant strains, CH38 with deletion 
of the whole nrs operon, CH39 with de letion of the whole dhb operon and CH40 wit h 
complete deletion of both, dhb and nrs gene clusters, were constr ucted in order to evaluate 
function of nrs in iron transport. FZB42 and its mutants (CH38, CH39 and CH40) were grown 
in Landy medium  with dif ferent iron c oncentrations (0.1 µ M, 0.2 µM and 0.4 µM Fe 2O3) at 
37°C and 210 rpm . The cell density was m easured at O.D. 600 every two hours for 13 hours. 
CH38 (nrs-) had a similar cell density as the wild type. CH39 (dhb-) and CH40 (nrs- and dhb-) 
grew m ore slowly than FZB42, but no obvious differences in cell growths were observed 
between CH39 and CH40 (Figure 32). 
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Figure 32. Cell gr owth curves of FZ B42, CH38, CH39 and CH40 in Landy m edium with 
different iron concentrations. 
 
The iron deprivation experiment did not reveal whether nrs belongs to the siderophore family. 
Therefore, I perform ed an additional e xperiment. CAS-assay was perform ed with 
supernatants from cell cultures grown in Landy medium. In order to eliminate the background 
from unspecific iron complexes, siderophore-free  CH3 was used as negative control. FZB42 
and CH38 secreted the highest am ount of siderophores after 24-hours of  growth. 
Concentration of siderophores decr eased after 36-hours. Whilst CH38 ( nrs-) and  wild type  
FZB42 did not dif fer, the am ount of sider ophores was dram atically reduced in CH39 ( dhb-) 
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after 24 and 36 hrs growth. These results indica ted that siderophores are produced in FZB42 
and the nrs mutant strain, but nearly nothing in CH39.  Notably, the amount of siderophores in 
CH39 was slightly hi gher than in the sfp mutant strain CH3 and the double dhb nrs  mutant 
CH40 (Figure 33) suggesting that nrs might somehow contribute to siderophore production in 
FZB42. 
In order to identify the product(s) of the nrs gene cluster , HPLC, LC- ESI MS and MALDI -
TOF MS were used to detect com pounds in  the supernatants of FZB42, CH38, CH39 and 
CH40 grown in Landy medium for three days, however, no noticeable peak could be detected 
in any of these strains. In addition, cell surface extraction coupled with MALDI-T OF MS, 
which allows detection of compounds binding at the cell membrane, did not yield results. 
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Figure 33. CAS assay: Using the supernatants of FZ B42 and its mutants in Landy medium with 
0.1 µM Fe2O3 
 
3.3.5 Competence and transformation in Bacillus amyloliquefaciens FZB42  
To find out whether B. amyloliq uefaciens FZB42 is transform able under laboratory 
conditions, FZB42 was grown in GCHE medium and cells were harvested at dif ferent times 
from m id-exponential growth phase to late st ationary phase. The experim ents showed that 
transformation happened in the m id-exponential phase and the time-span for competence was 
very short. However , it was not clear whet her transformation during m id-exponential phase 
resulted from a feature unique for FZB42 or  was dependent on the transform ation medium 
(GCHE) that differs from that used in Spizizen´s method [104].   
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Figure 34. Cell growth in GCHE medium: A. cell growth curves; B. the red labelled points (1, 
2, 3, 4, 5 and 6) were gathered for investigating transformation rate. 
 
In order to answer this question, developm ent of com petence in FZB42 was com pared with 
that of BS 168. Linearized plasm ids pFB01 a nd pDG268 (1 µg/m l) were used as exogenous 
DNA for FZB42 and BS168, respectively . The reason for using these tw o integration vectors 
was that both possess sim ilar features. An eryt hromycin resistance casse tte was inse rted into 
the amyC gene from  FZB42 using plasm id pF B01. Correspondingly , a chloram phenicol 
resistance cassette was in serted into the homologous amy gene of BS168 using plasm id 
pDG268. The lengths of the homologous flanking amy sequences from FZB42 and BS168 in 
pFB01 and pDG168 we re around 9 00 bp each.  The overnight LB cultures of FZB42 and 
BS168 were diluted into MDCH at O.D. 600 of 0.3.  The cells  were harvested at three different 
times during m id-exponential and transient phas e. T rue transform ants could grow on agar 
with the corresponding antibiotics  (erythromycin or chloramphenicol). They were unable to 
hydrolyze starch as indicated by absence of clear ing zones onto starch containing agar due to 
disruption of the amyC gene. Ef ficiency of transfor mation was calculated by the ratio of the  
number of transformants and the total number of living cells. The growth curve of FZB42 and 
BS168 showed two plateaus, one was in the mid-exponential phase and the other in the 
transient phase (Figure 34A). Notably, FZB42 was only competent during the plateau of the  
mid-exponential phase with a low transfor mation rate (betw een 6E-7 to 35E-7) ( Figure 35).  
On the contrary, only one transformant was found in the mid-exponential phase of BS168 and 
by then, transformation rate of BS tremendously increased during transient phase (Figure 35). 
The time-window in which FZB42 was competent was found surprisingly narrow, because the 
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transformation rate reached its maxim um at  approxim ately O.D. 600 1.2 and  decreased 
significantly either at 0.98 or  at 1.38. In contrast, the tim e window for com petent BS168 was 
wider and the transformation rate did little change during the 30-min period of investigation. 
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Figure 35. T ransformation rate of F ZB42 and BS168 in GCHE medium:  A. at the m id-
exponential phase; B. at the transient phase. 
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4 Discussion 
4.1 Genomic analysis of B. amyloliquefaciens FZB42 give deep insights 
into the mechanisms for plant growth promotion in Gram-positive 
bacteria 
As a repres entative of plant asso ciated B. amyl oliquefaciens, the genom e of environm ental 
FZB42 possess versatile gene clusters involved  in plant growth prom otion and biocontrol. 
Details about these genes are described in our previous publications ( Lit. 6, Lit. 7 and Lit. 8) 
and reviews ( Lit. 1 and Lit. 2). In this chap ter, several m olecular m echanisms exerted by  
FZB42 to enhance the plant growth are summarized. 
(1) Biofertilization: it is common knowledge, that not the absolute am ount of the nutrients, 
but the availability of these nutrients in the soil is the limiting factor for plant growth. FZB42 
can improve the nutrient availab ility in soil by different ways. Phytase, encoded in phyC, can 
be secreted by FZB42 into the environm ent, wh en concentration of phosphate is low [16, 
143]. Phytase converts insoluble or ganic phytic acid into the inor ganic form  available for 
plants. Furthermore, FZB42 secretes num erous metal binding proteins th at can form soluble 
chelate complexes with metal ions, like copper, iron, molybdenum. Secretion of siderophores, 
like bacillibactin is just one exam ple. The dhb gene cluster directs nonribosomal synthesis of 
bacillibactin. It was r eported th at bacillibactin binds soluble Fe 3+ to f orm a soluble 
siderophore-iron complex that can be actively transported into plant cells [144].  
(2) Phytostimulation: Phytostim ulators enhance plant growth in a d irect way . The 
mechanisms behind the stim ulatory ef fect on root developm ent and crop yield caused by 
FZB42 we are beginning to understand on the ba se of the genom ic infor mation available. 
Besides im provement of nutrients availabil ity, FZB42 can also produce the phytohorm one  
indole-3-acetic acid (IAA) to stimulate plant growth [18]. A careful examination of the whole 
genome sequence of B. amyloliqu efaciens FZB42 revealed three candidate genes with 
apparent homology to genes previously re ported to be involved in IAA m etabolism: ysnE, 
encoding a protein similar to IAA acetyltransferase from Azospirillum brasilense [145],  dhaS, 
similar to indole-3-acetald ehyde dehydrogenase from  Ustilago maydalis [146], and yhcX 
encoding a putative n itrilase similar to nitrilase2 from Arabidopsis thaliana [147]. Disruption 
of these genes perform ed in our group confirm ed that YsnE  and YhcX, but not DhaS, m ight 
participate in tryptophan-dependent IAA biosynthesis in FZB42 [18]. 
(3) Biocontrol: plant diseases are usually caused by phytopathogens, which can derogate 
plant growth. FZB42 protects plants f rom pathogenic bacteria and fungi by producing various 
antibiotics. The gene clusters, srf, bmy, fen , in total covering 137 kb, direct non-ribosom al 
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synthesis of the m ainly antif ungal acting lipopeptides surfacti n, bacillom ycin and fengycin 
(3.2.2.2). The gene clusters mln, bae , and dfn, with a total length of 199 kb were shown to 
direct synthesis of the antibacterial acting polyketides macrolactin, bacillaene, and difficidin. 
In addition, another operon encodes proteins  involved in synthesis and export of the  
antibacterial acting d ipeptide bacilysin. Recently, we have found that not only difficidin but 
also bacilysin play a key role in attacking fire blight, a serious disease of orchard trees caused 
by the plant pathogenic bacterium Erwinia amylovora [Lit. 2].  
On the contrary , gene clusters involved in ri bosome dependent synthe sis of  lantibio tics a re 
less rep resented in th e FZB42 ge nome. Apart of  two inco mplete gene clusters  involved in 
synthesis of m ersacidine and subtilin, only one  peptide-like com pound especially ef ficient 
against B. subtilis  m utant stra ins de ficient in th e alte rnative sigm a factor ECF W  has been 
detected in the culture fluid. The impressive genetic potentia l to produce antagonistic acting 
secondary m etabolites, not only enables FZ B42 to cope succes sfully with com peting 
organisms within its natural environm ent, but  also protects the plants from  pathogenic 
bacteria and fungi. 
(4) Induced s ystemic r esistance (ISR) media ted b y rhizobacteria: Plant g rowth-promoting 
rhizobacteria, in as sociation with plant roo ts, can tr igger induced systemic resistance (ISR).        
Commonly, plant response is triggered by pa thogenic m icroorganisms associated with the 
aerial portio ns of the plant [148]. However , also a blend of volatile or ganic co mpounds 
(VOCs), especially 3 -hydroxy-2-butanone (a cetoin) and 2,3-butaned iol, em itted by the 
nonpathogenic rhizobacteria B. subtilis  and B. amyloliqu efaciens, were shown to trigg er 
enhanced plant growth [149]. Acetolactate synt hase, AlsS, catalyzes th e condensation of two 
pyruvate molecules into acetolactate, which is decarboxylated by AlsD to acetoin. FZB42 
harbors these genes that catalyze the 2,3-butanediol pathway. 
(5) Rhizosphere competence: the ability of FZB42 to colonize on plant roots is a prerequisite 
for stim ulating plant growth. The c apabilities to surface adhesion, bio films for mation and  
swarming are essential for rhizosphere co mpetence. Notably , three unique genes, 
RBAM00750, 751 and 754, encoding proteins with a collagen-related GXT  structural m otif 
(CSM) and likely to be involved in surface adhesion or biofilm formation [150] were detected 
in the FZB42 genom e.  The com plete set of ge nes pr eviously id entified to be involved in 
biofilm and fruiting body for mation in B. subtili [151-153] have been also found in FZB42. 
Exopolysaccharides (EPSs) participate in biof ilm for mation through holding the chains of 
cells together in bundles. The 15-gene exopolysaccharide o peron epsA-O, which is believ ed 
to produce an EPS essentially for forming the biofilm in B. subtilis, exists also in the genom e 
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of FZB42 [151-153]. The c ounterparts of the genes essential for swar ming in B. subtilis, like 
swrA, swrB, efp [154], are present in the FZ B42 genome. Our genom ic analysis elucidates 
possible ways used by Gram-positive bacteria to colonize on plant roots [Lit. 6]. 
4.2 Competence for DNA uptake switches on in FZB42 during mid-
exponential phase  
Genetic co mpetence is  one of the survival s trategies used by bacteria to adap t to certain  
environmental conditions. The rate at which species are able to express genetic competence in 
response to  such cond itions is lik ely to infl uence th eir ability to com pete within their 
environment [155, 156].  W e have develope d a m ethod for  DNA transfor mation based on 
natural com petence of FZB42 [18]. The results described in section 3.3.5 dem onstrate that 
genetic competence is e xpressed earlier in B. amyloliquefaciens FZB42, than in B . subtilis 
168.  The genomic data offer several plausible explanations for this difference. 
All of the genes that are involved in the geneti c competence of BS168 are also present in the 
FZB42 genome, and most of them share 50-98% similarities in amino acid levels.  Exceptions 
include ComGD, ComGE and ComGF, which constitute part of the DNA transport machinery 
and share 47%, 42%, and 46% am ino acid similarities between the two genom es. Differences 
between the genes in FZB42 and BS168 may affect the efficiency with which they are able to 
bind and to take up exogenous DNA  [157].  These dif ferences may explain why the  
transformation rate of BS 168 was higher than that of FZB42 (3.3.5). 
The m ost striking dif ference between FZB 42 and BS168 in the m echanism of genetic  
competence is due to the quorum -sensing system . It is well accepted that accumulation of  
pheromones in the growth medium signals the presence of a sufficient number of congeners (a 
quorum), a nd triggers various cell-density -dependent processes [155]. ComX is the 
pheromone whose tryptophan residue is m odified with an isoprenyl by  ComQ [156]. ComX 
of FZB42 shows only 23% similarity to the BS168 gene, and ComQ shares only similarity of 
35%. Interestingly, the Com P proteins share 52 % similarity, but their variab le N-termini (1-
157 aa) share only 32% similarity at the amino acid level. The N-terminus of ComP contains a 
binding site for isoprenyl m odified ComX. These fi ndings suggest that the altered quorum -
sensing process in FZ B42 m ay be involved in early activati on of the com petent pathway 
during mid-exponential phase. 
Restriction-modification system  may par ticipate in degradation of  improperly modified 
exogenous DNA [158]. FZB42 encodes a uni que gene, R BAM_007140, which contains a 
conserved dom ain related to type I restrict ion-modification protei ns. Curiously , the GC-
content for these loci (33%) is  substantially lower than the overall genome average (46.6%), 
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which suggests that it is the result of a gene acquisition event. RBAM_007140 can degrade 
presumably unmethylated DNA, as exogenous DNA. This could be another reason for the low 
efficiency of transfor mation in FZB42. This  hypothesis should be te sted by preparing a 
mutant strain deficient in RBAM_007140. 
4.3 Production of secondary metabolites --- powerful tools for survival 
Secondary metabolites produced by  FZB42 might improve growth of FZB42 under special  
conditions e.g. within plant rhizosphere. In th is environment, many different microorganisms 
compete for their surv ival. T o deal with  this challenge, FZB42 has developed several 
strategies to suppress growth of competitors. Producing diverse antibiotics is one possibility . 
More than 14% of the F ZB42 genome is devoted to production of antibiot ics, a figure which 
widely exceeds the average number of antibiotics produced by Bacilli (4~5%) [28]. Two main 
groups of antibio tics play im portant roles in  s uppressing com petitors: the non-rib osomally 
synthesized lipopeptides, like ba cillomycin D a nd fengycin, which are responsible to inhibit 
growth of fungi and the polyketides bacillaen e, dif ficidin, and m acrolactin are m ajor 
secondary m etabolites acting against bacterial com petitors (see 4.3.1). In addition th e 
dipeptide bacilysin suppress bacteria and fungi as well. The unknown antibiotic possibly 
produced by RBAM_029230 seem s to provide an  antibiotic with a narrow host spectrum  
directed m ainly against its clo sest relatives (see 4.3.3). Another possibility to suppress 
indirectly growth of competitors is by depriving essential nutrients. The best studied example 
is production of siderophores [25, 159, 160]. The low soluble Fe 3+ ions are abundant in soil, 
but are inaccessible for living organisms [160]. Siderophores, like bacillibactin produced by 
FZB42, make accessible these ir on ions by form ing soluble Fe 3+-siderophore complexes that 
are actively transported into the cell by a specific transport machinery [144].  
4.3.1 Polyketides produced by B. amyloliquefaciens FZB42 are efficient in 
suppression of competitive bacteria 
During functional analysis of th e lipopeptides produced by F ZB42, it rules out that wild type 
FZB42 is a ble to inhibit growth of both, fungi (such as Fusarium oxysporum , Alternaria 
alternatae, Gaeumannomyces graminis  and Rhizoctonia solani ) and bacteria, like Bacillus 
megaterium [8]. However, mutants impaired in  li popeptide production only lost their ability 
to suppress growth of fungi, but were not altered in their ability to suppress growth of bacteria 
[8].  This indicates presence of other antibiotics in FZB42 able to inhibit growth of competing 
bacteria. According  to  the g enome sequence of  FZB42, three PKS gene clusters were 
identified. Using single and double deletion mutants of these gene clusters made it possible to 
assign them as bacillaen e, macrolactin and difficidin. The three polyketides showed d ifferent 
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levels in suppressing G ram-negative and Gram- positive bacteria, but ac tivities against fungi 
were not observed. Only the lipopeptide surf actin showed a very  weak activity agains t 
bacteria ([1 19]). This result indicates that lipopeptides and polyketides produced by B. 
amyloliquefaciens FZB42 have dif ferent specificities in attacking pathogenic bacteria and 
fungi. Dif ferent responsibilities by these an tibiotics m ake FZB42 more ef ficient against 
diverse co mpetitors. Depending on presen ce of fungi or bacteria in its enviro nment, B. 
amyloliquefaciens FZB42 might activate different signal transduction pathways, which could 
switch the expression between NRPSs and PKSs.  
4.3.2 nrs might be a novel siderophore 
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Figure 36. Hypothetical biosynthesis of nrs: A= adenylatio n dom ain A, AL  = acyl Co-A  
synthetase, ArCP = aryl carrier  protein, Cy = cy clization, PCP = peptidyl carrier protein, KS =  
β-ketoacyl synthase, AT = acyltransferase, M = methyltransferase, KR = ketoreductase, ACP = 
acyl carrier protein, O =Oxidoreductase, R = transcriptional regulator, T = transporter. 
 
The gene cluster or ganization of nrs is sim ilar to that in siderophore yersiniabactin ( Figure 
31). The three condensati on dom ains in NRPS of nrs gene cluster m ost probably direct a 
cyclization activity resulting in forming a thiazol ring within the com pound, which is sim ilar 
to biosynthesis of yersiniabactin ( Figure 36 ). T hree thiazol rings are linked directly in nrs 
according to the co-linear rule of PKS/NRPS biosynthesis (Figure 36), whereas one acyl keto-
group is inserted between the s econd and the third thiazol ring by  yersiniabactin synthetase. 
Unlike yersiniabactin synthetase, ArCP domain or other possible ACP domains are missing in 
front of NrsC, suggesting that the star ter unit of nrs m ight be thiazol ring ( Figure 36 ). A  
polyketide synthase containing β-ketoacyl synthase, Zn-dependent hydrolase (GloB) and acyl 
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Co-A synthetase domains m ight link one acyl-Co A substr ate o r its d erivatives o n the tr i-
thiazol ring structure, but th e exact substrate is unknown ( Figure 36). The hybrid NRSP/PKS 
compound m ight be released from  the last PKS module by a thioesterase ( Figure 36 ). 
However, it is unknow n whether the active form  of nrs is a m onomer or a m ultimer like 
bacillibactin. 
Mutant strains CH39 ( dhb-) and C H40 (nrs- and dhb-) did not show dif ferent growth under 
iron deprivation (Figure 32), but by CAS-assay we registered decrease of the siderophore level 
in the double m utant CH40 in  com parison with CH39 ( Figure 33 ). The am ount of the  
siderophores in CH40 was si milar to that of CH3 ( sfp-). These results suggest that nrs m ay be 
produced in FZB42 as a new siderophore. Howe ver, nrs could not be detected by HP LC, LC-
ESI MS and MALDI TOF MS in the supernatant of Landy medium. This might be due to the 
following reasons: 1 ) besides b acillibactin n rs is an add itional s iderophore that can be 
synthesized only in very low am ounts and in complete absence of ir on. 2) Further unknown 
modifications occur during biosynthesis of nrs, therefore its structure and m olecular weight 
might deviate from  the structure we expected  in accordance to  th e co-linear rule of  
NRPS/PKS. It has been reporte d t hat s iderophores c ould be  a subunit of bacteriocins. 
Microcin E492, a bacteriocin produced by en terobacteria, needs a post-translational 
modification to conjugate a si derophore with its peptide ( Figure 37) [161]. It is also possible 
that the m ain function of nrs is to modify an unknown bacterio cin because of its very weak 
siderophore activity. 
Peptide microcin B17
Enterobactin
Microcin E492  
Figure 37 Structure of microcin E492: conjugation of a ribosomal peptide and non-ribosomal  
enterobactin 
 
4.3.3 A new family of antibiotics in Bacilli  
A unique gene cluster 3.2.2.1 in FZB42 is related to the activity of an unknown ribosom ally 
synthesized compound that was detected during screening of sigW-dependent resistance genes 
[125].  Complete deletion of this  gene cluster in m utant CH5 re sults in losing this antibiotic 
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activity. According to our protein sequence analysis, RBAM_029230 could be the synthesis 
gene f or th is peptide a ntibiotic. Cystein e re sidues ar e es sential f or thioester lin kage with  
dehydrated Thr/Ser residues in pos t-translational modification of lantibiotics [33], but there is 
no cysteine in RBAM_029230 suggesting that this  novel antibiotic is not a lantibiotic. 
According to the size of the hypothetical mature peptide (36 aa and 3455.8601 Da), this could 
be the first bacteriocin type II in Bacilli. The gene cluster relate d to the unknown antibiotic 
activity in WY01 is similar to a  gene cluster occurring in Paenibacillus larvae subsp. larvae 
BRL-230010 suggesting that production of this an tibiotic might be not a rare phenom enon in 
nature. 
A strong antibiotic activity of this novel antibiotic  was detected in supernatant of mutant CH5 
(sfp- and yczE-). However, we were unable to detect specific peaks in both the supernatant and 
cell surface by LC-ESI MS and MALDI-T OF MS. One of the explanatio ns can be lim itation 
of these methods. The peptide backbone of the novel antibiotic does not contain T rp, Tyr and 
Cys, so it cannot be m ade visible by UV spectrophotometry. Obviously, HPLC, utilizing only 
this principle, could not dete ct this novel antibio tic. The low concentration of the com pound 
can be the second reason for our dif ficulties in detecting the com pound. Bacteriocins show 
strong antibiotic activity  already in a concentration less than 10 ng/m l [28].  Moreover , 
modifications on the backbone are comm on in bacteriocins [43], so the novel antibiotic could 
have been modified post-translationally and it s molecular mass might dif fer strongly to the 
expected one. The forth possibility is that the gene cl uster involving RBAM_029230 does not 
contain the structural gene for this unknown an tibiotic and m ight only be involved in its 
transport and/or immunity.  
4.4 Polyketides and their biosynthesis 
The polyketide synthases of bae, m ln and dfn s how some s triking featur es in the ir domain 
organization: 1) split m odule in tw o proteins , 2) tandem ly repeated ACP  dom ains and 3) 
trans-action of the domains. 
4.4.1 Split module on two proteins 
Unlike erythrom ycin synthases w here the modul es are always or ganized together in one 
protein [162], the m odules of bae, m ln and dfn were split alm ost on two dif ferent proteins. 
Split modules occur more usually after a KS do main. Another notable feature is  the presence 
of the non-canonical bi-modular sequence KS KR ACP KS0 DH ACP with a split downstream 
module in two proteins [78]. This  unusual pattern was found twice in bae and dfn gene  
cluster. KS 0 is a non-elongating KS, as evidenced by the finding that the DH  in the 
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downstream m odule is coupled with the KR from the upstream  module, which directs 
formation of the double bond in the polyketide. 
4.4.2 Tandemly repeated ACP domains 
Duplications of ACPs within the modules of polyketide synthase type I are very common, and 
eight of such modules were found in FZB42. The function of these tandemly repeated ACPs is 
unknown.  According to the activ ity of the repeated ACPs and the modification dom ains 
provided in the sam e modules, these ACPs can be  classified in five groups.  The group 1  
contains two ACPs in a m odule that does not  contain any modifica tion domain, like m odule 
14 of DfnJ (Table 13). It is hard to assign the functions of these both ACPS, because these two 
ACPs provide a complete conserved sequence with a serine active site, indicating that both of 
them should be active. It could be speculated th at one of them  could be suf ficient for the 
elongation step, but presence of two ACPs m ight speed up elongation. The m odule six of  
BaeL belongs to the group 2. In comparison to group 1, the sequence from one of the group 2 
ACPs is not com plete: ACP6-1 of BaeL  posse sses the se rine site f or atta ching th e Ppant 
moiety, but 27 am ino acids of the N-term inus in ACP6-1 are m issing. On the other hand, 
ACP6-2 contains a complete conserved sequence with a serine active site (Table 13). It can be 
speculated that the speed of modifying the serine residue of the short ACP6-1 by Sfp and/or of 
attaching of acyl-CoA substrates might be reduced compared to ACP6-2. The first ACP of the 
group 3 contains the whole seque nce with conserved dom ains except that the serine residue 
for m odification with Ppant is m issing, so on ly the second ACP  is functional in chain 
elongation (Table 13). All m odules belonging to group 3 c ontain keto-reductase, so the firs t 
dysfunctional ACP  could probably serve as ba rrier to  separate spatio temporally the 
modification reaction from  the Claisen condensation. This group of ACPs seem s to be m ore 
rate limited.  Group 4 provide two com pletely functional ACPs that follow the MT  domain 
directly. This type of duplicated AC P dom ains was already  well inves tigated in on e of the 
modules from  leinam ycin synthase. The firs t ACP  domain is involved in ensuing C-
methylation process and the sec ond ACP domain is used for the initial chain el ongation step 
[163]. A unique module of Dfn synthase is module 6 that has three tandem ACPs. These three 
ACPs are a com bination of group 3 and group 4 ( Table 13). The dif ference of group 4 and 
group 5 is that the latter has only DH and KR, but not MT  domains (Table 13). Like group 4, 
the first ACP can be involved in the modification process. To prove these speculations, further 
experiments like in-frame deletion of ACP and point mutation to substitute the serine residue 
by other amino acids should be performed in future. 
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Table 13. Classification of the duplicated ACPs in FZB42: 
Proteins Organization of the domains Classification of the ACPS
DfnJ KS14,ACP14,ACP14, Group 1 
BaeL KS6, ACP6-1, ACP6-2 Group 2 
MlnD/E KS5,ACP5-1/KR5,ACP5-2 Group3 
MlnG KS9,ACP9-1,KR9, ACP9-2 Group 3 
DfnF/G KS6,ACP6-1,DH6,KR6/MT6,ACP6-2,ACP6-3 Group 3, 4 
DfnD KS1,DH1,KR1,MT1,ACP1-1,ACP1-2 Group 4 
MlnB KS1,DH1,KR1, ACP1-1,ACP1-1 Group 5 
MlnE/F KS7/DH7,ACP7-1,ACP7-2,KR7 Group 5 
 
4.4.3 Cross-talk of trans-ATs in different gene clusters  
One of the m ost strik ing features  in the pks gene clusters of the FZB42 genom e is the 
organization of the acyl transferases. Three ATs in front of the bae gene cluster, one in front of 
the dfn and  mln gene cluster were identified in FZB42.  These PKS architecture, found 
recently in many polyketide synthase type I system in bacteria, is characterized by a discre te, 
iteratively acting AT protein that loads the extender units in trans to "AT-less" multifunctional 
type I PKS proteins for polyketide biosynthesis [75, 163].  
The A T trans-action phenom ena were observed unt il now only in genom ic systems  
harbouring just a single PKS ge ne cluster [163, 164]. No inves tigation has been performed in 
systems with several A T-less PKS gene clusters. B. amyloliquefaciens  FZB42 provides an 
excellent possibility to examine whether the AT-domains can act in trans among different pks 
gene clusters.  
The AT-domains are essential for their own polyketide production, because deleting any A T-
domain in its gene cluster impaired production of the respective polyketide, also in case of the 
three trans -ATs in f ront of  the bae gene cluster . As expected, MlnA T, preceding the 
macrolactin gene cluster, did not participate in  synthesis of dfn and bae, because th e amounts 
of these compounds in the mlnAT deletion mutant were found similar to that of  the wild type. 
Surprisingly, deletion of dfnAT led to a reduction in the amount of mln and bae, which implied 
that dfnAT could be engaged in both bi osynthesis of mln and bae, but  is not essential for their 
production. Assigning the specific functions of the three baeATs is not possible at present, due 
to possible polar ef fects of the deletions in troduced in  the respec tive g enes. However , 
comparison of the three mutants provided som e ideas about the roles of the three AT domains 
located in the bae gene cluster. The amount of m ln did not change evidently in m utant CH24 
compared with CH25, whose expression of BaeA T1 was not af fected. It m eans that BaeAT2 
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and BaeAT3 could contribute to biosynthesis of m ln, whereas BaeA T1 is not invo lved in  
production of mln. BaeAT3 is essential for production of dfn, because it could not be resto red 
by CH26 that expressed both Bae1AT and Bae2AT.  
In summary, I got first evidence th at BaeAT2, BaeAT3 and DfnAT are not only essential for  
synthesis of their own polyketides, but also important in biosynthesi s of other polyketides. 
Since the production of dfn needs both BaeA T3 and DfnAT, it implies that some of these AT-
domains could recognize specific substrates or connect specific ACPs. In addition, the 
presence of AT domains from other gene clus ters could im prove the production of m ln and 
bae, but was not essential. The trans-effect of AT domains is not restricted on their respective 
gene cluster but can also enhance synthesis of  other compounds synthesized by gene clusters 
located on fair distant sites of the genome.  
4.4.4 Substrate specificity of AT domains 
Bae1AT ha s been characterized as a m alonyl-CoA specific A T that accepts AcpK as a 
thiolation (T) dom ain substrate [165]. Bae3 AT, MlnA T and DfnA T are hybrid enzym es 
bearing also a predicted 2-ni tropropane dioxygenase (NPD)-like domain. It was suggested by 
analysis of conserved do mains that Bae3AT could probably recognize malonyl-CoA, because  
Bae3AT contains a FabD dom ain directly be hind the predicted 2-nitr opropane dioxygenase 
(NPD)-like dom ain [ 166]. B ae2AT, D fnAT and MlnAT contain an acyl transferas e dom ain 
cl08282, which, unfortunately, do not provide any clue for their target substrates.  
The 13C-feeding experiment demonstrated that acet ate/malonate is th e only substrate for the 
starter and the extender units  in biosynthesis of m ln ( 3.3.1.4).  According to the results 
described in 3.3.1.4, MlnAT alone is suf ficient for biosynt hesis of m ln. Therefore, it can be  
concluded that MlnAT can recognize acetyl-C oA and its derivate m alonyl-CoA as substrate.  
Because Bae2AT, Bae3AT and DfnAT could act as  ATs in biosynthesis of mln, it implies that 
Bae2AT, Bae3AT and DfnAT can use at least acetyl-CoA and its derivative malonyl-CoA as a 
substrate. 
4.4.5 Roles of modification enzymes in the pks operons 
β-keto-acyl reductase (KR), hydroxyacyl dehydrata se (DH) and enoyl re ductase domain (ER) 
are the enzy mes involved in dif ferent reduction  reactions o f β-keto groups, which result in 
stepwise conversion of the ke to-group to a single bond. Dependi ng on the level of reduction 
of the β-keto group, one can conclude  which modification dom ains should be present in a 
module. Notably, not all of these modificatio n enzym es were detected  within the modules  
present in the bae, mln and dfn gene clusters. The ER could not be detected in the 
corresponding m odules of the bae gene cluster , de spite that the re spective double bond is 
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reduced to a single bond. Moreover , one KR, one  DH and two ER were found absent in the 
dfn gene cluster . T wo DH and one ER were not present in the mln gene cluster . It was 
supposed that the function of these enzym es could be provid ed by other m odules or other 
proteins with sim ilar function in trans [119]. We have already dem onstrated that BaeS, a 
cytochrome P450 following the bacillaene stru cture genes is direc tly involved in the 
desaturation of the double bond in bacillaene, instead of an ER domain [Lit. 3]. A cytochrome 
P450 was deleted in dfnM, and surprisingly , no m ln and df n could be detected in HPLC 
according to the UV -spectrum and reten tion tim e for m ln and dfn. W e speculate that the 
cytochrome P450 in dfnM could act in trans in the mln and dfn gene cluster to desaturate the 
double bon d in m acrolactin and d ifficidin. T o prove this  speculation , the m utant will be 
further investigated by LC-ESI MS. Deletion of the TE domain in the dfn gene (CH10) cluster 
implied that the TE dom ain could not only cataly ze releasing of its product, but also takes 
over partially the function of the TE dom ain fr om the bacillaene polyketide synthase. A  3-
hydroxy-3-methylglutaryl-CoA synthase (HMG S) hom olog in DfnL  and an enoyl-CoA  
hydratase (EH) hom olog in DfnK were suppos ed to be involved in for mation of a  
exomethylene group in dfn [167]. No dfn could be detected in mutants deleted in one of these 
genes, but production of mln and bae was not affected. This indicates that DfnK and DfnL are 
only involved in biosynthesis of dfn. Further an alysis of these two m utants by LC-ESI MS is 
necessary to detect the interm ediates produced by them. Information from LC-ESI MS about  
CH10, CH15, CH16 and CH17 will contribute to a better understanding of the modification of 
polyketides in discrete AT-less polyketide synthases type I. 
Except reduction of the keto-gr oup to a single bond, there are some other m odifications of 
polyketides, like glycosylation ( 3.3.1.1). These particular modificat ions may be required for 
modulation of antibiotic activity. One of the most well known polyketides is macrolactin. The 
macrolactin ring can be modified by attachm ent of a malonyl- or succinyl-residue at position 
7 or a glycosidation at positions 7 or 15, thes e m odifications lead to a dif ferent activity 
spectrum in the members of the macrolactin family [89, 90, 168-170]. In this work, we detect 
four dif ferent m embers of m acrolactin produced by FZB42 ( 3.3.1.1). Furthermore, we  
detected another two dif ferent species of baci llaenes and hydrobacillaenes according to their 
MS, in addition to the isofor ms already dete rmined by Butcher et al. [ 130]. Howe ver, the 
exact chem ical structures of their modifications are unknown at present ( 3.3.1.1).  The  
tailoring m odifications are pe rhaps perform ed by external enzym es as m ethyl-, acyl- and  
glycosyltransferases, since no such f unctional genes or dom ains have been found within the 
pks gene clusters.  
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4.4.6 The pksX gene cluster is responsible for bacillaene production 
Since the d iscovery of the pksX system in the genom e of B. subtilis 168 [7], difficidin was 
believed as being its m etabolic product, however the pksX gene cluster shows high sim ilarity 
to th e gen e clus ter bae in FZB42 that was id entified as  being responsible for bacillaene 
synthesis. Our investigati on of the supernatant of B. subtilis  OKB105 dem onstrated that not 
only surfactin but also bacillaene is produced when a functional sfp gene was introduced. We 
have assign ed f or the first tim e the pksX gene cluster for production of bacillaen e, which  
made it possible to explain th e structure of bac illaene [130, 137]. A  car eful com parison of 
both gene clusters, pksX and bae, revealed, however , minor dif ferences: 1) pksF (beta-
ketoacyl synthase) does not exist in the genom e of FZB42. The pksCFGHI/acpK subcluster 
was believed to be involved  in the insertion of  a β-methyl branch on PksL [165]. Absence of  
PksF in the bae gene cluster of FZB42 doubts this conclusion. 2) pksA, the f irst gene in the  
pksX system, stands separate around 730 kb kb upstream of the bae gene cluster in FZB42. 
4.4.7 Bacillaene, macrolactin and difficidin are widely distributed in nature 
To prove, whether production of th e diverse polyketides observed in Bacillus 
amyloliquefaciens FZB42 is a unique property, another 29 Bacilli strains were investigated for 
their ability to produce bacillaene, dif ficidin and m acrolactin by LC-E SI MS and PCR. The 
result of LC-ESI MS was nicely corresponding to the result obtained by PCR-amplification of 
the trans-AT domains located within the respective gene clusters. Macrolactin was only found 
in the group of plant associated B. amyloliquefaciens  strains. The PCR fragm ent of their 
single AT domain had the same size as in FZB42 suggesting that the AT domain of mln is well 
conserved. In addition to the B. amyloliquefaciens strains, dif ficidin seemed to be produced 
by som e B. lichen iformis strain s according to the resu lt fro m LC-ESI  MS. Howe ver, PCR 
analysis of the AT domain implied that these strains do not possess the conserved AT domain. 
No other data support the idea that B. lichen iformis is cap able to prod uce polyketides. W e 
conclude that the result obtained from  LC-E SI is m isleading. The production of bacillaene 
seems to be more widely distributed in different species of Bacilli than the production of other 
polyketides. The three trans-AT domains of the bae cluster are varying according to o ur PCR 
analysis. In summary, our results from PCR analysis correlate nicely with the results obtained 
with chemical methods. This dem onstrates that  PCR can serve as a powerful tool for high-
throughput screening of producer strains of these polyketides. 
4.5 Sfp is necessary for both, polyketide and lipopeptide production 
Sfp is known to activate peptidyl carrier proteins (PCPs) of nonribosomal peptide synthetases, 
peptidyl carrier proteins in the NR PS-PKS hybr id (hPCP)  as well as acyl carrier proteins 
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(ACPs) of fatty acid and polyketide synthases [99]. In vivo  investigation of the Sf p deletion 
mutant CH3 confirm ed that Sfp converts the apo-form of PCP, ACP and hPCP  to the holo-
form.  
Marahiel´s group performed kinetic studies with  Sfp and AcpS for hPCP, ACP and PCP.  The 
data showed that catalytic activity of Sfp for hPCP lies between that for PCP and ACP, namely 
6-fold lower than for PCP  and 12-fold higher th an for ACP [98]. AcpS s howed high catalytic 
activity for ACP and very weak catalytic activity for hPCP in vitro, whilst no catalytic activity 
for PCP was determined [98]. A specific feature is that the catalytic activities of Sfp and AcpS 
for ACP  were dependent on the concentratio n of Apo-ACP  [98]. AcpS alone could not 
complement production of polyketides, lipopeptides and the siderophore in CH3 (sfp-) (3.3.3), 
which indicates that Sfp is the only PPant  transferase involved in production of these 
secondary m etabolites in vivo .  Modification of ACP , PCP  and hPCP  by Sfp is not only 
essential for both polyketides and lipopeptid es production, but also determ ining the 
production rate. It seem s that Sfp has a prefer ence for production of lipopeptides than for 
polyketides accord ing to sem i-quantitative an alysis p erformed with MALDI T OF MS an d 
kinetic studies [98].  
4.6 YczE might be involved in forming of a megaenzyme complex during 
synthesis of polyketides and lipopeptides 
YczE, a hypothetical m embrane protein, seems to be involved in produc tion and/or transport 
of polyketides and bacillom ycin D. YczE does not share sim ilarity with known transport 
related pro teins or con served domains. Expres sion of  bacillom ycin D was not restored by  
exchange the promoter by the IPTG-dependent promoter Pspac, which indicates that YczE does 
not act as a transc riptional activator in biosynthesis of bacillom ycin D [ Lit. 5]. One possible 
role of YczE can be post-translational m odification of enzym es involved in synthesis and/or 
export of secondary m etabolites. Because bio synthesis of su rfactin and fengycin was not  
affected in yczE deficient mutants, YczE is not involved in modi fication of Sfp. Straight et al. 
demonstrated by using Gfp, Cfp, Yfp fusion protei ns, that the bacillaene synthase form s a  
mega-complex in B. subtilis. This megaenzyme complex anchors at the cell membrane, whilst 
surfactin synthetase was soluble in cytoplasm  [171]. This s uggests that the assem bly line of 
some lipopeptides and polyketides is associated with a membrane sub-domain, either directly 
or by interaction with a membrane protein [171]. I hypothesize that YczE could be a candidate 
for a m embrane protein  associated with PK S or NRPS to for m a megaenzym e complex  
essential for biosynthesis of some polyketides and lipopeptid es. However , m y previous 
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protein structure analysis prov ided no clue about possible bi nding sites of YczE with the 
member of megasynthase complex. 
It is believed that checkpoints for transcriptio nal and/or posttranslational switching of the  
production of polyketides and lipopeptides exist in Bacilli. On transcr iptional level, a DegU 
knockout mutant (TF1) has com pletely lost its ability to produce bacillomycin D, and CH23 
(comA-) displayed reduced production of surfactin. Another possibility is  that FZ B42 uses  
different signal transduction pathways to g et information from the environm ent for deciding 
whether it should produce m ore antifungal lipopep tides or more polyketides acting against 
bacterial competitors. In this conte xt the role  of transcription regulator pksA remains also to 
be elucidated. In post-transla tional regulation, there are two ca ndidates, Sfp and YczE, which 
could form a second regulatory level in governing polyketide and lipopeptide production.  
4.7 Resistance against antibiotics in Bacillus amyloliquefaciens FZB42 
B. amyloliquefaciens FZB42 produces at least eight antibiotics or toxins to suppress growth of 
competitors in its d aily strugg le f or ava ilable ecological n iches. At the sam e tim e, FZB42 
must provide different mechanisms to protect them selves from antibiotics and toxins that are 
produced not only by themselves but also by other microorganisms.  
Immunity is the m echanism of self-protection from bacteriocins. It is es pecially important if 
the bacteriocin does not need a specific recep tor for its action, as in th e case for th e type A  
lantibiotics that form pores in the cytoplasmic membrane. Remarkably, the synthesis genes for 
the biosynthesis of known lantibiotics in  Bacilli are absent in the genom e of FZB42, but their 
immunity genes and regulators are present ( 3.2.2.1). The two-com ponent syste m 
Mrsk2/MrsR2 or SpaK/SpaR can activate the pr oduction of the imm unity genes MrsEFG or 
SpaEFG in FZB42, if m ersacidin or subtilin is produced by other comp eting strains in the 
environment. Intere stingly, another plant asso ciated B. amyloliqu efaciens strain, B946, was 
shown to actively produce m ersacidin (Vater unpublished observation), suggesting that this 
lantibiotic m ight be comm on in t his environm ent. The i mmunity genes albBCD are not 
present in F ZB42, but AlbG (a m embrane prot ein) is present in th e genom e of FZB42. It 
indicates that AlbG is probabl y involved in export of subtilosi n A. Unlike specific immunity , 
the yqeZyqfAB gene cluster prov ides an unspecific antibio tic resistance in a SigW -dependent 
manner. It was reported that the presence of this gene  cluster can pro tect the s trains against 
sublancin [125].  Screening the genome of FZB42 revealed, that all genes related to sublancin 
synthesis are absent in FZB42. Thi s is due to the deletion of the spβ2 prophage, whereas the 
yqeZyqfAB gene cluster is present. Although FZB42 does not produce any known 
bacteriocins, it contains a wide spectrum  of  resistance sy stems actin g again st d ifferent 
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bacteriocins. These cap abilities en able the b acterium to survive  within rh izosphere in  
permanent competition with other rhizobacteria.  
Bacitracin is a cyclic d odecylpeptide antib iotic that is non-ribosomally synthesized by B. 
licheniformis and B. subtilis  [172]. The com plexity of its re sistance m echanisms has been 
comprehensively analyzed: 1) expression of b acitracin-specific ABC transporters [173, 174], 
2) de novo  synthesis of undecaprenyl m onophosphate [175], 3) expressi on of alternative 
undecaprenyl pyrophosphate phosphatases [176] and 4) exopolysacch aride production [177]. 
Of these possibilities, induction of  bacitracin-specific ABC transp orters is the m ost efficient 
resistance mechanism. FZB42 provides a bacitracin-specific ABC transporter BceAB. BceRS, 
a two-component system, which is located upstr eam of the operon and probably regulates the 
expression of BceAB. 
The ydbST and fosB genes in a Bacillus strain [125] were identified as resistance genes acting 
against an unknown antibiotic that is ribosomally synthesized by B. amyloliquefaciens FZB42 
(3.2.2.1). Hom ologues of ydbST and fosB exist also in the genom e of FZB42. The ydbST 
genes encode related m embrane proteins of unknown function cont aining one and three 
conserved bacterial membrane flanked domains (pfam03703). 
Except surfactin, no evidence for resistance mechanism encoded in lipopeptide and polyketide 
gene clusters were detected in FZB42. SwrC , previously designated as multidrug efflux pump 
YerP, is self-resistant against surfactin [154]  and is also essential for swarming motility [178]. 
During screening of drug ef flux proteins, four  transporters (YkkCD, ErbAB, Y vaED and 
YvdSR) belonging to SMR fa mily were identif ied. Site-directed m utagenesis indicated that 
the conserved m embrane-embedded glutam ates in the first transm embrane helices of both 
EbrA and EbrB are req uired for multidrug efflux activity. However, the two gluta mates are 
non-equivalent since EbrA E15 is required for s ubstrate binding while EbrB E14 is not [133]. 
Absence of glutamate residues in YvaD, the analogue of EbrA, might hinder this SMR system 
to bind with its substrates. Th e other possibility is that Y vaD has a substrate s pectrum, 
completely dif ferent to that of the known SM R m embers. It is reported that EbrAB and 
YkkCD are broad-specif ic multidrug efflux pumps [134, 179]. However , whether these SMR 
members could pump out lipopeptides or polyketides is still unknown. Cloning of these genes 
in E. coli K12, an indicator strain sensitive for FZB42 antibiotics, can be a useful approach for 
investigating this question.  
4.8 Perspective 
Availability of the whole genom e sequence and  its demonstrated genetic am enability allows 
use of B. subtilis  168 as m odel strain for investigati on of molecular biology and cell biology 
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of Gram-positive bacteria. However, B. subtilis 168 is an early dom esticated laboratory strain 
underlying several rounds of X-ray irradiation, resulting in defi ciency in m any fea tures e.g. 
biofilm formation and nonribosomal produ ction of several secondary metabolites. One of the 
well-known exam ples is that silencing of a func tional Sfp leads to inab ility to produce the  
non-ribosomal synthesized antibiotics (bacilla ene, surfactin and fengycin) and siderophore 
(bacillibactin) [ 6]. However , natu ral isola tes of  Bacillus subtilis, which are r eflecting a  
metabolism unim paired by secondary genom ic mutation are often not DNA  transform able 
under labo ratory cond itions. Genetic am enability, a rare feature in n ature iso lates, together 
with its ability to prod uce a vast array of  dif ferent secon dary m etabolites, is on e of  the 
advantages in applying the whol e sequenced FZB42 as a model strain for research, especially 
in context of plant growth prom otion and bi ocontrol. Genetic m anipulation of the unique 
genes related to plant growth  promotion in F ZB42, transcri ptome analysis and proteome  
investigation will provide a deeper insight about the genes involved in such processes.  
Antibiotic production is not only an interesting subject for biocontrol research but also for  
several applications in medicine. Dramatic increase of multidrug resistances is a big challenge 
for developing new antibiotics dealing with multi-resistant bacteria. The design of such drugs 
would be greatly facilitated by a deeper knowledg e of gene organization and the structures of 
the underlying transport system s, which are rece ntly poorly understood. The capacity of the 
antibiotics biosynthesis m achinery in FZB42 is com parable with that of the well-known 
antibiotic pr oducer Streptomyces strains, paving the way for developm ent of novel drugs 
useful as biopesticid es in agricu lture (bioco ntrol) and in m edicine as well. Especially 
biopesticides originating from FZB42 and other related plant-associated B. amyloliquefaciens 
strains will f airly enhance appl ying of biological tools in an efficient and m ore sustainab le 
agriculture. Occurrence of AT-less PKSs in FZB42 demonstrates that the principles underlying 
biosynthesis of polyketides are more diverse than originally  expected. Full understanding of 
the dif ferent underlying biological m echanisms will significan tly enhance future 
bioengineering of tailor-made antibiotics. 
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5 Appendix 1:  
 Supplementary figure 1. bae biosynthesis pathway [Lit. 3]: 
 
 
 
 
Supplementary figure 2. mln biosynthesis pathway [Lit. 4]: 
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Supplementary figure 3 dfn biosynthesis pathway [Lit. 7]: 
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* Enzym e functions necessary  but not detectable inside  the corresponding m odules are 
indicated by red filled circles.  The thiola tion domains (T, ACP) predic ted to be ina ctive are 
not filled in  the box. The KS domains without  elongation function are not filled in the box. 
The red circle shows the postion where the cyclization of dfn happens. The green circel shows 
the –OH group where the phosphate group combines. 
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Supplementary figure 4.  Comparison of the pol yketides production in t he mutants with the dif ferent 
AT-domain deletion. 
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Supplementary table 1. Drug efflux protein in the genome of Bacillus amyloliquefaciens FZB42: 
Gene 5'-end 
(bp) 
3'-end 
(bp) 
family 
TC No.
Product function Note  
Mdr 3053 85 306917 2.a.1.2.8 Multidrug-ef flux 
transporter 
multidrug efflux   
Blt 1053 467 1054663 2.A.1.2.8 Multidrug resistance 
protein II  
multidrug efflux   
ydgK 5787 43 579952 2.A.1.2.X Putative 
bicyclomycin 
resistance protein  
multidrug efflux   
yybF1 2544 377 2545583 2.A.1.2.X Hypothetical 
transport protein  
drug efflux   
RBAM03031 3074 660 3075856 2.A.1.2.X Multidrug resistance 
protein  
drug efflux   
RBAM03600 3599 461 3600661 2.A.1.2.X Putative drug 
resistance transporter  
multidrug efflux   
yybF 3876 926 3878128 2.A.1.2.X Conserved 
hypothetical protein  
drug efflux   
lmrB 269539 270972 2.A.1.3.X Drug-export protein  drug efflux   
ycnB 4084 48 409872 2.A.1.3.X Putative multidrug 
resistance protein  
multidrug efflux   
yfnC 7450 17 746246 2.A.1.3.X Putative 
fosfidomycin 
resistance protein  
multidrug efflux  
yhcA 9092 94 910887 2.A.1.3.X Hypothetical 
transport protein 
multidrug efflux   
RBAM02833 2884 258 2885923 2.A.1.3.X Putative permease 
MDR type  
drug efflux   
ydhL 5938 06 594966 2.A.1.X.X Conserved 
hypothetical protein  
chloramphenicol 
efflux 
  
yfmO 7551 89 756371 2.A.1.X.X Putative multidrug-
efflux transporter  
multidrug efflux   
yfiU 8471 08 848700 2.A.1.X.X Putative multidrug-
efflux transporter  
multidrug efflux   
yfhI 8563 82 857579 2.A.1.X.X Conserved 
hypothetical protein  
metabolit efflux   
yitZ 1096 434 1096974 2.A.1.X.X Putative multidrug 
resistance protein  
multidrug efflux   
yubD 1240 251 1241808 2.A.1.X.X Conserved 
hypothetical protein  
multidrug efflux  
RBAM01682 1671 661 1672987 2.A.1.X.X Conserved 
hypothetical protein  
unknown   
ytbD 2732 693 2733890 2.A.1.X.X Putative arabinose 
efflux permease  
multidrg efflux   
yttB 2855 838 2857022 2.A.1.X.X Conserved 
hypothetical pr otein  
protein 
multidrg efflux   
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Gene 5'-end 
(bp) 
3'-end 
(bp) 
family 
TC No.
Product function Note  
yuxJ 2974 106 2975243 2.A.1.X.X Conserved 
hypothetical protein  
multidrg efflux   
yusP 31 11720 3113313 2.A.1.X.X Putative multidrug-
efflux transporter  
multidrg efflux   
yvkA 3350 957 3352292 2.A.1.X.X Conserved 
hypothetical protein  
multidrug efflux   
ywoG 3478466 3479660 2.A.1.X.X Putative transporter   drug efflux   
ywoD 3481 317 3482681 2.A.1.X.X Conserved 
hypothetical protein  
drug efflux   
ywfA 3598 000 3599238 2.A.1.X.X Conserved 
hypothetical protein  
drug efflux   
YdfJ 5707 40 572891 2.A.6.X.X Putative antibiotic 
transport-associated 
protein 
unknown   
yojI 2043 242 2044598 2.A.66.1.X Putative multidrug 
resistance protein  
drug efflux   
ykkC 1254 881 1255217 2.A.7.1.5 Putative Multidrug 
resistance protein  
multidrug efflux ykkC/ykkD (SMR)* 
ykkD 1255 219 1255531 2.A.7.1.5 Putative Multidrug 
resistance protein  
multidrug efflux ykkC/ykkD (SMR) * 
ebrB 1779 353 1779706 2.A.7.1.6 Multidrug resistance 
protein  
multidrug efflux ebrA/ebrB (SMR) * 
ebrA 1779 724 1780038 2.A.7.1.6 Multidrug resistance 
protein  
multidrug efflux ebrA/ebrB (SMR) * 
yvaD 4688 08 469215 2.A.7.1.X Hypothetical protein  multidrug efflux yvaE/yvaD (SMR) * 
yvaE 4692 12 469577 2.A.7.1.X Putative multidrug-
efflux transporter  
multidrug efflux yvaE/yvaD (SMR) * 
yvdR 5980 85 598399 2.A.7.1.X Conserved 
hypothetical protein 
metabolite-drug 
efflux 
yvdS/yvdR (SMR) * 
yvdS 5983 99 598728 2.A.7.1.X Conserved 
hypothetical protein  
metabolite-drug 
efflux 
yvdS/yvdR (SMR) * 
ycxC 3719 86 372948 2.A.7.3.X Conserved 
hypothetical protein  
metabolite-drug 
efflux 
ycxC/yyaM 
ydzE 5847 34 585604 2.A.7.3.X Hypothetical protein  metabolite-drug 
efflux 
ybfH/ydzE 
yojE 2046 866 2047762 2.A.7.3.X Hypothetical protein  metabolite-drug 
efflux 
yojE 
yvbV 3249 444 3250359 2.A.7.3.X Conserved 
hypothetical protein  
metabolite-drug 
efflux 
yvbV/yoav 
yxxF 3734 444 3735355 2.A.7.3.X Conserved 
hypothetical protein  
metabolite-drug 
efflux 
ydeD/yxxF 
RBAM01170 1 158999 1159721 3.A.1 Putative ABC- type 
multidrug transport 
system, permease  
unique RBAM 01171(A)/RBAM01170(M) 
bceB 2858 044 2859984 3.A.1 Bacitracin export 
permease protein  
Bacitracin bceA(A)/bceB (M) 
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Gene 5'-end 
(bp) 
3'-end 
(bp) 
family 
TC No.
Product function Note  
bceA 2859 981 2860733 3.A.1 Bacitracin export 
ATP-binding protein  
Bacitracin bceA(A)/bceB (M) 
RBAM03133 3165 194 3166127 3.A.1 Putative multidrug 
ABC transporter ,  
ATPase component  
unique RBAM 03133(A)/RBAM03134(M) 
/RBAM03135(M) 
RBAM03134 3166 153 3167245 3.A.1 Putative multidrug 
ABC transporter , 
permease  
unique RBAM 03133(A)/RBAM03134(M) 
/RBAM03135(M) 
RBAM03135 3167 249 3168392 3.A.1 Putative multidrug 
ABC transporter , 
permease  
unique RBAM 03133(A)/RBAM03134(M) 
/RBAM03135(M) 
spaG 3210 566 3211336 3.A.1 Lantibiotic ABC 
transporter permease  
subtilin spaF(A)/spaE (M)/spaG(M) 
spaE 321 1333 3212067 3.A.1 Lantibiotic ABC 
transporter permease  
subtilin spaF(A)/spaE (M)/spaG(M) 
spaF 3212 064 3212777 3.A.1 Lantibiotic 
transporter (A TP-
binding protein)  
subtilin spaF(A)/spaE (M)/spaG(M) 
mrsF 3770 199 3771108 3.A.1 Putative ABC 
transporter, A TP-
binding protein  
mersacidin m rsF(A)/mrsG(M)/mrsE(M) 
mrsG 3771 107 3771863 3.A.1 Putative ABC-
transporter inte gral 
membrane protein  
mersacidin m rsF(A)/mrsG(M)/mrsE(M) 
mrsE 3771 882 3772614 3.A.1 Putative ABC-
transporter inte gral 
membrane protein  
mersacidin m rsF(A)/mrsG(M)/mrsE(M) 
yfiN1 2259 17 227057 3.A.1.X.X Putative ABC-type 
multidrug transport 
system, per mease 
component  
unknown y fiL(A)/yfiM(M)/yfiN1(M) 
A= ATP binding domain 
M= Transmembrane domain 
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